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ABSTRACT
Despite the realisation of the importance of CD28 in T cell activation very little is 
currently known concerning the nature of the costimulatory signals. Research has been 
hampered by the requirement for TCR engagement to enable observation of a 
costimulatory effect, making it difficult to assess the relative contribution of CD28 
signals as distinct from those of the TCR. The observation that activated human T cell 
blasts could be stimulated via the CD28 surface molecule in the absence of antigenic 
challenge thus provided a very useful model for the investigation of costimulatory 
signals in isolation. Utilising SEA-responsive T cell blasts the effects of CD28 
mediated costimulation on IL-2 gene transcription and the signalling pathways 
involved, were investigated.
Whilst stimulation of the quiesced T cell blasts with DR4/B7-SEA transfectants 
induced full activation and IL-2 production the addition of CHO-B7 cells alone resulted 
in time dependent proliferation but no observable IL-2 output. These latter responses 
were shown to be sensitive to inhibition by a number of agents including CsA, 
rapamycin, and the PKC inhibitor Ro 31-8220. Furthermore whilst the acidic 
sphingomyelinase inhibitor, chloroquine completely inhibited all B7 induced 
proliferation, the PI3 Kinase inhibitor, wortmannin was found to have limited effects 
indicating that PI3 Kinase was not a major mediator of the B7-induced proliferation.
A study of transcription factor induction following B7 stimulation revealed the 
existence of two CD28 regulated factors, AP-1 and NFkB; the absence of NFAT 
induction correlating with the lack of IL-2 production. Preincubation of the cells with 
chloroquine inhibited the induction of both factors whilst wortmannin only affected 
AP-1 expression. This suggests that whilst CD28 may signal via both pathways, the 
activation of acidic sphingomyelinase appears to be of greater importance in these 
activated cells.
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CHAPTER ONE - INTRODUCTION
1.0 THE IMMUNE SYSTEM
The highly complex immune system has evolved as a protection against invading 
pathogens. It comprises a number of different cell types with specific functions in the 
mediation of an immune response and it is the interaction between and the controlled 
activation of these cells which confers efficiency and specificity to an immune 
response. One of the major mechanisms by which immune protection is achieved 
involves the processing of foreign antigens and their presentation to thymus-derived 
lymphocytes (T cells) by APCs. This event represents the initiation of an immune 
reaction involving both cell-mediated and antibody-mediated responses and results in 
eradication of the foreign antigen and development of immune memory to aid 
subsequent challenge by antigen.
Several different subsets of T cells have been described including helper (Th) and 
cytotoxic (CTL) T cells, characterised by their expression of surface molecules and the 
effects induced following their activation. Whilst CD8 + CTL cells respond to antigens 
presented by class I Major Histocompatibility Complex (MHC) molecules and 
generally elicit a cytotoxic response following activation, MHC class II reactive CD4+ 
Th cells respond to antigen by cytokine production and activation of bone marrow 
derived lymphocytes (B cells). The CD4+ subset, comprising approximately 60% of 
peripheral blood T lymphocytes, has been shown to play a major role in the specific 
recognition and response to foreign antigens.
1.0.1 ANTIGEN PRESENTING CELLS AND PEPTIDE PRESENTATION
Resting CD4+ peripheral blood T cells whether they are naive (CD45RO-) or memory 
cells (CD45RO+) require two signals for full activation (review Schwartz, 1990). The 
first signal (signal 1) is delivered via the TCR and in vivo is usually triggered following 
the ligation of the TCR by an antigenic peptide bound to a MHC class II molecule on 
an antigen presenting cell (APC). Several different cell types can act as APCs including 
monocytes, activated B lymphocytes and dendritic cells (Yokochi et al., 1982; 
Freedman et al., 1991; Young et al., 1992; Hart et al., 1993). All are positive for the 
Human Leukocyte antigen (HLA-DR) alleles and have the ability to present antigen in 
the context of other required adhesion and costimulatory molecules. In vivo the 
presented antigen is usually a peptide derived from a larger antigenic protein. 
Following invasion of the body by the foreign antigen, the proteins are phagocytosed by 
macrophage-like cells, broken down into smaller peptide fragments, incorporated into
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the peptide binding grooves of the MHC molecules and then presented on the surface of 
the APC. The immunogenicity of each peptide fragment is dependent upon its ability to 
bind an autologous MHC molecule as the TCR recognises the whole complex and not 
just the peptide.
1.0.2 THE TCR AND THE T CELL REPERTOIRE
The TCR is a glycoprotein heterodimer comprising aP or yS chains (review Eckels, 
1990); the former being expressed in 95% of peripheral T cells. The structure of these a  
and P chains closely resembles that of an antibody in that both possess variable (V), 
joining (J) and constant (C) regions, however, the p chain also contains a diversity 
domain (D) (Davis and Bjorkman, 1988). Within the V/Ja and the VDjp domains lie 
three hypervariable regions called the Complementarity Determining Regions (CDRs) 
and it is these which confer the recognition specificity onto the TCR. Studies of the 
interactions occurring between the TCR/ peptide- MHC complex are still in progress 
but it appears that the CDR1 and CDR2 may contact the MHC molecule whilst the 
CDR3 interacts with the peptide (Davis and Bjorkman, 1988). As there are several 
existing alleles for each V, D and J domain the complex mechanism of gene 
rearrangement and recombination of the domains generates extremely large numbers of 
T cells with diverse TCR specificities. However, whilst this enables an individual to 
respond to an enormous range of antigenic peptides, at the same time, the generated T 
cell repertoire includes a large number of potetially autoreactive T cells.
1.0.3 THYMIC SELECTION
An autoreactive T cell is one which recognises an self antigen in the context of a self 
MHC molecule and is therefore potentially harmful to the body. In order to prevent 
self-reactivity, developing T lymphocytes undergo a selection procedure in the thymus 
to remove self or non responsive T cells. Whilst negative selection removes T cells 
which do not recognise autologous MHC, the removal of self-reactive T cells is known 
as positive selection or clonal deletion (Kappler and Marrack, 1987) and results in the 
death of T cells which respond to self antigen-MHC presented by thymic APCs. 
Although very little of this process is currently understood it does appear to be the 
major mechanism for the removal of autoreactive T cells and occurs during 
development prior to the release of the thymocytes into the periphery.
1.0.4 TOLERANCE
There is evidence indicating that some self reactive cells escape selection and procede 
to the periphery. However, it appears that their activation is usually suppressed by as
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yet little understood mechanisms, broadly classified as peripheral tolerance. This was 
originally thought to involve a third defined subset of T cells known as suppressor cells 
although the existence of such cells has been difficult to demonstrate. An alternative 
mechanism proposed for the functional suppression of such cells is clonal anergy which 
is discussed in more detail below. Since potentially autoreactive cells can be detected in 
the peripheral blood of normal healthy individuals an active suppression process must 
be occurring. Unfortunately occasionally a lapse in peripheral tolerance or a direct 
activation of self-reactive T cells occurs which can result in the onset of autoimmune 
disease. Rheumatoid Arthritis is a common example during which an immune response 
is mounted against the joints resulting in a very painful and crippling disease.
The reason for a failure in peripheral tolerance is not known but it is unlikely that there 
is a single cause. Since two signals are required for T cell activation the failure could 
reside with either the antigen or the costimulatory molecule. Epitope mimickry whereby 
the self antigen/ MHC complex resembles an antigenic peptide has been proposed as 
one possible mechanism whilst tissue injury can result in the exposure of self antigens 
not encountered and selected against in the thymus. Alternatively self-reactive T cells 
may be activated if they encounter high concentrations of self antigen in the presence of 
aberrant costimulatory molecule expression. Numerous studies have been carried out to 
attempt to establish the trigger factors and although some progress has been made with 
the identification of susceptibility markers the discordancy of autoimmune disease in 
families and twins argues against a purely genetic aetiology and implies the additional 
involvement of an environmental trigger (Zanelli et al., 1995). Research has shown that 
different MHC class II alleles can present an antigen in different ways which may result 
in an alteration of the immunogenicity of the peptide. This has been demonstrated in 
patients with R.A who, compared to the general population, have a predominance of 
HLA-DR4Dw4 and HLA-DRlDwl alleles (Zanelli et al., 1995). This implies that such 
alleles may be more efficient at presenting self joint peptides and these are now 
regarded as susceptibility markers for the disease. In contrast other alleles have been 
demonstrated to have protective effects including HLA-DR2, HLA-DR7 and HLA-DR8  
(Zanelli et al., 1995). However, these genetic markers are not absolute and as the 
identity of the trigger factors are still not known further research is required before 
effective treatments of such autoimmune diseases will be possible.
1.0.5 ANERGY AND APOPTOSIS
Activation of the TCR in the absence of a second or costimulatory signal results in the 
cell becoming hyporesponsive or anergised (review Schwartz, 1993) which has been 
observed in a number of in vitro models. Jenkins et al (1990) characterised the anergic
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state as a failure of aCD3-stimulated resting T cells to respond to further stimulation 
and a lack of IL-2 production, whilst Lamb et al (1983) demonstrated similar effects in 
peptide-stimulated T cell clones. Interestingly the stimulation of T cells using fixed 
APCs also induces anergy, presumably due to the inability of these cells to upregulate 
the costimulatory molecules following TCR/MHC ligation (Jenkins and Schwartz, 
1987). Anergy can be reversed by incubation of the cells with interleukin-2 (IL-2) 
(Beverly et al., 1992) and is thought to be a protective mechanism to prevent T cell 
activation in inappropriate situations. Clonal anergy has been proposed to be the major 
mechanism involved in the maintenance of peripheral tolerance, induced in autoreactive 
T cells when encountering self antigen in the absence of a costimulatory molecule. The 
induction of anergy may also underlie the mechanism of natural and induced tolerance 
since in vivo challenge with antigen alone has been shown to result in a long term 
hyporesponsiveness to the antigen. This phenomena is currently being investigated as a 
possible treatment for allergy (Yssel et al., 1994).
A second mechanism for downregulation of a cell is apoptosis or programmed cell 
death (PCD) (MacDonald and Lees, 1990; Cohen et al., 1992). This is an active 
process, distinct from normal cell necrosis, during which the cells receive specific 
stimuli causing the condensation of DNA, chromosomal degradation and budding of the 
nuclei followed by a disintegration of the cell. Several molecules have now been 
identified which can positively (e.g Fas, TNF, CTLA-4) (Itoh et al., 1991; Alderson et 
al., 1995; Dhein et al., 1995; Smith et al., 1994; Schultz-Osthoff et al., 1994; Gribben et 
al., 1995) or negatively (bcl-2) (Boise et al., 1993b; Bissonette et al., 1993) regulate the 
apoptotic process. This is a rapidly expanding field which is too complex for a detailed 
discussion here although several recent observations indicate that the factors regulating 
T cell activation and apoptosis show considerable overlap. TCR induction alone has 
been reported to upregulate Fas ligand on the surface of T cells whilst CTLA-4 is 
bound by the CD28 ligands B7-1 and B7-2 and appears to activate similar signalling 
pathways. Thus the outcome of T cell stimulation seems to be far more complex than 
which surface molecules are ligated and may involve interactions between several 
intracellular signalling pathways.
1.1 COSTIMULATION
The required second signal necessary for full T cell activation is provided by a 
costimulatory molecule. As demonstrated by experimental data, candidate molecules 
for such a costimulatory task must satisfy a number of specified criteria. These were 
summarised by Jenkins et al (1988) as: a) the ability to provide costimulation from a 
cell not providing signal 1 b) the ability to provide a signal which can synergise with
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CD3 stimulation resulting in proliferation and c) the ability to generate a signal which is 
time dependent in its ability to induce proliferation. One candidate costimulatory 
molecule meeting these criteria is CD28, a 44kDa homodimeric surface molecule 
expressed constitutively on 95% of CD4+ T cells (June et al., 1990; Turka et al., 1990). 
Engagement of CD28 by its ligand B7 has been proposed as the main costimulatory 
signal in the activation of resting T cells (Linsley et al., 1991a; Gimmi et al., 1991) 
although the discovery of secondary ligands for both CD28 (B7-2) (Freeman et al., 
1993b; Azuma et al., 1993) and B7 ( CTLA-4) (Linsley et al., 1991b) has now made the 
situation more complex. A diagram summarising the interaction of these different 
molecules is shown in figure 1 .0 .
The criteria specified above discount adhesion molecules as costimulators. Although 
these molecules appear to be able to synergise with CD3 stimulation to induce 
proliferation, they are only effective on the same cell as the MHC class II molecule 
therefore the purpose of many of these adhesion molecules may simply be to bring the 
two cells into close proximity for the stimulatory interactions to occur. Varying abilities 
of B7 and LFA3 to costimulate anti-CD3 - induced responses were detected by Sansom 
et al (1993) depending upon the origin of signal 1. Using purified T cells only B7 could 
costimulate an anti-CD3 signal whilst both B7 and LFA3 could costimulate the lectin, 
phytohaemagglutinin (PHA), with an additive signal observed if given in combination. 
Stimulation with the superantigen Staphylococcal enterotoxin B (SEB) required the 
presence of a class II MHC molecule and whilst both B7 and LFA3 could costimulate 
this signal if on the same cell, only B7 was operative from a third party cell. Such 
findings indicate a complex interaction of different signalling pathways and a 
requirement for synergy to induce a full activation response. Lucas et al (1995) 
demonstrated that naive T cells, deficient in CD28, could be induced to proliferate 
using high concentrations of antigen alone. The response was vigorous but short lived 
and proliferation ceased completely after 48 hours, furthermore, no IL-2 was produced 
by the cells during the stimulation. Addition of a B7 costimulation to CD28+ cells 
decreased the concentration of antigen required and resulted in a prolonged 
proliferation and IL-2 production.
1.1.1 B7-1
The first identified ligand or counter receptor for CD28, B7/ BB-1 (CD80) was a 30 
kDa, type 1 transmembrane glycoprotein. This is a member of the immunoglobulin 
superfamily, having two immunoglobulin (Ig) like extracellular domains consisting of a 
single ' V1 domain and a single Ig constant domain (Freeman et al., 1989). B7-1 was 
first described as an inducible B cell antigen whose expression could be induced by a 
number of factors including class II MHC ligation with TCR, cAMP and Interferon y
(IFNy). It has been detected on many types of APCs and also on repeatedly activated T 
cells (Sansom and Hall, 1993) but in contrast to the constitutive expression of CD28 on 
resting T cells, B7 is only expressed on activated APCs. Increased expression of B7 
after MHC class II/ TCR binding implies there may be functional signal transduction 
through the MHC molecule as well as via the TCR (Nabavi et al., 1992). Upregulation 
of B7 was also observed in cultured dendritic cells which had not been directly 
stimulated but may have responded to cytokines produced by other cell types (Hart et 
al., 1993). An example of this was observed on stimulation of B cells with IL-2 and IL- 
4 which both induced B7-1 expression whilst IL-7 has been shown to upregulate B7 
levels on activated T cells (review June et al., 1994).
The requirements for B7 in T cell activation have been investigated by numerous 
groups (Gimmi et al., 1991; Harding et al., 1992; Linsley et al., 1991a) and have 
involved the use of stimulatory and blocking monoclonal antibodies to CD28 as well as 
CTLA-4 Ig fusion molecules. The CTLA-4 Ig chimeric constructs comprise the 
extracellular domain of the second B7 ligand, CTLA-4, with the constant region of the 
IgGl heavy chain. This forms a non- stimulatory, soluble complex with a high affinity 
for the B7 molecules which will block interactions between B7 and CD28. Addition of 
this complex during alloantigenic challenge has been shown to result in a 
hyporesponsive state or anergy (Linsley et al., 1992b). Furthermore long term survival 
of both allogeneic and xenogeneic grafts have been observed in costimulatory deficient 
transplants (Lenschow et al., 1992) hence B7-blocking molecules may have an 
important role to play in immunotherapy. Conversely, transfection of tumours to induce 
overexpression of B7 has been found to decrease tumour growth and promote recovery 
(Townsend and Allison, 1993), however, the mechanism behind the latter appears to be 
more dependent upon cytolytic CD8 + T cells. Although activated by the tumours 
bearing antigen on class I MHC, the lack of costimulation makes the CD8 + cells 
dependent upon CD4+ help for IL-2 and proliferation. Transfection of B7 into the 
tumour cells provides the missing costimulation resulting in CD8 + cell IL-2 production 
and clonal expansion followed by cytolysis of the tumour cells. Interestingly further 
challenge with B7-negative tumour cells also resulted in cytolysis due to the presence 
of the preactivated CD8 + cells and cross reactivity of the tumour antigens suggesting 
tumour immunisation. Thus B7-1 would appear to be an extremely important regulator 
of the T cell activation process and may therefore be a major target for manipulation of 
the immune system.
1.1.2 B7-2
The second CD28 ligand to be described, B7-2 (CD8 6 ) is a 70kDa glycoprotein, which 
although a member of the same immunoglobulin family, shows limited sequence
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homology to B7-1 (Azuma et al., 1993). In contrast to B7-1, B7-2 is expressed 
constitutively on the surface of resting monocytes and dendritic cells and on activated 
lymphocytes and therefore may be the first ligand encountered by CD28 during the 
activation process.
Studies comparing the effects mediated by the two B7 molecules have produced 
conflicting results. Lanier et al (1995) could find no differences in the T cell responses 
to B7-1 or B7-2 with regards to their ability to costimulate proliferation, cytokine 
production and the generation of cytotoxic lymphocytes (CTL). However, two groups 
have reported that B7-1 and B7-2 differentially activate T helper cell (Th) subsets. 
Although equal stimulators of IL-2, IL-2 receptor (IL-2R) and IFNy, B7-2 is capable of 
inducing much higher levels of IL-4, especially in naive cells, which has the effect of 
pushing the cells towards a Th2 phenotype (Freeman et al., 1995). Kuchroo et al (1995) 
found that administration of B7-1 or B7-2 specific antibodies to an EAE model could 
also influence the outcome of the disease. Whilst blocking B7-1 decreased the disease 
incidence, blocking B7-2 increased the disease severity. This is consistent with B7-2 
driving the protective Th2 phenotype and B7-1 the inflammatory mediating Th-1 
subset. However, during an allergic reaction it is the Th2 subset which mediates the 
hypersensitivity response (Yssel et al., 1994) whilst the Thl subset is protective. 
Further research is required to confirm these differences but if correct the information 
may be able to be utilised in the design of more specific therapeutic treatments for the 
control of autoimmune disease.
1.1.3 CD28
The human CD28 gene is arranged into 4 exons resulting in four different mRNA 
transcripts depending upon the gene splicing. The first pair, 3.7 and 3.5kbp have poly 
adenylation extensions compared to the second pair, 1.5 and 1.3kbp. The difference 
within the pairs represents the extracellular domain deletion encoded for in exon 2 (Lee 
et al., 1990). The CD28 gene possesses an AP-1 transcription factor regulatory binding 
site in the 5' untranslated region which explains its inducibility by phorbol esters, 
however, under more physiological conditions the CD28 gene is regulated by TCR- 
derived signals and B7 ligation. CD28 levels rise following T cell activation through 
the TCR, presumably to increase the cells ability to receive costimulation. Following 
B7 ligation of CD28 there is a transient decrease in CD28 mRNA lasting 4-24 hours 
accompanied by a slower but more prolonged decrease in surface expression of the 
molecule (Linsley et al., 1993).
It has long been known that CD28 exerts one of its costimulatory functions via 
stimulation of IL-2 production. This is achieved in two ways; the first by a direct effect
on IL-2 gene transcription and the second by a stabilisation of the IL-2 mRNA. Little is 
known about the mechanism controlling the latter although it is believed to involve a 
CD28-mediated inhibition of mRNA degradation which relies on an AU rich region at 
the 3' terminus of the mRNA (Lindsten et al., 1989b). Details of the effects of CD28 on 
gene transcription will be discussed further.
CD28 also appears to have a direct effect on the expression of the IL-2R; a trimeric 
complex comprising the ot,p and y subunits. Different affinity receptors have been 
identified and associated with different combinations of the subunits. The high affinity 
receptor comprises all three subunits whilst the intermediate, Py and the low affinity 
receptor only a . The latter appears to be a sink for excess IL-2 since the p and y 
subunits are required for receptor internalisation and signalling (reviewed by Taniguchi 
and Minami, 1993). The P subunit is also shared with the IL-15 receptor (Giri et al., 
1994) and may explain similarities in the properties of the two cytokines. Unlike the p 
subunit which is expressed constitutively, the a  subunit is only expressed after 
stimulation. This upregulation can be induced by CD28 alone but is considerably 
enhanced in level and duration by the concomitant stimulation of CD2 (Cerdan et al., 
1992). This combination of signals also stimulates increased IL-2Rp expression via 
mechanisms which again seem to involve gene transcription and mRNA stabilisation. 
However, the IL-2Rp mRNA does not bear the usual AU rich sequence required for 
CD28 mediated stabilisation so how this is achieved is not yet known. The increase in 
IL-2RP occurs slightly later than the upregulation of IL-2Ra but can be explained by 
the differences in the critical regulatory transcription sites. IL-2Roc transcription 
depends upon activation of an NFkB motif within its promoter region to increase gene 
transcription (Arima et al., 1992) whereas the IL-2Rp subunit is dependent upon an Ets 
binding site (Lin et al., 1993). The significance of these differences have yet to be 
realised.
As well as an effect on IL-2 and IL-2R, CD28 can also regulate the levels of numerous 
other cytokines including IL-3, IL-5, IL-10, GM-CSF, TNFa, IFNy and IL-4. The 
increase in IL-4 production following CD28 activation is moderate compared to its 
effects on IL-2 but appears to be more pronounced in cells with a low IL-2 output. 
Interestingly the production of IL-4 appeared to be mediated via IL-2 as an inhibitory 
mAb to IL-2 and IL-2R decreased the observed levels of IL-4. This also appeared to be 
true for the other reported CD28-regulated cytokines IL-5, IL-10 and IFN-y (Kuiper et 
al., 1994b). However, CD28-responsive elements (CD28RE) have been identified in the 
gene promoter regions of EL-3, GM-CSF and EFN-y (Fraser and Weiss, 1992) indicating 
a direct effect on the gene. Further research is therefore awaited to clarify these effects.
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1.1.4 CTLA-4
CTLA-4 was discovered following a search for T cell surface antigens which were 
involved in cytotoxicity (Brunet et al., 1987) during which, closer examination of this 
molecule revealed significant homology to the costimulatory molecule CD28. Both are 
members of the immunoglobulin supergene family with a single extracellular ' V' - like 
domain and map to the same region of the human genome, chromosome 2q33. Their 
similarities in structure, sequence homology and gene location point to an evolutionary 
gene duplication (Harper et al., 1991).
Until very recently the knowledge of the properties of CTLA-4 was little more than a 
series of apparently contradictory, isolated observations. Unlike CD28, CTLA-4 
expression levels on resting T cells are extremely low but can be increased by 
activation of the cells with a combination of TCR and CD28 mediated signals. The 
increase in expression is slow and only becomes maximal after 48-72 hours. Even at 
this stage CTLA-4 expression is only 2-3% of CD28 expression (Linsley et al., 1992a). 
This may appear so insignificant as to be irrelevant until it is realised that the avidity of 
CTLA-4 for the CD28 ligands B7-1 and B7-2 is 20-100 fold higher than for CD28 itself 
(Linsley et al., 1991b). It may therefore be unnecessary for the expression levels of 
CTLA-4 to be that high in order to achieve a maximal response.
The effects of CTLA-4 stimulation are still a matter of conjecture. In vitro studies have 
indicated both stimulatory and inhibitory effects for CTLA-4 activation. Krummel and 
Allison (1995) found that in the presence of immobilised anti-CD3, soluble CTLA-4 
mAb synergised with and potentiated the proliferative effect of anti CD28. However, if 
the CTLA-4 and CD28 mAbs were also immobilised proliferation and IL-2 production 
was inhibited. Several reports have indicated that unlike CD28, stimulation of CTLA-4 
leads to apoptosis (Gribben et al., 1995) and in further support of this are two recently 
published studies concerning the fatal lymphoproliferative disorders observed in a 
strain of CTLA-4 deficient mice (Waterhouse et al., 1995; Tivol et al., 1995). Thus it 
now appears evident that CTLA-4 has a negative regulatory role in the control of T cell 
activation and proliferation, however, further detailed studies will be necessary to 
elucidate the differences in the signalling pathways of CD28 and CTLA-4.
Like CD28 CTLA-4 has been shown to bind both B7-1 and B7-2 and does not appear to 
significantly differentiate between the two in terms of affinity. A rather surprising 
discovery was the higher affinity of CTLA-4 for the B7 ligands, compared to that of 
CD28, since it had been thought that CD28, due to its high level of expression, would 
play the major role. However, when considering the constitutive expression and 
inducibility of the ligand pairs it would appear that CD28 may be the primary ligand for
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B7-2 whilst the CTLA-4 / B7-1 interaction could occur 48-72 hours after activation 
when the surface expression of these inducible molecules is maximal. Due to its 
delayed expression it appears the role of CTLA-4 could be secondary to the initial 
CD28 costimulation and may cause the termination of the proliferative response.
Many of the CD28/ B7-1 costimulation studies carried out so far have involved the use 
of gene knockout or transgenic mice. These provide an invaluable tool for the study of 
the importance of these molecules and the roles they play in T cell activation. Whilst 
B7-1 deficient mice appeared, developed and reacted normally to antigenic challenge 
(Freeman et al., 1993a), CD28 deficient mice showed a considerably impaired immune 
response (Shahinian et al., 1993). This provides further evidence indicating that CD28 
can be activated by alternative ligands other than B7-1 whilst the presence of a 
functional CD28 receptor is an absolute requirement of an efficient immune system and 
gives credence to the theory that the CD28/ B7-2 interaction may be the primary and 
most essential costimulus in the activation process.
1.2 SIGNAL TRANSDUCTION
To obtain a greater appreciation of these activation molecules and how they function it 
is necessary to understand the mechanisms by which surface receptor stimulation 
effects a change in the activation state of the cell. Downstream signalling from surface 
receptors can be organised into a series of linear signalling pathways which ultimately 
converge to affect gene transcription. However, several key proteins have been 
identified including the GTP-binding protein, ras and the mitogen activated family of 
serine /threonine kinases (MAPK) which appear to impinge upon a number of different 
pathways and may act as junction switches to control the final outcome of the surface 
receptor stimulations.
1.2.1 TCR-CD3 SIGNALLING
Interactions between the TCR/ CD3 complex on the T cell and the MHC class II 
molecule initiate a complex series of events which result in activation of the T cell, 
lymphokine production and proliferation. Gradually the mechanisms of this signalling 
cascade have been unravelled although with the discovery of each new protein kinase or 
phospholipase the overall picture becomes an ever more complex network of interacting 
and overlapping pathways. However, the physiological significance of these different 
pathways and the mechanisms by which they are triggered remains to be elucidated. 
Stimulation of the TCR/ CD3 complex in conjunction with the CD4 molecule leads to 
activation of phospholipase Cyl (PLC) resulting in the production of inositol 
triphosphate (IP3 ) and diacylglycerol (DAG). The former promotes the release of
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calcium from intracellular stores whilst the latter activates PKC. Although the pathways 
diverge at this point they reconverge downstream in the activation of the transcription 
factor NFAT, a DNA binding complex comprising a PKC-induced nuclear subunit and 
a constitutive cytoplasmic subunit which is translocated to the nucleus following 
calcium stimulation. This general overview of TCR signalling is summarised in figure
1. 1.
Research undertaken recently has shown this description of TCR signalling to be a 
considerable oversimplification and although the picture is not yet complete several 
gaps in our knowledge have been filled. The first discovery was that the TCR/ CD3 
complex actually comprises seven different subunits. The majority of CD4+ helper T 
cells express the ap  heterodimeric TCR, although the existence of $  populations are 
known. The ap  molecule is responsible for the specific recognition of and interaction 
with the antigenic peptide in the MHC class II groove. The cytoplasmic tails of these 
ap chains, however, are extremely short and do not participate in signal transduction; a 
job which falls to the coassociated CD3 invariant chains. Five different chains have 
been described y, 8, £, £ and v which associate non covalently with each other and with 
the aP TCR. These chains have a dual purpose being required for the assembly and 
surface expression of the TCR as well as transducing the signal initiated by antigen 
recognition. One common feature of the cytoplasmic tails of these molecules is the 
presence of a highly conserved signalling motif. Originally known as the Reth motif, it 
is now more commonly referred to as the TAM (tyrosine - activated motif ) or the 
ARAM (antigen recognition activation motif) sequence (Reth, 1989). The sequence 
consists of paired tyrosine and leucine or isoleucine residues in the form Y-XX-L-X7 -8 - 
Y-XXL. Whilst the majority of ARAM containing proteins carry one copy of the 
sequence the CD3 £ and v chains carry multiple copies, three and two respectively 
(Sancho et al., 1993). Coupled with the fact that the £ chain can function in a number of 
homo and heterodimeric forms (£-£, £— and £-y) the indication is that this may 
operate as the main signal transducing molecule. Studies carried out in transformed cell 
lines using chimeric CD8a /CD3 £ constructs showed that antibody induced ligation of 
CD3 £ was sufficient to induce T cell activation as measured by tyrosine 
phosphorylation, calcium flux and IL-2 production (Koysau et al., 1994). However, 
Brocker and Karjalainen (1995) later proved that this was not the case for resting T 
cells which required full receptor stimulation and costimulation to induce activation. 
This group also showed, however, that previously activated T cells behaved in a similar 
fashion to transformed cells indicating that once the activation has been initiated fewer 
signals are required to maintain the activated state. Further studies of the function of the 
ARAM motif indicated a requirement for phosphorylation on the tyrosine residues prior 
to the association with the SH2 domains of the Syk- family protein kinase ZAP-70 (^
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associated protein) (Chan et al., 1992). This phosphorylation is thought to be carried out 
by the src family kinases lck and fyn (Chan et al., 1995).
1.2.2 PROTEIN TYROSINE KINASES
Protein tyrosine kinases can be subdivided into two families; the membrane associated 
src family comprising p56 lck and p59 fyn (reviewed (Rudd et al., 1994)) and the 
cytoplasmic syk family comprising syk and ZAP (Chan et al., 1994). ZAP-70 is 
required for T cell development and TCR function and can associate with any tyrosine 
phosphorylated ARAM containing protein via its two SH2 domains although the 
association with CD3 £ is best described. ZAP-70 itself undergoes phosphorylation on 
tyrosine 493 following TCR activation resulting in catalytic enzymatic activity and it is 
proposed that this phosphorylation event is undertaken by a src family kinase, probably 
p56 lck (Chan et al., 1995). The src family members lck and fyn contain both SH2 and 
SH3 domains and membrane-associate via cotranslational myristylation and post 
translational palmitylation (Chan et al., 1995).
The associations occurring between these various tyrosine kinases appear rather 
complex. The CD3£ chains require phosphorylation before they can bind ZAP which 
itself requires phosphorylation in order to bind lck which has been proposed as one of 
the main candidates for the original phosphorylations of CD3£. Another candidate p59 
fyn has been found to associate with the CD3 chains in resting cells via the ARAM 
sequences, however, its binding requirements appear to be less specific than those 
observed for ZAP. Single mutations within the ARAM motif had little effect upon fyn 
binding but completely abrogated ZAP associations. Furthermore single base pair 
deletions disrupted ZAP binding but not that of fyn (Timson-Gauen et al., 1994). One 
possible explanation is that fyn association is more dependent upon the interaction 
between its associated fatty acids and the secondary structure of the ARAM motif than 
on the binding of specific amino acid residues within the motif.
Lck binds to the CD4 molecule whilst fyn is TCR associated but both have been shown 
to associate with a presently unidentified 120kDa protein in unstimulated Jurkat cells 
via SH3 domain binding (Reedquist et al., 1994). Phosphorylation of this 120kDa 
molecule is apparently one of the first signalling events, occurring within 1 0  seconds of 
CD3 stimulation and peaking at 30 seconds. It is thought that the phosphorylated 
protein may then interact with the SH2 domains of the PTKs in order to transduce 
further signals. These interactions between the TCR/ CD3 complex and the associating 
PTKs are shown in figure 1.2 along with the structure of the PTK binding domains.
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1.2.3 THE ROLE OF PKC
Currently the exact nature of the signals transduced by the PTKs is not known and 
although it is possible to identify downstream targets of TCR signalling the links 
between them are still somewhat uncertain. Much of the signalling data has been 
confused by studies carried out in a variety of T cell types. It is clear that the 
operational signalling pathways in immortal transformed cell lines such as Jurkats vary 
considerably from those observed in T lymphoblasts which again may vary from resting 
peripheral T lymphocytes. Such an example is the effect of PKC activation on the TCR 
induced calcium signal as investigated by Cantrell et al (1989). Following TCR ligation 
intracellular calcium levels rise by two mechanisms. The first involves a release of 
calcium from intracellular stores by IP3 , a metabolite of PIP2  hydrolysis mediated by 
PLC, whilst the second mechanism is via an influx of calcium from outside the cell 
through membrane channels. In Jurkat cells PLC activation appears to be inhibited by 
PKC whereas in T lymphoblasts PKC activation has no direct effect on IP3  levels 
(Ward and Cantrell, 1990). The reason for this difference is still unknown although 
studies of enzyme heterogeneity have indicated differences in PKC and PLC isotypes in 
the two cell types. Currently at least eleven different PKC isotypes have been identified 
(Hug and Sarre, 1993) which can be subdivided into three groups. The first comprising 
a , Pi, P2  and y are calcium dependent and can be activated by phorbol esters. The 
second group 5 , e, v and T are calcium independent but still respond to phorbol esters 
whilst the final three PKC £, X and 1 are calcium independent and phorbol ester 
insensitive. Differences between members of the same group have yet to be elucidated. 
The main isotype in Jurkat cells appears to be PKCa whilst the p form is more 
predominant in T lymphoblasts. The significance of this difference has not yet been 
elucidated although considering the involvement of PKC enzymes in regulating 
intracellular pathways it may account for a number of the abnormal responses observed 
in most immortal cell lines in response to phorbol ester stimulation.
1.2.4 THE MAPK CASCADE
It is not yet known what role PKC has in the activation of the downstream signalling 
molecule ras which appers to be at the start of a number of protein kinase cascades. At 
present the literature is still confusing with various studies claiming PKC to be 
upstream and/ or downstream of ras signalling (Williams et al., 1995).
Ras is a 21kDa GTP binding protein which is responsible for the activation of the 
MEKK, raf-1, by mediating its translocation from the cytoplasm to the plasma 
membrane (Leevers et al., 1994). Ras itself is activated by SOS, a nucleotide exchange 
factor which converts the inactive GDP bound ras to an active GTP bound form which
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can then bind the amino terminal regulatory domain of raf-1 (Daum et al., 1994). 
Inactive ras is regenerated by GAP (Kazlauskas, 1994). At the membrane the ras bound 
raf- 1 undergoes activation by an as yet unknown mechanism involving phosphorylation 
on a number of serine/ threonine and tyrosine residues. One suggested candidate for the 
serine/ threonine phosphorylations is PKC a  (Daum et al., 1994) whilst the src kinases 
may be responsible for the tyrosine phosphorylation. Ras activation of raf-1 begins the 
serine/ threonine protein kinase cascade consisting of a series of phosphorylation 
reactions each activating the next downstream kinase. The target of raf is MEK or 
MAPKK (Jelinek et al., 1994), a dual specificity kinase which can phosphorylate both 
threonine and tyrosine residues of MAPK which appears to be an important molecule in 
the signalling pathway. Two members of the MAPK family which have been isolated 
are named ERK-1 and ERK-2 (review Ruderman, 1993). Their targets are numerous 
but all appear to have the role of releasing the cell from cycle arrest. They include the 
phosphorylation of the regulatory TCF/ Elk-1 component of the c-fos gene promoter 
(Marais et al., 1993) and phosphorylation of the serine/ threonine kinase pp90RSK S6  
kinase (Erikson, 1991), not to be confused with the p70 S6  kinase to be discussed later. 
A current overview of the TCR-associated signalling pathways is given in figure 1.3.
1.2.5 THE JNK SIGNALLING PATHWAY
In addition to c-fos activation the MAP kinases have also been implicated in the 
phosphorylation of c-jun although this was shown not to be mediated by ERK but by 
other members of the MAPK family, the c- jun amino terminal kinases , JNK1 and 2 
(Hibi et al., 1993). A study by Su et al (1994) showed that whilst the MAP kinases 
could be activated via PMA or TCR signals alone, JNK activation required two signals. 
These could be provided by PMA and ionomycin or physiologically following TCR and 
CD28 ligation. This was confirmed by a sensitivity of JNK activation to CsA and that 
PMA alone or constitutive ras only resulted in a partial induction of JNK. This latter 
observation of a single stimulus producing partial induction, however, was made in 
Jurkat cells and may not be representative of normal T cells. The requirement for two 
signals to induce full activation of the enzyme and the induction observed in the 
presence of TCR and CD28 ligation indicates that JNK may have an important role in 
the integration of these two major signalling pathways. In support of this, investigations 
concerning the role and activation of the JNK have revealed that they are implicated in 
the responses to growth factors and other environmental stimuli (Coso et al., 1995) and 
appear to be activated under conditions of cell stress hence their original nomenclature 
of stress activated protein kinases (SAPK). As well as TCR and CD28 several other 
surface stimuli have been identified which are able to activate JNK including TNFa, 
IL-1, UV light and heat shock. Although little is known about the signalling pathway 
mediated by these molecules it appears to involve the ras- like GTPases Cdc42 and
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Rac-l(Coso et al., 1995; Minden et al., 1995). The target of Cdc42 and Rac-1 appears 
to be a new kinase PAK which in turn activates MEKK, SEK(JNKK) and finally SAPK 
/ JNK. Activation of JNK leads to phosphorylation of the amino terminus of the 
transcription factor c-jun which is discussed in more detail later.
1.3 CD28 SIGNALLING PATHWAYS
Currently very little is known concerning the signalling pathways activated following 
CD28 engagement although early studies showed an insensitivity to cyclosporin A 
(CsA) indicating a calcium independent pathway (reviewed in June et al., 1990). Since 
like the TCR, CD28 has no intrinsic kinase activity, co-immunoprecipitation of several 
tyrosine phosphorylated proteins after B7 ligation implied association with a protein 
tyrosine kinase (PTK). The identity of this kinase is still unknown although the src 
family kinases are the main proposed candidates (reviewed Rudd et al., 1994; Raab et 
al., 1995; Lu et al., 1992). Recently, however, several signalling molecules associated 
with CD28 have been identified and are summarised in figure 1.4.
1.3.1 PHOSPHATIDYLINOSITOL-3-KINASE (PI3 KINASE)
The first important discovery was the detection of PI3 Kinase products following CD28 
receptor stimulation (Ward et al., 1993). This led to further investigations and the 
subsequent demonstration of the association between CD28 and PI3 Kinase (Prasad et 
al., 1994), hence the proposal of PI3 Kinase as a major participant in the signal 
transduction pathway of CD28.
PI3 Kinase is a heterodimeric lipid kinase molecule which phosphorylates the 
membrane lipid phosphatidylinositol on the 3 position of the inositol ring (see figure 
1.5). This leads to the generation of a number of different D-3-phosphoinositides 
including phosphatidylinositol-(3)-monophosphate (PtIns(3)P), phosphatidylinositol- 
(3,4)-bisphosphate (PtIns(3 ,4 )P2 ) and phosphatidylinositol-(3,4,5)-trisphosphate 
(PtIns(3,4,5)P 3 ). Whilst all of these molecules have been implicated as messengers in 
a number of signalling pathways the (3,4,5) trisphosphate form appears to be the most 
active molecule although the details of its exact targets are still unclear.
PI3 Kinase itself comprises two subunits; the p85 regulatory subunit containing two 
SH2 domains and one SH3 domain and the pi 10 catalytic subunit (Hiles et al., 1992). 
Analysis of target specificity indicate the SH2 domains bind a core phosphotyrosine 
motif, YMNM such as is found in the cytoplasmic tail of the CD28 molecule (Prasad et 
al., 1994) and PI3 kinase recruitment to CD28 has been demonstrated in 
immunoprecipitates of the CD28 molecule following antibody or B7 ligation. The
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association is rapid, occurring within 30 seconds of CD28 engagement and has a 
duration of at least 30 min (Lu et al., 1995). Much of the data concerning CD28 / PI3 
Kinase association and function was elucidated with the aid of the enzyme inhibitor 
wortmannin. This compound, a fungal metabolite, was found to inhibit the catalytic 
activity of PI3 Kinase by blocking the ATP binding site on the pi 10 subunit but it does 
not, however, prevent CD28 recruitment of the kinase (Ward et al., 1995). For a long 
time the intermediate steps between PI3 Kinase binding and the downstream targets of 
CD28 signalling remained unknown although with the recent discovery of protein 
kinase B (PKB) (Burgering and Coffer, 1995) and S6  kinase (reviewed Downward, 
1994) the identity of at least some of these targets at last appear to be emerging. 
Furthermore Racl has recently been shown to be another downstream target of PI3 
Kinase signalling (Hawkins et al., 1995) and may explain the ability of CD28 to 
regulate JNK activation.
The serine/ threonine kinase PKB (c-akt), as expected, has sequence homology to the 
other protein kinases PKA and PKC. It was discovered as the cellular homologue of the 
viral transforming protein v-Akt and was found to be activated following PDGF and 
EGF receptor stimulation. Interestingly PKB activation was also found to be sensitive 
to inhibition by wortmannin, placing it as a possible downstream target of PI3 Kinase. 
The cell cycle regulator p70S6 kinase is activated by serine / threonine phosphorylation 
and has been shown to be regulated by both the EGFR and by phorbol esters (reviewed 
Erikson, 1991). These data taken in combination with the sensitivity of S6  kinase to 
wortmannin led to the hypothesis that PI3 Kinase activation of PKB via the production 
of D -3- phosphoinositides may in turn activate p70S6 kinase. Much of this hypothesis 
is based on studies conducted using constitutively activated and dominant negative 
mutant PKB constructs (Burgering and Coffer, 1995). Furthermore since it is already 
known that p70S6 kinase activation can be inhibited by rapamycin binding to its target 
protein and that phorbol ester stimulation of S6  kinase is rapamycin but not wortmannin 
sensitive (Chung et al., 1994) the current hypothesis is that PI3 Kinase may activate 
PKB which in turn triggers target of rapamycin to activate S6  kinase. Further research 
will be necessary to confirm this sequence and many of the specific details of 
interactions have yet to be elucidated.
One recent study carried out by Hutchcroft et al (1995) found that treatment of Jurkat 
cells with PMA actually inhibited the recruitment of PI3 Kinase to CD28 without 
affecting the downstream effects of CD28 on IL-2 production. PMA was thought to 
exert its effects by serine/ threonine phosphorylation of a target site on the CD28 
cytoplasmic tail close to the PI3 Kinase binding site as demonstrated in vitro and was 
unaffected by the addition of wortmannin. Unfortunately the study was not carried out 
in normal T cells so it is not possible to establish whether this is a peculiarity of the
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transformed cell line or whether it is a feature of all activated cells that PI3 Kinase 
recruitment is not required for IL-2 production. Previous studies have shown a 
significant inhibition of proliferation and IL-2 production in resting T cells by 
wortmannin although activated cells appeared less affected (Ueda et al., 1995). Since 
IL-2 production was not inhibited in the Jurkat cells this may indicate another role for 
PI3 Kinase in cellular activation other than in the regulation of IL-2 gene transcription.
1.3.2 THE SPHINGOMYELINASE PATHWAY
A very recent discovery concerning CD28-mediated activation of the enzyme 
sphingomyelinase, has revealed a possible second signal transduction pathway. Since 
the sphingomyelin signalling pathway was first described by Okazaki et al in 1989 it 
has been linked to the signal transducing abilities of several important surface receptors 
including Fas, TNFa and IL-lp (Cifone et al., 1993; Dressier et al., 1992; Mathias et 
al., 1993). This appears rather contradictory since, in some circumstances, activation of 
these molecules has been shown to result in growth arrest and apoptosis whilst CD28 is 
a potent pro-proliferative, costimulatory molecule. However, since in the presence of 
additional signals TNF and IL-1 have also been shown to be stimulatory (Smith et al., 
1994; Muegge et al., 1989) it appears that the outcome following activation of this 
pathway may be more complex than at first thought and numerous studies are now 
being carried out to try and resolve this issue.
The sphingomyelin pathway, summarised in figure 1.6, originates from the membrane 
sphingosine- based phospholipid, N- acylsphingosin- 1- phosphocholine which 
undergoes hydrolysis by a phospholipase enzyme, sphingomyelinase. It is this enzyme 
which is activated following stimulation of the surface signal transducing molecules 
although the actual mechanism of interaction between the receptor and the enzyme has 
yet to be elucidated. So far two different forms of the sphingomyelinase enzyme have 
been described (Kolesnick, 1991). A membrane- bound neutral form which is 
dependent upon magnesium was the first to be discovered and is activated by IL-1. A 
second form which is magnesium independent is found sequestered in the acidic 
lysosomes. However, since the hydrolysis reaction is proposed to take place at the 
membrane the maintenance of the acidic environment for the latter enzyme does not 
seem possible and has raised speculations of receptor internalisation and endosomal 
acidification (Kolesnick and Fuks, 1995). A recent study by Boucher et al (1995) 
reported that the acidic form of the enzyme was activated by CD28. Interestingly TNF 
has recently been shown to activate both forms of the enzyme (Wiegmann et al., 1994) 
although a correlation between the enzymatic form activated and the various effects of 
TNF has not yet been elucidated.
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1.3.3 THE DOWNSTREAM TARGETS OF CERAMIDE
The outcome of sphingomyelinase activation is the generation of phosphorylcholine 
and ceramide; the latter being the active signalling entity. The number of targets for 
ceramide appears to be increasing rapidly as the unravelling of the pathway continues 
but it is generally agreed that it can activate at least four downstream molecules. The 
first is the guanine nucleotide exchange protein, Vav which has sequence homology to 
other members of the family such as the ras- activating protein, SOS (Gulbins et al., 
1994). In addition to its nucleotide exchange capabilities Vav also bears a lipid binding 
domain similar to that found on PKC for DAG and phorbol esters. The significance of 
this has yet to be understood but it raises the possibility of a link between the CD28- 
mediated sphingomyelin pathway and the TCR mediated MAPK cascade. A second 
target for ceramide is a 97kDa proline directed serine/threonine protein kinase named 
CAPK (Kolesnick and Golde, 1994; Mathias et al., 1991). This is a membrane bound 
kinase which has been shown to bind TNF and IL-1 receptors with high affinity. One 
identified target for this kinase is the proto-oncogene Rafl (Yao et al., 1995); forming 
yet another link with the MAPK cascade. The third ceramide target, in contrast to the 
last, is a phosphatase of the serine /threonine class 2A family, CAPP (Dobrowsky and 
Hannun, 1992). The active molecule comprises a heterotrimeric complex of which the P 
subunit is essential for phosphatase activity. CAPP is proposed as the mediator of the 
apoptotic signals of ceramide since its activation closely matches the ceramide induced 
apoptotic events and it can be inhibited by okadaic acid (Hannun, 1994). The final 
target for ceramide is the atypical PKC£ (Lozano et al., 1994). As mentioned previously 
this PKC isotype is unresponsive to DAG and phorbol esters but appears to mediate the 
phosphorylation and hence subsequent degradation of IkB, the inhibitory subunit of the 
NFkB transcription factor complex. Degradation of IkB allows free translocation of the 
NFkB to the nucleus where it participates in regulation of IL-2 gene expression.
With so many different targets delivering both proliferative and apoptotic signals it is 
difficult to understand how the ceramide pathway can be rationalised. However, recent 
discoveries of the inhibitory ability of DAG on ceramide-mediated apoptosis has 
suggested one possibility Whilst pro-apoptotic agents such as Fas and TNF activate 
ceramide only, TCR signals in conjunction with a costimulatory signal as would be 
encountered during an immune response, would activate both DAG and ceramide. 
Furthermore several studies have shown a protective effect of PKC activation in the 
prevention of apoptosis induced by a variety of stimuli. This indicates that DAG may 
have a protective role by preventing the transduction of the ceramide-mediated 
apoptotic signals whilst allowing transduction of the proliferative signals. Therefore the 
outcome of T cell stimulation may rely on the relative balance between the protective 
TCR-induced DAG and the costimulaton-mediated induction of ceramide.
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As originally observed there are several points on the CD28 signalling pathway which 
allow overlap and synergy with the TCR pathway. However, the recruitment of the 
sphingomyelinase pathway and the activation of PKC£ does appear at present to 
distinguish the two and may be the one specific marker of the CD28 pathway. Thus a 
synergy of the two signalling pathways would be required to induce full activation of 
the cell. This is supported by the observation that stimulation of the TCR alone often 
induces anergy whilst activation of the sphingomyelinase pathway frequently causes 
apoptosis. Simultaneous delivery of both signals, however, satisfies all the requirements 
of activation and proliferation.
1.4 TRANSCRIPTION FACTORS
At whichever point the TCR and costimulatory pathways intersect, one outcome of 
receptor stimulation is the induction of interleukin- 2  gene transcription, resulting in the 
production and release of the main T cell proliferative cytokine IL-2. The means by 
which this is achieved is via the complex series of signalling steps discussed above and 
which culminate in the regulation of DNA binding proteins. These regulatory proteins 
or transcription factors, bind to the promoter regions of genes 5' to the start site and 
regulate the transcription of the gene. Their actions are usually to promote gene 
transcription although some inhibitory transcription factors have been identified 
(Nakabeppu and Nathans, 1991). Rather than being single proteins transcription factors 
are often complexes with modular arrangements resulting in the formation of distinct 
domains. The DNA binding domain often consists of an a helix motif surrounded by or 
incorporating several positively charged amino acid residues. A second domain, the 
transactivation domain, mediates cooperative interactions between transcription factor 
complexes. Transcription factors are not generally functional as isolated units but 
instead interact with other adjacent factors with the result that the entire promoter 
region when occupied by a full set of transcription factors, acts as a coordinated 
regulator of the gene.
In the next few paragraphs the structure, activation mechanisms and regulation of 
transcription factors in general will be discussed followed by more specific features 
concerning the transcription factors involved in the regulation of the interleukin- 2  gene. 
The single distinguishing feature of a transcription factor which separates it from other 
signalling and enzymatic proteins is its ability to bind specific sequences of double 
stranded DNA. These sequences, ranging from 5 to 20 amino acids, have largely been 
conserved through evolution and several transcription factor complexes such as NFkB 
appear to be ubiquitous whilst others such as NFAT appear to be lineage specific.
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1.4.1 STRUCTURE
Most transcription factors appear to fall into one of four structural categories depending 
upon the mechanism of their DNA binding domain, these being helix-tum-helix (HTH), 
zinc finger, leucine zipper and helix-loop-helix (HLH) (Papavassiliou, 1995). A 
structural diagram of the four motifs is shown in figure 1.7. The first motif is the HTH 
which is found in a diverse range of transcription factors, some of which are essential 
for the differentiation of haemopoietic precursor cells. The HTH motif is found within 
the homeodomain and consists of three consecutive a  helices. Adjacent domains can 
interact with and influence the DNA binding ability and functional activation of the 
complex. A relevant example of an HTH motif transcription factor is found in the POU 
family comprising the Octamer proteins discussed below.
The second motif which functions as a dimer, is the zinc finger motif, found in a wide 
range of transcription factors including the oncogene bcl-6 , the tumour suppressing 
protein WT1 and the erythroid differentiation factor GATA-1. This motif consists of 
either a pair of histidines and a pair of cysteines or two pairs of cysteines coordinating a 
zinc ion with the DNA binding being mediated by specific residues at the base and 
body of each loop.
The third category has the unusual name of the leucine zipper motif based on the 
observation of two transcription factors zipping together by interlocking of the leucine ' 
teeth ’. An a  helix forms the backbone of the DNA binding domain, every seventh 
amino acid of which is a leucine. The complex formed by the zipping together of the 
homo or heterodimeric units results in a stable structure exhibiting the correct 
configuration for DNA binding. An example of such a complex is found in the AP-1 
transcription factor comprising the leucine zipper proteins fos and jun.
Finally there is the HLH group comprising members which bind immunoglobulin gene 
enhancers such as the c-myc factors involved in growth regulation. These show much 
similarity to the leucine zipper factors with a positively charged region responsible for 
DNA binding and an adjacent dimerisation domain.
1.4.2 ACTIVATION
An alternative classification system involves the differences in modes of activation of 
the transcription factors. They can be broadly subdivided into one of three activation 
mechanisms : a) those factors that are activated by protein kinases which translocate 
from the cytoplasm to the nucleus following receptor stimulation; b) those factors
21
which are present in the cytoplasm and undergo phosphorylation to induce their own 
translocation to the nucleus and c) those factors which are released from an anchor or 
inhibitory binding protein and are then able to translocate. However, these categories 
are not mutually exclusive as some transcription factors can be activated by multiple 
pathways. One example is c-fos, a transcription factor which functions in a complex 
with c-jun proteins to form the AP-1 transcription factor. The c-fos gene itself is under 
regulatory control by several cis- acting DNA elements including a serum-response 
element (SRE), the c-SIS- inducible element (SIE), an AP-1 binding site and a cAMP 
response element (CRE) (reviewed in (Edwards, 1994)) as shown in figure 1.8. The 
SRE alone contains binding sites for several different transcription factors including 
those for a serum response factor (SRF), a site for Elk-1, a member of the Ets family of 
proto-oncogenes and nuclear factor - IL- 6  which appears to link the SRE to the AP-1 
binding site. Binding of Elk-1 appears to be dependent on the presence of bound SRF 
and data indicate it is this ternary complex (TCF) which is regulated by signals from the 
MAP kinase pathway (Whitmarsh et al., 1995). This provides an example of the first 
method of transcription factor activation. Following receptor stimulation, activation of 
the MAP kinase signalling pathway results in the rapid (5-10 min) translocation of 
active ERK and p90rsk S6  kinase to the nucleus where they phosphorylate and hence 
activate the Elk-1 and SRF factors respectively.
The additional signalling events required for the transcription of c-fos provide an 
example of the second mechanism of transcription factor activation and involve the 
activation of a family of latent cytoplasmic factors known as signal transducers and 
activators of transcription (STAT) proteins (Edwards, 1994; Brunn et al., 1995). 
Discovery of these proteins is relatively recent and the nomenclature of the different 
family members has not yet been formalised. However, all are activated via tyrosine 
phosphorylation probably involving a member of the Janus kinase family (JAK1, 2, 3 
or TYK2) (Asao et al., 1994; Bacon et al., 1995; Wilks and Harpur, 1994). These lie 
downstream of a number of IFN, growth factor and cytokine receptors including IFN a  
and p, IL-2, IL-4 and IL-12. Since this pathway is independent of ras activation it can 
be considered as a completely separate activation signal from that provided via MAP 
kinase. Phosphorylation of STAT proteins is thought to result in a conformational 
change allowing their dissociation from the surface receptor, dimerisation and their 
translocation to the nucleus where they bind specific DNA sequences in gene 
promoters. In the case of c-fos STAT proteins have been shown to associate with 
another factor named p48 and together they bind the SIE upstream of the SRE and 
participate in the regulation of c-fos transcription (Edwards, 1994).
The third mechanism of activating transcription factors is typified by the NFkB 
transcription factor complex which, in unstimulated cells, remains sequestered in the
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cytoplasm bound to an inhibitory protein IkB. Activation of the cell results in the 
phosphorylation and subsequent degradation of this inhibitory protein so releasing the 
NFkB which translocates to the nucleus to effect its actions. Since NFkB has a major 
role to play in IL-2 gene regulation the remainder of the activation of this type of 
transcription factor will be discussed below.
1.5 THE IL-2 GENE PROMOTER
The IL-2 promoter extends approximately 300bp upstream of the 5' start site from -326 
to +46bp (Jankevics et al., 1994). Within this region are encoded the binding sites for 
between six and eight identifiable transcription factor binding sequences (see figure 
1.9). The number of factors varies depending upon the cell types used for the 
experiments and whether complex sites are considered as single or separate units. 
Generally single binding sites have been identified for NFAT and NFkB, whilst two 
AP-1 and two Oct sites have been demonstrated. A seventh site labelled the CD28 
response element (CD28RE) shows much similarity to the NFkB site discussed below. 
The existence of multiple sites does not, however, mean that all are functional and in 
fact DNAse I footprinting of the IL-2 promoter only detected protein protection at the 
proximal and not the distal AP-1 binding site (Durand et al., 1988). Whether the other 
sites arose simply by DNA duplication or whether they have a relevant function is still 
unknown.
The generation of IL-2 requires the occupancy of all the functional transcription factor 
binding sites. Fiering et al (1990) discovered that a threshold concentration of the 
NFAT transcription factor was required in the promoter region before transcription was 
activated. Although many transcription factors appear to be driven by PKC activation 
and calcium alone (ie TCR signals) costimulatory signals may provide the enhancement 
required to synthesise sufficient transcription factor to overcome the threshold barrier. 
The purpose of threshold levels is currently unclear but may either regulate the 
specificity of which gene is activated by having different transcription factor thresholds 
for different genes or the purpose may be to ensure that IL-2 transcription only occurs 
in response to a strong antigen-induced challenge.
1.5.1 AP-1
AP-1 is a ubiquitous transcription factor which is involved in the regulation of many 
genes concerned with cell growth and differentiation. Binding of the complex to the 
IL-2 promoter has been demonstrated in both mature CD4+/ CD8 " and immature CD4-
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/CD8 " thymocytes but not during the intermediate CD4+/CD8+ stages when the cells 
are undergoing selection. The AP-1 complex binds to a highly conserved DNA 
sequence termed the TPA-responsive element (TRE) (TGAGTCA) due to its binding 
capabilities of phorbol ester-induced complexes. The activation requirements for AP-1 
have been somewhat confused by the use of transformed cell lines such as Jurkats 
which often show some constitutive activity. Furthermore Los et al (1994) reported that 
AP-1 activity could be induced in Jurkat cells by stimulation with PMA alone and that 
this activity was downregulated by the addition of antiCD28 antibodies. In contrast, an 
alternative report by Rincon and Flavell (1994) on the induction of functional AP-1 
activity in primary mouse T cells demonstrated a requirement for full TCR activation 
and costimulation. In general it appears that production of a transcriptionally active 
AP-1 complex occurs in two or more stages. PMA stimulation of the cell can induce 
DNA binding of the AP-1 complex but this has no functional activity. Calcium and 
costimulatory signals are then required for post translational modification of the 
complex to make it functionally active. Serine/ threonine phosphorylation sites have 
been identified at both the amino and carboxy terminals of the c-jun subunit of the 
AP-1 complex and the amino terminal site appears to be under the regulatory control of 
the MAP-family kinase JNK (Hibi et al., 1993). Phosphorylation of serine 63 and 73 of 
c-jun leads to an increase in the transcriptional activity of the complex. Interestingly 
JNK has been proposed as one of the downstream targets of CD28 activation and it 
therefore may explain the requirement for costimulatory signals in the post translational 
modification. Phosphorylation of the carboxy terminal site of c-jun appears to have an 
inhibitory effect on DNA binding. This phosphorylation on serine 243 and 249 and 
threonine 231 appears to be mediated by casein kinase II or GSK3 but is reversed after 
phorbol ester treatment which induces DNA binding. The mechanisms controlling the 
phosphorylation and dephosphorylation of these sites is still unknown as the kinases 
themselves do not appear to be phorbol ester regulated and the existence of a candidate 
phosphatase has not yet been proved. There is some speculation that there is no 
enzymatic regulation but a conformational regulation instead and that phosphorylation 
of the amino terminal sites causes a conformational change in the c-jun subunit 
reducing the accessibility of the carboxy terminal sites to the phosphorylating kinases 
(Papavassiliou and Bohmann, 1995).
The AP-1 complex is a dimer comprising members of the c-jun and c-fos protein 
families. Though c-jun homodimers will bind and activate TREs the heterodimeric 
complex of fos and jun has a considerably higher binding affinity. Several members of 
each family have been identified and multiple dimeric complexes have been shown to 
be functional. The c-fos family comprises the members c-Fos, FosB, Fra-1, Fra-2 and 
FosB2 whilst the jun family consists of c-Jun, JunB and JunD, however, the elements 
FosB2 and JunB have been shown to exhibit some inhibitory effects (Nakabeppu and
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Nathans, 1991; Chui et al., 1989). The subunits associate via a leucine zipper motif 
which brings the basic amino acids together to allow DNA binding. This is mediated 
via cysteine residues which are required to be in the reduced state (i.e. -SH) (Abate et 
al., 1990). This may explain why AP-1 binding and activation is induced in antioxidant 
conditions and inhibited in the presence of oxidative compounds. Furthermore, Handel 
et al (1995) proposed that DNA binding of AP-1 could be inhibited by the presence of 
gold thiol compounds due to an interaction between the gold and the cysteine residues 
on fos and jun. This may underlie the rationale behind the use of gold compounds in the 
treatment of rheumatoid arthritis due to the inhibition of AP-1 induction of 
inflammatory cytokines.
1.5.2 OCT
A second ubiquitous transcription factor associated with IL-2 gene transcription is 
Oct-1, a constitutive member of the POU domain multigene family, which recognises 
and binds several degenerate sequences based around the motif ATTTGCAT 
(Bamruker et al., 1988). Two putative binding sites have been identified within the IL-2 
promoter; one at position -63 to -93 and a second at -242 to -256. Although present in 
resting cells the Oct-1 protein requires activation by signals from the TCR before 
becoming functional and does not respond to PMA alone (Durand et al., 1988). Further 
studies of the binding requirements for Oct- 1  at the proximal site revealed that it 
actually functions as a complex with an octamer associated protein (OAP). This has 
since been identified as AP-1, which explains the requirement for TCR stimulation and 
the sensitivity of the complex to CsA (Ullman et al., 1993). This complex is separate 
from the AP-1 binding site further upstream but it appears both are required for IL-2 
transcription since mutation in either site abrogated IL-2 production. A similar site was 
observed in the promoter region of the IL-4 gene but in this case the binding sites for 
Oct-1 and AP-1 were separated by a binding site for NFAT (Pfeuffer et al., 1994). 
Analysis of the activation requirements for the IL-4 promoter, however, revealed that 
binding of NFAT actually inhibited Oct binding indicating the latter may function as a 
negative regulator of this cytokine.
A second inducible factor of the same family has been identified and named Oct-2 
(Kang et al., 1992). This factor was detected in B cells and peripheral blood T cells but 
only in some T cell lines and not in Jurkats (Staudt et al., 1988). The induction of Oct-2 
is first observed about 3 hours after stimulation of the cell indicating it may play a role 
in the long term changes in gene expression rather than cytokine regulation.
25
1.5.3 NUCLEAR FACTOR of ACTIVATED T CELLS (NFAT)
The existence of the NFAT transcription factor was known for a long time before the 
identity of its components were discovered and it was originally thought to be the T cell 
specific factor which differentiated T cell cytokine production from other cells bearing 
gene regulating promoter sequences. However, it has since been shown that NFAT is 
not unique to T cells and is also expressed in B cells and several other immune sites 
(review Hoey et al., 1995). Considering the ubiquitous nature of the majority of the 
transcription factors the question arises as to how one gene is specifically activated 
without switching on others regulated by the same factors. One answer may lie in the 
subtle differences in protein isotype within the complexes or as discussed previously in 
the threshold concentrations of the factors. Furthermore whilst NFAT induction in T 
cells has been demonstrated at two hours it could not be detected in B cells until 24 
hours after stimulation (Verweij et al., 1990). Thus NFAT may have completely 
different roles in different cell types.
NFAT comprises two components; an inducible nuclear component which appears to 
be PMA regulated and a constitutive but inactive cytoplasmic component which 
requires the presence of calcium for its activation and subsequent translocation to the 
nucleus (Northrop et al., 1993). Here the two subunits combine to form a single 
complex which associates with a DNA binding site positioned at -255 to -285 in the IL- 
2 promoter. Similar binding sites have been observed in the promoter regions of several 
other T cell cytokine genes including IL-4, IL-5, IFNy and GM-CSF (review Rao, 
1994). The nuclear subunit has now been identified as AP-1 which explains its PMA 
inducibility. Much work has been undertaken to identify the fos and jun members 
involved and whilst one group identified Fra-1 and JunB as the major factors (Boise et 
al., 1993a) it now appears that like AP-1 itself several different heterodimeric 
complexes can carry out this role. In the IL-2 gene promoter the complex binds as a 
single entity whilst in the IL-4 gene the two units appear to bind adjacently in a 
cooperative manner but can be considered as separate (Rooney et al., 1995). However, 
this work was carried out in murine cells and may not extend to the human gene 
promoter.
The cytoplasmic unit, referred to here as NFAT, is now known to comprise a family of 
proteins each containing a DNA binding site and a specified region bearing limited 
homology to the Rel domain of kB proteins (Nolan, 1994). Three members of the 
family were originally identified and labelled NFATc, p and x (Northrop et al., 1994; 
Masuda et al., 1995). More recently another group has identified a further two members 
NFAT3 and NFAT4 (Hoey et al., 1995). Although shown to be different from NFATc
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and p it remains to be seen whether either correspond to NFATx. The reason for the 
multiplicity of cytoplasmic units is currently unclear as only NFAT3 has been 
demonstrated to have a significantly different binding requirement and tissue 
distribution but further research may resolve this issue. At present all forms can 
effectively be considered as having identical properties in that their activation requires a 
calcium signal initiated by TCR engagement. Calcium binds cooperatively to a binding
protein, calmodulin and it is this complex which activates the phosphatase calcineurin 
which is responsible for the dephosphorylation of the cytoplasmic NFAT. Once 
dephosphorylated the NFAT subunit can translocate to the nucleus and participate in 
gene transcription. This sequence of events is a major activation pathway and it is the 
target of the immunosuppressive agents CsA and FK506 (McCaffrey et al., 1993). 
Association of these agents with their respective binding proteins, cyclophilin and 
FKBP, enables their association with and inhibition of calcineurin resulting in a very 
effective inhibition of IL-2 generation and hence the immune response thus indicating 
the vital role played by NFAT in the activation process.
1.5.4 NFkB
The NFkB transcription factor was first discovered associated with the promoter region 
of the immunoglobulin light chain, kappa and was thought to be B cell specific (Sen 
and Baltimore, 1986). It has since been shown to be a ubiquitous factor, occurring in 
the promoter regions of a number of inflammatory cytokines. It is also utilised by 
several viral pathogens to subvert the cells machinery into the production of viral 
proteins. One such virus is the human immunodeficiency virus which contains two 
NFkB elements in the long terminal repeat region (Nabel and Baltimore, 1987).
NFkB is a heterodimeric complex consisting of two members of the Rel family of 
transcription factor proteins. Five members have been identified so far; c-Rel, RelA 
(p65), RelB, NFkBI (p50) and NFkB2 (p52). All contain a N terminal Rel homology 
domain of approximately 300 amino acids and can interact to form a variety of homo 
and heterodimeric complexes including the p65/ p50 heterodimer, which is usually 
considered as the standard NFkB complex. The NFkB binding sites are based on the 
sequence GGGACTTTCC but a considerable amount of degeneracy has been observed 
in different gene promoters and it may be that different dimeric complexes show 
binding preferences to different sequences introducing some specificity to gene 
activation. The structure of the p50 homodimer has been studied and has revealed the N 
terminal Rel homology domain consists of two p-barrel domains which grip the DNA 
in the major groove (Muller et al., 1995a). It is proposed that when solved, the 
structures of the other functional dimers will reveal similar binding mechanisms.
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NFkB binding can be demonstrated in Jurkat cells following PMA stimulation alone 
although like AP-1 this does not result in a functional complex. A second signal 
appears to be required indicating a role for modification of at least one of the 
components. NFkB occurs as an inactive cytoplasmic complex bound to an inhibitory 
anchor protein IkBoc (Baeuerle, 1991). This is one of a family of proteins characterised 
by their ability to bind and inhibit the effects of the Rel proteins and which contain a
series of ankyrin domains conferring a specific structural motif. IkBoc associates with 
the NFkB complex via the C terminal domains of the transcription factor in such a way 
as to mask the nuclear localisation signals of the NFkB complex (Beg et al., 1992). This 
prevents its translocation to the nucleus and hence its effect on gene transcription. It has 
been shown that nuclear NFkB activity can be induced following stimulation of the 
cells with a number of agents including PMA, TNF and IL-1 (Baeuerle, 1991). This is 
achieved by phosphorylation and degradation of the I kBoc protein allowing free 
translocation of the NFkB. Although the actual mechanism by which this occurs is not 
fully understood recent studies by several groups have supplied some of the details. 
Chen et al (1995) revealed that the ubiquitin- proteasome pathway may be involved in 
the removal of IkBoc whilst Brockman et al (1995) showed that the degradation 
depended upon the presence and phosphorylation of two serine residues in the N 
terminal domain of the IkB a  molecule. Interestingly it was found that neither 
phosphorylation nor ubiquitination were sufficient to induce dissociation of the IkBoc 
from the NFkB complex; an event which required the binding of the 26S proteasome. 
IkB a  levels were shown to fall 2 to 5 minutes after PMA treatment and remained 
depressed for an hour (Henkel et al., 1993). Reappearance of cytoplasmic IkBoc follows 
gene transcription and protein synthesis which interestingly is initiated via NFkB 
(Brown et al., 1993) therefore indicating that NFkB can regulate its own activity via an 
autoregulatory feedback mechanism. Agents generating oxidant conditions have also 
been shown to activate NFkB ( L o s  et al., 1994 and 1995) and this is thought to be 
mediated via reactive oxygen intermediates (ROIs) which may also regulate IkBoc 
degradation although the mechanism is unclear. This is opposite to the generation of the 
AP-1 transcription factor which is enhanced by antioxidants and appears rather 
contradictory since both are required for IL-2 gene transcription. However, the redox 
regulation may be more important in the expression of other genes which are only 
regulated by one or other of the two factors. Both AP-1 and NFkB are, however, 
regulated by glucocorticoids. These are reagents which have been used routinely for 
several years in the treatment of chronic inflammatory diseases and yet their mode of 
action was not fully understood. It was known that glucocorticoid drugs could bind 
steroid receptors in the cytoplasm, translocate to the nucleus and bind as transcription 
factors to DNA binding sites (review Marx, 1995). However, many of the genes 
repressed by glucocorticoid treatment did not have binding sites in their promoter
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regions. It was noted, however, that the drugs also down regulated AP-1 activity but the 
extent of this was insufficient to account for the full effect of the drugs. Recently two 
groups have shown that glucocorticoids can also inhibit NFkB activity (Auphan et al., 
1995; Scheinman et al., 1995). This is mediated via an increase in IkBoc transcription 
which results in a large increase in the cytoplasmic levels of the inhibitory protein. 
Thus as soon as the NFkB is released from one IkB a  molecule it is bound by another 
before it can reach the nucleus. Since NFkB is involved in the transcriptional regulation
of a number of inflammatory cytokines this could explain why the glucocorticoid drugs 
are so effective as immunosuppressants. It may also help in the design of more specific 
drugs which will inhibit inflammation without the many other side effects of the 
glucocorticoids.
1.5.5 CD28RC
The CD28 response complex (CD28RC) is a new transcription factor which binds to 
the IL-2 promoter at position -154 to -164 and which was first described by Fraser and 
Weiss in 1991. However following the report that the complex may comprise the Rel 
family members it has been proposed as an extra NFkB complex rather than a new 
transcription factor. Ghosh et al (1993) investigated the complex and reported the 
presence of c-Rel, Rel A and NFkBI proteins which together bind a sequence on the 
IL-2 promoter bearing some homology to the NFkB binding sites. However, this report 
is currently disputed by a second group who could find no evidence for the binding of 
NFkB family proteins to this site (Verweij, personal communication). The CD28RC 
was originally described as a CD28-induced factor but although stimulation of CD28 
enhances its expression, ligation of the surface receptor is not essential for transcription 
factor induction and one group has induced the complex using PMA alone (Bryan et al., 
1994). Unfortunately much of the information concerning the induction and function of 
this complex has been confused by the use of transformed cell lines which can be 
activated independently of costimulatory signals, however, the few studies carried out 
in peripheral blood T cells did give some insight into the signalling pathways involved 
in the generation of this complex. It is difficult to distinguish CD28RC induction from 
the induction and regulation of NFkB complexes other than by the indication that the 
CD28RC involves a ternary complex which appears to assemble in the nucleus rather 
than being present in an inactive form in the cytoplasm. Stimulation of peripheral blood 
T cells with PMA and aCD28 antibodies resulted in an increase in the nuclear 
translocation of c-Rel compared to that observed with PMA treatment alone (Bryan et 
al., 1994). This was accompanied by a prolonged downregulation of IkB of up to 12 
hours compared to the usual 1 hour although the mechanism for this is not yet known.
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Furthermore CD28 costimulation induces an increase in the phosphorylation of the c- 
Rel protein which appears to be required for functional activity of the complex.
A second study by Los et al (1995) showed that ligation of CD28 resulted in an increase 
in ROIs and an induction of CD28RC and NFkB complexes. The former was measured 
as an increase in the intracellular levels of hydrogen peroxide with a concomitant 
decrease in the antioxidant glutathione. The linkage between the CD28 receptor and the 
induction of ROIs is thought to be mediated via protein tyrosine kinases since 
preincubation with the PTK inhibitor, herbimycin abrogated the response. One reported 
downstream target of PTKs is phospholipase A2  which cleaves arachadonic acid to 
generate the precursors of prostaglandins and leukatrienes. Whilst inhibitors of the 
prostaglandin pathway had no effect, a 5- lipoxygenase inhibitor blocked the 
downstream activation of CD28RC and NFkB by CD28, implying this enzyme plays a 
role in their generation. This further extends the link between redox reactions and 
transcription factor regulation although the reason for this and its significance still 
eludes us.
Interestingly, a second agent which appears to have immunosupressive effects is the 
protein kinase A activator, forskolin. Although not used clinically, laboratory 
experiments have indicated that it inhibits the translocation of NFkB complexes by 
retarding IkB degradation (Neumann et al., 1995). In addition PKA activation produces 
an increase in the non-NFKB regulated cytokine IL-4 which exerts an anti-inflammatory 
effect. In vivo PKA is known to be activated by prostaglandin E (Phipps et al., 1991), 
an additional product of the enzyme phospholipase A2. Thus PKA may be activated in 
parallel and could act as a physiological regulator of CD28 signalling and IL-2 
production. Furthermore PKA has been shown to inhibit the interaction between ras and 
raf on the mitogen activated signalling pathway (Wu et al., 1993) and may thus prove to 
be an important negative regulator of T cell signalling.
1.6 SUMMARY AND AIMS
It is evident from the summary above that whilst we have a basic understanding of the 
pathways involved in the transduction of a signal from a surface receptor to gene 
regulation in the nucleus, much of the detail is still missing. Furthermore although 
CD28 activation is known to be a critical step in this activation process its specific role 
is far from clear. Does CD28 activate specific signalling pathways or is it just an 
enhancer of TCR derived signals ? Certainly much of the current work points to a 
considerable overlap of different signalling pathways and one of the major problems to
30
date has been the inability to completely separate the signals emanating from the two 
receptors and therefore to study the role played by CD28 in isolation.
Previous studies have shown a global requirement for CD28 costimulation in the 
activation of resting T cells although the identity and specific role of the CD28 derived 
signals has not been fully addressed. The initial aim of this work was therefore to 
establish in vitro assays to determine the requirement for and function of CD28 signals 
in specific T cell activation events. These v/ere assessed using proliferation assays to
highlight the role of CD28 in cell cycle progression and cytokine production and 
transcription factor detection assays as a signal transduction endpoint. Although some 
reports have indicated a role for CD28 in the modification of the IL-2 regulatory 
transcription factors the information is rather fragmented and has largely arisen from 
stimulation of transformed cells in the presence of PMA.
Even more fragmented is the information surrounding the identity of the signal 
transduction pathways associated with CD28. As to the reported involvement of PI3 
Kinase and acidic sphingomyelinase in CD28 signalling, although both enzymes have 
been proposed to be activated following CD28 ligation, the relative contributions and 
main role of each pathway in the activation process is still unclear. Further investigation 
is obviously required to establish whether the pathways are activated simultaneously 
and if so whether they act independently or synergistically to mediate a response.
The use of mitogenically-activated transformed cell lines as models of T cell activation 
has provided a considerable amount of data on the receptor-to-nucleus signal 
transduction pathways and T cell activation events. However, several assays have also 
indicated that the responses shown by these cells are not always an exact representation 
of the responses in normal T cells due to the presence of constitutively activated 
pathways in the transformed cells. Using the knowledge gained from these initial 
studies it is therefore now necessary to develop similar studies using normal T cells 
activated by physiological stimuli to provide more relevant results.
The following report describes the work carried out in the pursuit of these aims and 
involves the study of cellular responses in both resting T cells and in the established T 
cell model, Jurkat cells. Whilst these two models provided some information on the 
requirement for costimulation and its overall effects on T cell activation, the ability to 
study the effects of CD28 signalling was considerably enhanced by the development of 
a new T cell model. This model, based on previously activated quiescent T cell blasts, 
was responsive to B7 stimulation alone in the absence of concomitant TCR engagement
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and enabled the study of the effects of CD28 ligation both in terms of downstream 
targets and signalling pathways activated, in relative isolation. Although this model was 
not a exact representation of a resting T cell it retained the characteristic feature of 
requiring two signals for full activation and unlike the Jurkat cells responded normally 
to mitogenic and antibody stimulation. B7 stimulation of these T cell blasts provided 
some important new information on CD28 mediated signalling and may still prove a 








Figure 1.0 A sim plified diagram  showing the interactions between the main T  cell and 

































Figure 1.1 A simplified diagram  showing the main signal transduction pathways 
originally thought to be involved in T cell activation ( reproduced from ' T Cell Anergy 
'{Schwartz})
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Figure 1.2 The association between the TC R/ CD3 complex and protein tyrosine kinases
Figure A shows the relative associations o f different PTKs with different m em bers o f 
the TC R/ CD3/ CD4 complex in T  cells whilst figure B details the functions o f the 





























Figure 1.4 A sim plified diagramatic representation of the current understanding 
of the main CD28 signalling pathways
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Figure 1.5 A diagramatical representation of the structure and different phosphorylated 
forms of the phosphoinositide molecules associated with PI3 Kinase signalling activity
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Figure 1.6 (A) A general model of the structure of biological membranes (M olecular Cel! 
Biology. Darnell,J., Lodish,H. and Baltim ore,D . page 5 7 1).(B) Sphingomyelin hydrolysis 
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Figure 1.7 The four different structural forms of  transcription factor protein complexes 
(reproduced from ' Transcription Factors’ {Papavassilou})
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Figure 1.8 A diagramatic representation of the promoter region of the c-fos gene 
showing the known regulatory binding sites (reproduced from a review by {E d w ard s})
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Figure 1.9 The Interleukin-2 promoter region showing the location and composition of the known regulatory transcription factors
CHAPTER TWO - METHODS
2.0 Reagents
Unless otherwise specified, all laboratory reagents were purchased from Sigma with the 
exception of the following which were kindly donated from various sources. The Jurkat 
cells and Quantikine cytokine assay kits (R&D Systems Cat. Nos. IL-2 D2050, IL-4 
D4000) were donated by Dr. A. Lennard at the Yamanouchi Research Institute in Oxford 
whilst the CTLLs and the recombinant IL-2 standard were obtained from the National 
Institute of Biological Standards and Controls (NIBSC). The IL-2 which was used to 
culture the T cell blasts was obtained from Glaxo, the staphylococcal enterotoxin A 
(SEA) was a gift from M. Dohlsten, Pharmacia, Sweden and the GST-jun fusion protein 
was supplied by J. Woodget, Toronto. The antibodies used in the experiments were 
obtained from a variety of sources. OKT3, OKT11, HB8784 and L243 were all obtained 
from ATCC, E2H10, UCHT4 and UCHM1 were donated by Prof. P. Beverley, Dr. P. 
Linsley supplied the 9.3 and BB-1 antibodies and Dr. I. McLennan donated the anti 
CD19. Finally the PKC inhibitor Ro 31-8220 was a gift to the pharmacology department 
of the University from Roche Pharmaceuticals.
2.1 Cell culture
Assays were carried out using the Ieukaemic T cell line Jurkat, peripheral blood T cell 
blasts and purified resting T cells, the latter two of which were prepared from blood 
samples from normal donors. Both the T cells and the Jurkat cells were cultured in 
175cm2 tissue culture flasks at concentrations of 1.5-3xl06/ml in RPMI 1640 containing 
10% FCS supplemented with penicillin and streptomycin (see appendix 1).
The transfected cell lines were produced in our laboratory as previously described 
(Sansom et al., 1993). Briefly CHO cells were transfected with human cDNA's encoding 
various antigens including B7-1 (CD80) and HLA-DR4 using the pEE6 expression 
vector under the control of a CMV promoter (see appendix 5). Positive clones were 
selected and expression levels of the relevant antigen monitored regularly using FACS 
analysis of surface staining.
All the transfectant cells were cultured in Glutamine -Free DMEM containing 10% FCS 
supplemented with nucleosides, sodium pyruvate and antibiotics as above (see appendix 
1). This media was used to allow for selection of surface expression under the regulation 
of glutamine synthase. The cells were passaged every three days by aspiration of the 
media followed by a PBS wash and a 5 minute incubation with trypsin at 37°C. The cells 
were then dislodged by gentle tapping of the flask. Following the addition of media to
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inactivate the trypsin, 90% of the cells were removed and the remaining diluted to 
volume with fresh media.
2.2 FACS Analysis
FACS analysis of the cells being used for experimental purposes provides a relative 
quantitation of constitutive and inducible cell surface antigens and can give an indication 
of how stimuli may affect a particular cell type or help to explain why cells respond in a 
particular way to a certain treatment. The analysis involves labelling of surface markers, 
using specific monoclonal antibodies followed by detection using a fluorescent labelled 
antibody which targets the primary antibody. FACS analysis of resting T cells or T cell 
blasts prior to their use in an experiment also provided quality control information on 
cells obtained from different donors.
Typically 5xl05 cells were stained for relevant surface markers using standard mAbs, 
OKT11 (aCD2), OKT3 (aCD3), E2H10 (aCD4), UCHT4 (aCD8), HB8784 (aCD25),
9.3 (aCD28), BB-l(aB7-l) and L243 (aHLA-DR) whilst cells in medium were used as 
a negative control. Supernatants, obtained from hybridoma cell lines, contained antibody 
concentrations of approximately lpg/ml. 50jll1 of the hybridoma supernatant were added 
to the cell suspension and incubated at 4°C for 45minutes. Excess or unbound primary 
antibody was removed by washing the cells in PBS. Cells were recovered by 
centrifugation at 1500rpm for 5 minutes (Beckman GPR) and primary antibodies were 
detected using polyvalent a  mouse FITC incubated as above. After washing the cells 
were resuspended in 1ml of PBS and analysis was carried out on a Becton Dickinson 
FACStar at 488nm using a 60mW laser. 5000 events were typically recorded as a 
representative sample.
2.3 Preparation of T cell blasts from peripheral blood
Due to the large numbers of cells required for some of the assays it was not possible to 
obtain sufficient resting T cells from blood donations. An alternative option was to 
expand cell numbers by the production of T cell blasts which would proliferate to 
exogenous stimuli and which could then be quiesced to give a more physiological model 
of T cell activation. A standard protocol, detailed below, was adopted for the production 
of T cell blasts to minimise differences between cultures.
50 - lOOmls of blood were collected into heparinised tubes (0.1%v/v of 5000U/ml, 
'Monoparin' CP pharmaceuticals). The blood was diluted 1:1 with PBS, layered onto a 
lymphoprep gradient (density 1.077g/ml, Nycomed) and centrifuged without a brake at 
1500rpm for 30min (Mistral 2L). The serum was aspirated off and the buff interface was
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collected. These mononuclear cells were then washed three times with RPMI 1640 
containing 10% FCS. The cells were counted using a Neubauer haemocytometer and the 
volume adjusted to give a concentration of 5xl06 cells/ml. The cells were placed in a 
tissue culture flask and stimulated with the phorbol ester, PMA (50ng/ml) and the 
calcium ionophore, ionomycin (lflM) (Calbiochem Cat. No. 407950). The cells were 
cultured for 8 days with media being added as required. After this period the cells were 
washed twice in RPMI 1640 with 10%v/v FCS and were then used for the various 
experiments. To generate staphylococcal enterotoxin A (SEA)-responsive blasts PBMCs 
were prepared as described above and soluble SEA was added at a concentration of 
lOng/ml. After 8-10 days the blasts were restimulated with SEA antigen pulsed onto 
DR4/B7 transfectants which acted as APCs.
To bind the antigen to the transfectants, SEA (lOng/ml) was added to DR4/B7 
transfectants (5xl06/ml) and incubated at 37°C for 4 hours with occasional gentle 
mixing. The cells were then washed twice and fixed in glutaraldehyde as described 
below. The transfectants were added to the blast cultures at a ratio of 1: 5 T cells which 
were then left a further 4-10 days with the addition of RPMI 1640 media containing 10% 
FCS as required. The media was supplemented with IL-2 (lOOU/ml recombinant human 
IL-2) every 4 days.
2.4 Preparation of purified T cells
Purified resting T cells were prepared from blood samples initially using the same 
method as described above. However, after counting, the PBMCs were placed in petri 
dishes and were incubated at 37°C for 1 hour to remove adherent cells such as 
monocytes. The non-adherent cells were carefully removed and washed twice in media. 
The final pellet obtained after washing was resuspended in 500jil each of L243 and 
CD 14 antibody supernatants and lOpl of CD 19 ascites to label any remaining MHC class 
II DR4 positive cells, monocytes and B cells respectively. The cells were placed on a 
rotator at 14°C for an hour and were then washed again. The recovered pellet was 
resuspended in 500|il of media and 50jil of immunomagnetic sheep anti-mouse IgG 
beads before another incubation period on the rotator. The cells were diluted out in media 
and applied to a magnet three times to remove the bead-bound cells. The remaining cells 
were washed, counted and FACS analysed. Typical preparations were >95% CD3+.
2.5 Proliferation assays
Proliferation assays enable the establishment of a response profile showing the general 
functional effects of different stimulation conditions on different cell types. Thymidine is 
required by proliferating cells during DNA synthesis and its rate of uptake into a cell is
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proportional to the amount of proliferation. This relatively sensitive assay measures 
changes in cell proliferation by recording 3H-Thymidine incorporation. In the assay, cells 
are incubated in the presence of various reagents to allow the effects on proliferation to 
occur. The cells are then supplied with 3H-Thymidine and later, after a further 
incubation, analysed to assess the amount of Thymidine incorporated. By comparing the 
levels of radioactivity in stimulated and unstimulated cells an assessment can be made of 
the effect of the stimulus.
In order to prevent high background counts due to CHO/transfectant proliferation these 
cells were fixed prior to use. This effectively kills the cell stopping all further growth and 
intracellular reactions but leaves the cell whole, enabling its surface molecules to interact 
with corresponding ligands/ receptors on other cells. To fix the transfectants 2-5xl06 
cells were trypsinised, washed twice in PBS and then resuspended for 2 min in 1ml 
0.025% v/v glutaraldehyde. The cells were vortexed to ensure complete resuspension and 
then diluted with media. After centrifugation at 1500rpm for 5 minutes the cells were 
washed twice in media and resuspended at the required concentration for the assay. 
Control wells of fixed transfectants alone were included in the assay to ensure the 
fixation procedure was complete and that any proliferation could not be attributed to the 
transfectants themselves.
In stimulation assays 5xl04 T cell blasts and purified resting T cells were aliquotted into 
round-bottomed 96-well plates. Fixed transfectants were added at 2xl04 cells per well 
and the other stimuli used at the concentrations stated in individual experiments. 
Monoclonal antibodies were added in soluble form in combination with a sheep anti- 
mouse IgG cross-linking agent (Sigma M l522) unless otherwise stated and each 
treatment was carried out in triplicate.
The assays were incubated at 37°C for the appropriate length of time. 50pi of supernatant 
were then removed from each well and assayed for IL-2 production as detailed below. 
lpCi of 3H-Thymidine (6.7 Ci/mmol, ICN Cat No.2406605 ) was added to each of the 
wells and the plate was returned to the incubator for a further 8 hours. After this time the 
cells were harvested onto glass fibre filters, separated into tubes containing 0.5mis 
scintillation fluid (Wallac ' Optiscint HiSafe') and the radioactivity was measured using a 
P liquid scintillation counter.
Proliferation assays were carried out on the Jurkat T cell line as described above except 
that the cells were seeded at an initial concentration of 5xl03 Jurkat cells / well. All other 
conditions were identical to those for the T cell blasts.
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2.6 Cytokine analysis
IL-2 production by stimulated cells was routinely measured using a bioassay based on 
the proliferation of an IL-2 dependent cell line, CTLLs. Some IL-2 and IL-4 assays, 
however, were carried out using ELISA kits and were performed according to the 
manufacturers instructions.
2.6.1 CTLL IL-2 Bioassay
Murine CTLL cells undergo IL-2-dependent growth and if calibrated can be used to 
measure IL-2 concentrations in sample supernatants. CTLL cells were cultured in RPMI 
1640 containing 10% (v/v) FCS, as for the peripheral blood T cells (see appendix 1) and 
fed with human recombinant IL-2 at 10-15 U/ml on a three day cycle. When required, the 
cells were passaged before being fed IL-2. The viability of the cells was checked using 
trypan blue exclusion and was routinely greater than 90%.
An IL-2 standard curve was produced by two-fold serial dilutions of an IL-2 standard in 
the range of 0.019 - 20 U/ml. 5x103 CTLL cells were added to each well of a round- 
bottomed 96 -well plate containing 50pl of IL-2 standard or a 1:10 dilution of sample 
supernatant. Both samples and standards were assayed in triplicate. The plate was 
incubated overnight, 0.5 pCi of 3H Thymidine were added to each well and then the assay 
was incubated for a further 4 hours before the cells were harvested onto glass fibre filters. 
A calibration curve was plotted from the standards and the concentration of IL-2 in the 
samples was calculated.
2.6.2 ELISA assays
The enzyme linked immunosorbant assay (ELISA) is a relatively rapid and sensitive 
assay for the detection of soluble proteins in cell supernatants and works on the principle 
of detection of specific proteins by antibody binding.
Briefly supernatant samples taken from the proliferation assays were aliquotted into 96- 
well plates coated with a specific antibody to the protein of interest. After a period of 
incubation to allow binding, excess supernatant was removed and specific binding was 
detected using a second antibody also directed against the protein. This was linked to an 
enzyme which in the presence of added substrate caused a rapid colour change which 
could be rated visually or by spectrophotometry. IL-2 and IL-4 standards were used to 
calibrate the assays which were analysed on a plate reader at 450nm (Dynatech 
MR5000).
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2.7 Analysis of the effect of PMA stimulation on Jurkat cells
Results obtained from the proliferation assays indicated that whilst PMA in the presence 
of ionomycin induced proliferation in normal T cells this stimulus had an inhibitory 
effect on Jurkat cell proliferation. Due to this unexpected observation additional 
experiments were undertaken to further investigate these effects. Three assays described 
below were performed to assess the effects of PMA on Jurkat cell cycle and viability.
2.7.1 Cell viability
Jurkat cell suspensions of lx l06/ml were aliquotted into 24-well plates and either left 
unstimulated or treated with a combination of PMA (30ng/ml) and ionomycin ( IjllM). 
The cells were incubated at 37°C for 72 hours after which period an aliquot was removed 
and mixed 1:1 with Trypan blue dye. Cell number and viability were then assessed 
visually with the aid of a Neubauer haemocytometer.
2.7.2 Propidium iodide staining of nuclei to assess apoptotic cell death
Cytospins were prepared from a second aliquot of the cells. Once dry the slides were 
fixed in acetone for 5 minutes and allowed to air dry. Propidium iodide(PI) solution was 
added in excess for 30 seconds and then removed by washing the slides with PBS. 
Mountant (95% glycerol, 2.5% 1,4 Diazabicyclo 2,2,2 octane in PBS) was immediately 
added and a coverslip placed over the sample. Cellular staining was assessed visually 
using a fluorescent microscope and comparisons between the stimulated and 
unstimulated cells were made.
2.7.3 Cell cycle analysis
In addition the effect of PMA stimulation on Jurkat cell cycle was assessed. lxlO6 cells 
were pelleted by centrifugation at 1500rpm for 5minutes (Beckman GPR). The pellet was 
resuspended in 500|il of ice cold 80% ethanol in PBS and the cells were incubated at 4°C 
for 2 hours. Cell pellets were obtained as before and were resuspended in PBS containing 
RNase (20jig/ml). The cells were incubated for 30 minutes at 37°C prior to the addition 
of PI (4|ig/ml). After a further 15 minute incubation at room temperature the cells were 
centrifuged and resuspended in PBS before being analysed for PI fluorescence at 580nm 
by FACS using a 60mW laser.
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2.8 Electromobility gel shift assay (EMSA)
EMSA allow the detection of specific DNA-binding proteins (transcription factors) in 
extracts produced from resting and stimulated cells. Nuclear extracts, prepared from cell 
cultures, are incubated with radiolabelled oligonucleotides which are short sections of 
double stranded DNA, the sequence of which defines a binding site for the relevant 
transcription factor. Bound and free oligonucleotide can be separated on a non- 
denaturing polyacrylamide gel due to retardation of the protein/ DNA complexes and can 
then easily be visualised by autoradiography.
2.8.1 Preparation of the nuclear extracts
Cells (approximately 6xl07) were taken from culture, washed twice in medium, counted, 
resuspended at a concentration of 3-5xl06/ml and replaced in 50ml plastic tubes. Stimuli 
were added at the specified concentrations and when required glutaraldehyde fixed 
transfectants were added a ratio of 1: 5 T cells.
Following a 4 hour incubation at 37°C with occasional gentle mixing, the cells were 
washed in cold PBS. The pellet was resuspended in 400pl of hypotonic buffer 1 with 
0.2% NP40 (lOmM Hepes pH 7.9, 1.5mM MgCl2 , 10mM KC1, 0.5mM DTT, 0.2mM 
PMSF, 0.7mM pepstatin, ImM E64 and 0.5mM leupeptin) transferred to an eppendorf 
and left on ice for 15 minutes. Nuclei were pelleted by centrifugation at 2000rpm in a 
bench top microfuge (Beckman GS15R) for 10 minutes and the supernatant containing 
the cytoplasmic extract was retained for functional assays and stored at -80°C until 
required.
The nuclear pellet was gently washed in 800pl of buffer 1 containing 8.5% sucrose and 
recovered by centrifugation as above. The clean nuclei were gently resuspended by 
sequentially adding lOOpl aliquots of hypertonic buffer 2 ( 20mM Hepes pH 7.9, 25% 
glycerol, 0.42M NaCl, 1.5mM MgCl2, 0.2mM EDTA, 0.5mM DTT and protease 
inhibitors as above) to a final volume of 400pi and incubated on ice for 20 minutes 
during which period the nuclei lysed releasing the proteins into the supernatant. Nuclear 
membranes and DNA were removed by centrifugation at 14000rpm for 30 minutes. 
Ammonium sulphate (0.33g/ml) was added to the supernatant to a final concentration of 
3M to precipitate the proteins which were then pelleted by centrifugation as described 
above. The protein pellet was finally resuspended in 50|il of buffer 3 (20mM Hepes 
pH 7.9, 20mM KC1, ImM MgCl2, 2mM DTT, 17% glycerol and 0.2mM PMSF) and 
assayed for protein content using the Biorad dye reagent as described below. Aliquots of 
the extract were flash frozen in liquid nitrogen and stored at -80°C until required.
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2.8.2 Biorad protein assay
The protein content of the nuclear extracts was assessed using Biorad dye reagent. This is 
a colourimetric assay based on the Bradford dye- binding procedure which measures the 
colour change observed following the binding of Coomassie brilliant blue G-250 dye to 
the basic and aromatic amino acid residues of proteins. The assay was calibrated using a 
standard curve but since purified transcription factor protein was not available, BSA was 
used as a relative standard.
A calibration curve of 0-10pg/ml of BSA standard was constructed by serial dilution in 
PBS and the samples were prepared by adding l|il of extract to 800|il of PBS. 200|il of 
dye reagent ( 55% phosphoric acid, 15% methanol; Biorad, Cat. No. 500 0006) were 
added to 800pi of each standard and sample. After a 5 minute incubation period at room 
temperature the samples were assayed by UV / visible spectrophotometry at 595nm 
(LKB biochrom Ultrospec II). A calibration curve was plotted and the concentration of 
each of the extracts calculated.
2.8.3 Labelling of the oligonucleotides
Oligonucleotides, typically between 15 and 30 bases, representing the sequence of the 
appropriate transcription factor binding site, were synthesized as two complementary 
single strands. One oligonucleotide strand was radiolabelled by the transfer of a y-32P 
molecule from y-32P-ATP by the bacterial enzyme T4 polynucleotide kinase prior to the 
annealing of the complementary strands. This reaction occurs independently of oligo 
sequence and can also be employed in the labelling of double stranded oligonucleotides. 
The DNA sequences of the oligonucleotides used are shown below. The AP-1 and NFAT 
oligonucleotides were a kind gift from Dr. A. Lennard at the Yamanouchi Research 
Institute in Oxford whilst the NFkB oligonucleotide was purchased from Promega (Cat. 
No. E3291)
AP-1 5' CGC AAG TGA CTC AGC GCG 3' 
3' GCG TTC ACT GAG TCG CGC 5’
NFAT 5’ GGA GGA AAA ACT GTT TCA TAC AGA AGG CGT 3’ 
3' CCT CCT TTT TGA CAA AGT ATG TCT TCC GCA 5’
NFkB 5' AGT TGA GGG GAC TTT CCC AGG C 3’ 
3' TCA ACT CCC CTG AAA GGG TCC G 5'
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A labelling reaction containing 50ng of single stranded oligonucleotide, 
25|iCi 32P y-ATP (4500 Ci/mmol, ICN Cat. No. 38101X), PNK buffer and enzyme 
(Sequitherm kit, Epicentre Technologies) in a final volume of 5|il was incubated at 
37°C for 40 minutes. The reaction was stopped by heating to 70°C for a further 10 
minutes to deactivate the enzyme. 50ng of the complementary strand were added and 
the reaction diluted to IOjllI with TE buffer (see appendix 2). The two strands were 
annealed by heating to 65°C for 5 minutes, followed by incubation at 37°C for 5 
minutes. The samples were then cooled to room temperature before being diluted to 
lOOpl with TE buffer and placed on ice. Unincorporated label was removed by passage 
of the oligonucleotide solution through a Sephadex G50 spin column (Pharmacia Cat. 
No. 17-0862-01) equilibrated with TE buffer. An aliquot of the eluate was taken prior 
to each experiment and a sample of this was counted for radioactivity. The aliquot was 
then diluted to give 20000cpm / |xl ready for addition to the binding mix.
2.8.4 EMSA
Typically 15jxg of nuclear extract in 12p,l of buffer 3 were added to a binding mix 
containing l|ig poly dl-dC (Pharmacia Cat. No. 27-7880), 7.5% %  glycerol, 38mM 
KC1 and 0.6mM MgCl2 . After a 10 minute preincubation period radiolabelled 
oligonucleotide was added (40000cpm in 2pl ) to give a final volume of 20|il. The 
samples were incubated for 20 minutes at room temperature before loading onto a 5% 
%  native (non denaturing) polyacrylamide gel (see appendix 3). 5|il of 6% w/v loading 
dye (see appendix 2) was added to a no-extract control as a marker during the running 
of the gel. The gel was run in 0.5x TBE ( see appendix 2 ) at a constant voltage of 150V 
for a period of approximately two hours. On completion the gel was fixed in 10%v/v 
MeOH, 10%v/v glacial acetic acid and 5%% glycerol prior to drying onto filter paper 
and autoradiography. The duration of the exposure of the film varied depending upon 
the relative abundance of the protein and the activity of the oligonucleotide but was 
typically 24 hours.
2.9 Sphingomyelinase assay
Several signalling pathways in T cells, including that of CD28, have been proposed to 
involve the activation of the phospholipase enzyme sphingomyelinase. This, when 
activated, hydrolyses the sphingosine-based membrane lipid, sphingomyelin to produce 
ceramide and phosphocholine. This assay, based on the method described by Boucher 
et al (1995), enables the detection of sphingomyelinase activity by the measurement of 
phosphocholine levels in aqueous cell extracts. Stimulated cells are incubated with 14C 
sphingomyelin and the radioactive products are detected by chromatographic or 
scintillation methods. The latter method was used here to assess sphingomyelinase 
activation in cells taken from cultures used for the EMSA.
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T cell blasts or Jurkat cells were incubated in serum- free RPMI 1640 medium at 37°C 
for a minimum of two hours to ensure against serum induced enzyme activation. 3xl06 
cells in lOOpl aliquots were then transferred into individual eppendorfs and the 
appropriate stimuli were added. All the transfectants used were glutaraldehyde fixed 
and washed twice prior to mixing. At the relevant time points the reaction was stopped 
by immersion of the eppendorf in liquid nitrogen, followed by dilution of the sample 
with 1ml of ice cold PBS and centrifugation for 10-15 seconds at 2000rpm using a 
refrigerated microfuge (Heraeus Biofuge Fresco). Cell pellets were washed twice in 
cold PBS, once in buffer A (20mM Tris- HC1 pH 7.4, 137mM NaCl, ImM MgCl2, 
ImM CaCl2 and protease inhibitors as for EMSA buffer 1) and were recovered by 
centrifugation as above. The final pellet was incubated on ice in 200p,l of buffer A 
containing 0.5% NP40 for 15 minutes. Supernatants were recovered following 
centrifugation at 13000rpm for 5 minutes and assayed for protein content using the 
Biorad dye method detailed above. 30-50|ig of protein were diluted in buffer B 
(250mM NaAc, ImM EDTA (pH5), l.lpC i/m l 14C-Sphingomyelin (Amersham 
CFA566)) to a final volume of 50|il. After incubation for 2 hours at 37°C the samples 
underwent chloroform : methanol extraction (2:1). Briefly 800jil of the chloroform/ 
methanol mix were added to the sample which was diluted to a final volume of 1.1 mis 
with H20 . After vortexing and high speed centrifugation as above 200|il of the aqueous 
phase were mixed with 5mls of scintillation fluid and counted. A timecourse of enzyme 
induction was plotted as percentage increase above basal levels.
For experiments involving enzyme inhibitors the cells were preincubated for 1 hour 
with appropriate concentrations of the inhibitor or PBS vehicle after the incubation in 
serum-free medium.
2.10 JNK assays
JNK activation can be detected in vitro as a phosphorylation of the JNK substrate, 
c- jun. In this assay, based on the method described by Derijard et al (1994), lysates 
from stimulated cells are incubated in vitro with the fusion protein GST-jun 
comprising amino acids 5-89 of the N terminus of c-jun. Addition of radioactive 
phosphate enables the phosphorylation of the GST-jun by activated enzyme which can 
then be detected by gel autoradiography.
5xl06 Jurkat cells or T cell blasts were stimulated for a period of time (1-30 minutes ) 
and were then lysed in buffer A with 0.2% NP40 as described above (sphingomyelinase 
assay). The 1ml lysate was incubated overnight on a rotator at 4°C with GST-jun coated 
agarose beads. The beads were pelleted by gentle centrifugation and were washed once 
in lysis buffer and once in kinase buffer ( 25mM Hepes pH7.4, lOOmM NaCl, 5mM 
MnCl2, lOmM MgCl2, IOOjiM Sodium orthovanadate and 10pM Mg2+ ATP). The
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kinase buffer was aspirated from the bead pellet which was then resuspended in a 
further 30|il of kinase buffer at room temperature. To this were added lOfiCi of 32P f  
ATP (4500 Ci/mmol, ICN Cat. No. 38101X) and the samples were left for 30 minutes. 
The reaction was stopped by two washes in kinase buffer containing 30 mM EDTA 
followed by draining of the pellet and its resuspension in lOpl of sample buffer (see 
appendix 2). The samples were boiled for 10 minutes and run on a 10% SDS-PAGE gel 
(see appendices 2 and 3). Protein was visualised by coomassie staining before the dried 
gel was autoradiographed. Results are shown as an image captured using Imagedok 
analysis program software.
After optimisation of the assay in Jurkat cells using U.V stimulation, the B7-stimulated 
T cell blast cytoplasmic extracts produced as by-products of the EMSA were analysed 
for JNK activity as a comparison between the ability of stimuli to induce transcription 
factor and JNK activity.
2.11 DNase 1 footprinting assays
A DNAse footprint assay is based on a similar principle to that of the EMSA. Cells are 
stimulated to produce transcription factor proteins which bind a large specific 
radiolabelled probe usually coding the whole gene promoter of interest. The DNA is 
then degraded using a DNase digestion enzyme. However, the regions of DNA bound 
by protein are protected from DNase digestion and can be gel analysed to reveal their 
position within the gene promoter. This enables a better assessment of physiological 
binding to gene promoters as it allows competition between factors for binding sites as 
well as cooperative binding. Experiments were carried out to assess the protected 
regions of the IL-2 promoter with the aim of studying the binding characteristics of the 
CD28RC.
The footprint assay required the preparation of nuclear extracts as detailed above and 
the generation of both an oligonucleotide probe and a G+A sequencing marker the 
preparation of which is based on the Maxam and Gilbert sequencing method (Sambrook 
et al., 1989) and which is described briefly below.
2.11.1 Plasmid preparation
A PCR product of the IL-2 promoter region was generated at the Yamanouchi Research 
Institute at Littlemore Hospital Oxford and kindly donated. This was subcloned directly 
into the mammalian TA cloning vector, pCR3 (see appendix 5) by ligation of the insert 
into the vector which was carried out overnight at 14°C with unligated and religated 
controls. Competent E. Coli Top 10F cells were transformed with the ligations by heat 
shock using an Invitrogen eukaryotic TA cloning kit (Cat No. K3001-01). Briefly 2pl
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0.5M P-mercaptoethanol were added to a 50|il aliquot of Top 10F cells and mixed by 
gentle stirring. 2 pi of ligation mix were then added and the samples incubated on ice for 
30 minutes. The samples were placed in a water bath at 42°C for exactly 30 seconds and 
then returned immediately to ice for a further 2 minutes. 800|il of SOC media (see 
appendix 4) were added to each vial which were then placed in an orbital shaker at 37°C 
for 1 hour. Aliquots were then plated out on ampicillin-containing agar plates (see 
appendix 4) and left at 37 °C overnight.
Several bacterial colonies were picked at random from the agar plates and grown 
overnight in 5ml broth minicultures (see appendix 4). Minipreps were prepared from 
each using the standard alkaline lysis protocols by Bimboim and Doly and Ish-Horowicz 
and Burke which are described in Maniatis (Sambrook et al., 1989). Single and double 
restriction enzyme digests were carried out and analysed on a lx TAE buffered 1% 
agarose/ ethidium bromide gel (see appendices 2 and 3) to isolate cultures carrying the 
IL-2 promoter insert. A 500ml maxiprep was prepared from one positive culture using 
the above methods and the plasmid prep was PEG purified (R. Treisman, Maniatis 
(Sambrook et al., 1989)). The pellet was resuspended in TE buffer and the DNA 
concentration was assessed by spectrophotometry at 260nm.
2.11.2 Footprinting Probe
30pg of the plasmid were cut to completion with a restriction enzyme approximately 
lOObp from the site of interest to leave a 5' overhang. Excess calf intestinal phosphatase 
(CIP) (Boehringer Mannheim Cat. No. 713023) was then added to the reaction mix 
which was incubated at 37°C overnight to ensure complete removal of the 5' terminal 
phosphatases. The CIP was removed by one phenol only and one phenol/ chloroform 
extraction followed by ethanol precipitation. The recovered linear plasmid was 
resuspended in TE at 2.5fig/pl and a 5|ig aliquot was removed for 5' end labelling. The 
labelling reaction was carried out as described for the EMSA oligonucleotide but before 
purification the plasmid was cut for a second time using excess of a restriction enzyme 
cutting at a site 60-700 base pairs from the first.
The probe was purified by adding loading dye (see appendix 2) directly to the digest mix 
and running the sample on a 5% non denaturing acrylamide gel (see appendix 3) in 
lxTBE (see appendix 2) at 150V for approximately 2 hours. The gel was exposed to X- 
ray film for 2 minutes and the required band was located and excised with the aid of 
fluorescent markers to help alignment of the film and gel. The probe was electroeluted 
from the gel slice in 0.5xTBE at 100V for 1 hour into a high salt solution. Purified probe 
was recovered by phenol/chloroform extraction and ethanol precipitation in the presence
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of excess glycogen to act as a carrier. The probe was stored at -20°C until required when 
activity was assessed by p emission counting.
2.11.3 G+A Sequencing Ladder
200000cpm of probe was diluted to 20|il with H2 O and placed on ice for 5 minutes. 50|il 
of Formic acid were added and the probe incubated at 20°C for 3.5 minutes. The reaction 
was stopped with 180|il of HZ stop solution followed immediately with 750jllI of ethanol. 
The probe was recovered by precipitation on dry ice for 10 minutes followed by 
centrifugation at 14000rpm for 20 minutes in a microfuge. The pellet was resuspended in 
0.3M NaAc and reprecipitated with ethanol. The recovered pellet was washed with 
ethanol and dried before resuspension in 1M piperidine and incubation at 90°C for 
30 minutes. The pellet was lyophilised for 4 hours, resuspended in water and lyophilised 
again overnight. After a third lyophilisation the pellet was resuspended in water and the 
activity assessed by p emission counting. An aliquot of marker corresponding to 
7000cpm was then taken to which 5 jllI of formamide blue were added in preparation for 
gel loading.
2.11.4 DNase 1 Digestions
The initial assay was to determine an appropriate concentration of DNase enzyme to 
obtain optimal digestion. Two sets of eppendorf tubes with and without cell extracts were 
set up covering a range of DNase enzyme concentrations as lower concentrations were 
required in the absence of extract. 12p,g of extract in a final volume of 20p,l ,were 
incubated at room temperature for 10 minutes in the presence of salt mix (KC1, MgCl2 ), 
extract buffer and poly dl-dC (l|ig). 2jil of probe representing 20000cpm were then 
added and the mix preincubated at 20°C for 20 minutes to allow protein binding to reach 
equilibrium. 3p.l of the appropriate DNase 1 solution was then added to the mix followed 
exactly 1.5 minutes later by 200p.1 of stop solution. The digestions were recovered by 
phenol/ chloroform extraction followed by ethanol precipitation. The pellets were 
resuspended in 5p,l formamide blue and both the samples and G + A marker were boiled 
for 2 minutes.
2.11.5 Gel
The samples were loaded onto a 6% gradient sequencing gel (see appendix 3) and run in 
lxTBE at 1000V/ 50mA for approximately five hours until the cyanol blue had reached 
the bottom of the plate. The gel was removed and fixed for 20 minutes in 10%methanol / 
10% acetic acid prior to drying and autoradiography . The G+A ladder was aligned with 
the IL-2 promoter sequence enabling location of the protected regions.
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Several experiments were carried out initially in order to optimise the conditions required 
including titrations for DNase, poly dl-dC and MgC^. Extracts produced from 
stimulated and unstimulated cell cultures were then tested to obtain appropriate 
footprints.
2.12 Reporter construct assays
Reporter construct assays have proved extremely useful as laboratory tools especially for 
the study of the regulation of gene promoters by transcription factors. Two, well 
characterised protocols involve the cellular transfection of transcription factor driven 
CAT (Gorman et al., 1982; Sleigh, 1986) or luciferase reporter constructs. Plasmids 
containing either a constitutive promoter or multiple transcription factor binding sites 
upstream of the enzyme reporter gene are transfected into a host cell (see appendix 5). 
The transfections can be achieved in a variety of ways although the methods detailed 
here involve the technique of electroporation. After a recovery and stimulation period if 
required, the cells are lysed to produce cytoplasmic extracts containing the transcribed 
enzyme. An in vitro assay then enables measurement of enzymatic activity which can be 
correlated with the activation of the cell by the stimulus or in the case of constitutive 
activity, acts as a positive control. The aim of these assays was to assess the ability of 
certain stimuli to induce functional transcription factor complexes. Whilst the EMSA 
detects the induction of a transcription factor it does not show that this is functional 
transcriptionally. Initially constitutive CAT assays were carried out to enable 
optimisation of the electroporation conditions required for the transfection of the cells 
but these were later replaced by luciferase assays due to the reported increased sensitivity 
of the latter (Alam and Cook, 1990).
2.12.1 Electroporation of Jurkat cells
Initial electroporation conditions were obtained from the literature and were then 
optimised for the Jurkat cells in terms of voltage, time constant and electroporation 
buffer to give a maximal permeabilisation to viability ratio. Comparisons between 
different conditions were made using an FDA/ PI FACS analysis assay.
Jurkat cells were washed and resuspended in either HeBS or Ca2+/ Mg2+ PBS buffer at a 
concentration of 5xl06/ml and were electroporated over a range of voltages (200-400V) 
at varying capacitances (250-960p,F). A 200|il aliquot of electroporated cells were placed 
on ice and incubated for 10 minutes with 4pg/ml PI. The cells were then diluted in 1ml 
of culture medium and incubated at 37°C for 30 minutes. Following this they were 
washed in PBS and resuspended in 1ml of PBS containing O.lng/ml FDA solution. 
FACS analysis of the cells produced a single and double stained profile of the cell
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permeabilised and viable. It was optimisation of this latter subset which was required to 
ensure a good transfection and recovery rate of the cells.
2.12.2 CAT Assay
Once the conditions had been optimised Jurkat cells were transfected with constitutive 
CAT constructs (CMV-CAT plasmids, Invitrogen) to optimise the detection assay. 
Cells were electroporated, diluted in medium and cultured for 48 hours. Cell pellets 
were obtained after counting and centrifugation and were resuspended in ice cold 
0.25M Tris-HCl pH 7.5 at 5xl07/ml. The cells were lysed by three freeze thaw cycles in 
liquid nitrogen and the supernatant was recovered by high speed centrifugation. The 
cytoplasmic extracts were frozen rapidly in liquid nitrogen and stored at -20°C until 
required.
Several methods have been described for the detection of CAT activity but a technique 
based on liquid scintillation counting (Neumann et al., 1987) was selected. An assay 
cocktail consisting of lOOmM Tris-HCl pH 7.8, ImM Chloramphenicol and O.lmM 14C 
acetyl Co A (ICN Cat. No. 13070L) was prepared. 200pl of this mix were then added to 
50jil of cytoplasmic extract and overlaid with 5mls of scintillation fluid. Following the 
enzymatic transfer of the 14C- acetyl group to the chloramphenicol, this molecule then 
partions into and activates the water immiscible scintillation fluid to cause an increase 
in detectable cpm. Any residual 14C acetyl Co A remains in the layer below the 
scintillant. The samples were assayed at hourly intervals by (3 scintillation counting to 
enable the construction of graphs of extract volume and electroporation conditions 
against time.
2.12.3 Luciferase Assay
The cells were electroporated as described above and cultured for 24 hours. Pelleted 
cells were washed twice in PBS and then resuspended in Reporter Lysis Buffer 
(Promega Cat. No. E4030) at lx l0 7/ml. After a 15 minute incubation at room 
temperature the cells were transferred to an eppendorf, cooled on ice and then vortexed 
for 10-15 seconds. Supernatants were recovered from a 15 second high speed 
centrifugation, underwent a single freeze-thaw and were stored at -70°C until required.
Luciferase activity was assessed by mixing 20|il of the extract with IOOjllI of luciferase 
assay reagent and measuring the light emitted using a Bio-orbit 1251 luminometer. If 
the machine is calibrated absolute values can be calculated otherwise results are 
expressed as relative activity compared to controls.
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RESULTS
GENERAL AIMS OF THE WORK
The primary aims of this study were to investigate the role of CD28 as a costimulatory 
molecule in T cell activation, with particular reference to its regulation of IL-2 
production. Previous studies have reported CD28-mediated effects on the gene promoter 
region which regulates IL-2 transcription although little is actually known concerning the 
participating role of CD28 signals as compared to those of the TCR. It was therefore 
proposed to further investigate the effects of CD28 on the IL-2 promoter and the 
signalling pathways utilised in the transduction of the signals from the cell surface to the 
nucleus. This was achieved using a variety of different techniques designed to provide 
qualitative and functional data arising from activation of the CD28 signalling pathway.
T CELL MODELS
Much of the previous work which has been carried out to establish the role of CD28 in 
transcriptional activation has been undertaken in immortalised cell lines such as Jurkat 
cells. Whilst these cells provide an easily available model system for such studies, their 
transformed phenotype means that responses observed may not always be an exact 
representation of the responses of resting T cells. Extrapolations from such in vitro to in 
vivo systems and responses should therefore be made with caution. The present study 
involved the development of a more physiological model system in which to investigate 
the role of CD28. Whilst Jurkat cells were still employed as controls in the establishment 
of the various techniques, more physiological T cell models were used where possible to 
ensure the relevance of the results. Comparison of the different cell models enabled the 
limitations of each model to be highlighted to aid their appropriate usage in future 
studies.
DATA
Variations in responses of different T cell blast and resting T cell cultures were 
commonly observed due to the varying sensitivity of the blood donors to different stimuli 
although the trends remained reproducible. It was therefore not possible to display the 
mean results of the repetitions despite a minimum of an n of 3 for each experiment. Data 
have therefore been shown as a representative experiment with the standard error 
representing variations in the triplicate readings. The absence of an error bar indicates an 
error of less than 5%.
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CHAPTER 3 - THE ROLE OF CD28 AS A COSTIMULATORY MOLECULE
3.0 COSTIMULATION
Since the aims of the study centred around the role of CD28, it was important to first 
have an understanding of the effects on the T cells of CD28 stimulation alone and as a 
costimulatory molecule in the presence of TCR engagement. The antigenic signal can be 
mimicked by the use of cross-linked monoclonal antibodies to CD3 (review Janeway, 
1992; Kuiper et al., 1994a; Costello et al., 1993) and many previous studies have utilised 
anti CD28 monoclonal antibodies to ligate the costimulatory surface receptor and induce 
activation (Kuiper et al., 1994a; Costello et al., 1993). However, since in the laboratory 
established B7-1 transfected CHO cell lines were available, initial experiments were 
undertaken to investigate the ability of these transfectants to costimulate anti-CD3 - 
stimulated T cells in proliferation assays. Figure 3.0 shows a representative assay 
comparing proliferative responses observed in resting purified peripheral blood T cells 
(A) and in peripheral blood mononuclear cells (PBMCs) (B). The cells were incubated 
with the appropriate stimuli for 72 hours before the assessment of proliferation by 3H- 
Thymidine incorporation. As shown, whilst both cell types had negligible basal 
proliferation, PBMCs could be induced to proliferate in the presence of anti-CD3 alone 
whilst the purified T cells required both TCR and CD28 ligation. Addition of fixed CHO 
cells did not alter the responses but, in the presence of B7, proliferation increased in both 
cell types. This indicated that the B7 transfected CHO cells could provide adequate 
costimulation and that the induced response was specifically due to B7 and not to other 
features of the CHO cells.
Thus the observations made from these experiments indicated that the CHO-B7 
transfectants were acting as an efficient costimulatory signal in these cells and that whilst 
the presence of B7 enhanced PBMC responses it was an absolute requirement for 
purified T cell activation.
3.1 USE OF PERIPHERAL BLOOD T CELL BLASTS
Due to the sensitivity limitations of several of the techniques used in this study, large 
numbers of T cells were required to enable detection and interpretation of the response. 
Whilst purified T cells could be regarded as the most physiological in vitro model of a 
resting T cell it was not possible to obtain a sufficient quantity to carry out all the 
required assays. PBMCs, although available in larger numbers, contain a mixed 
population of cells including monocytes and B cells and were therefore unsuitable for use 
as a specific T cell model. The preparation of T cell blasts from PBMC cultures, 
however, enabled expansion of the T cell population alone and resulted in a non-clonal
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but responsive cell culture. Since these cultures were derived from resting cells it was 
hoped that they would prove to be a more relevant T cell model than the transformed 
Jurkat cell line. Thus PBMCs purified from human blood donations were stimulated with 
PMA and ionomycin to activate the T cells and the T cell blasts were allowed to grow 
out in culture for 4-10 days before being used for the various assays.
Proliferative responses were obtained for both the PMA/ ionomycin T cell blasts (figure
3.1 A) taken from culture 8 days after the initial stimulation and for the Jurkat cells (B) as 
a comparison . Although compared to the unactivated cells basal proliferation of the T 
cell blasts was quite high, like the resting cells both anti-CD3 and B7 transfectants were 
required to induce proliferation although aCD3 alone did induce low levels of IL-2 . 
However, contrasting results were obtained with the Jurkat cells. These cells proliferate 
continuously in the absence of any extracellular stimuli and in an IL-2 independent 
manner. Consequently the basal proliferation of the Jurkat cells was extremely high 
making it difficult to assess the effects of a stimulus. As shown, stimulation of the Jurkat 
cells with anti CD3 in the presence or absence of B7 had little significant effect on basal 
proliferation levels nor did these stimuli induce any significant IL-2 production. Thus 
even from these initial experiments it appeared that the T cell blasts more closely 
represented resting T cells than the Jurkat cells.
3.2 EFFECTS OF PMA
Many of the previous studies undertaken to investigate the costimulatory role of CD28 
have occurred in the presence of PMA and ionomycin (June et al., 1989). These two 
stimuli supposedly substitute for TCR ligation by directly activating PKC and triggering 
calcium entry respectively; downstream events which normally occur following 
engagement of the T cell receptor. As a comparison to the responses obtained following 
ligation of the TCR-CD3 complex using cross-linked antibody, the effects of PMA and 
ionomycin were also investigated in the different cell models.
Stimulation of resting T cells and T cell blasts with PMA and ionomycin induced 
proliferation and IL-2 output in both cell types (figure 3.2). This response was somewhat 
surprising especially in the resting T cells since stimulation of the TCR alone in the 
absence of a costimulatory signal is known to be insufficient for full activation (Harding 
et al., 1992). Furthermore, unlike the results seen with anti-CD3 antibodies, addition of 
B7 transfectants to the resting T cells appeared to decrease the responses whilst a slight 
increase in IL-2 production was observed in the T cell blast cultures. Thus PMA and 
ionomycin appeared to be providing different signals than the anti-CD3 antibody.
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Interestingly, the observed responses of Jurkat cells revealed that whilst they were 
relatively unresponsive to stimulation via their surface receptors they were highly 
sensitive to stimulation with PMA and ionomycin. Incubation of the Jurkat cells with 
PMA alone or in the presence of ionomycin dramatically inhibited the basal proliferation 
whilst inducing large amounts of IL-2 (figure 3.3). Addition of B7 transfectants to the 
PMAI ionomycin stimulated Jurkat cells had little effect on the PMA-induced inhibition 
of proliferation but induced a further increase in IL-2 production. Since PMA and 
ionomycin are proposed to be activating stimuli this negative effect on proliferation was 
unexpected and implied a substantial difference in signalling outcome in the transformed 
Jurkat cells compared to normal T cells.
Following this observation further studies were undertaken to investigate the effects of 
PMA on Jurkat cells. Assessment of cell viability as measured by trypan blue exclusion 
was inconclusive since although there appeared to be fewer cells in the stimulated 
cultures at the end of the experiment, those cells that remained were still viable. The PI 
stained cytospins were also difficult to interpret due to low level staining and the small 
number of cells examined. FACS analysis of a timecourse of PMA stimulation provided 
the most information and showed an increase in Jurkat cell death over time, a loss of S 
phase cells and an accumulation of the remaining live cells in G2 phase (figure 3.4) 
indicating the cells were undergoing cycle arrest prior to death.
3.3 COSTIMULATION OF A SUBOPTIMAL PMA INDUCED RESPONSE
Since the PMA and ionomycin stimulation appeared to be providing a maximal response 
it was possible that the high concentration of PMA (30ng/ml) may have been activating 
both the TCR and costimulatory pathways. It was therefore decided to reduce the 
concentration of PMA used in an attempt to separate activation of the two signalling 
pathways and observe a costimulatory role for B7 in mitogenically-activated normal T 
cells. PMA titration proliferation profiles were obtained for Jurkat cells, resting T cells 
and the T cell blasts (figure 3.5) which revealed several interesting points. The three cell 
types demonstrated different sensitivities to PMA stimulation both in respect to each 
other and when comparing effects on proliferation and IL-2 production. Interestingly in 
all three cell types induction of IL-2 decreased at the highest dose of PMA implying a 
toxic effect.
As observed during the initial assays the addition of PMA to Jurkat cells inhibited their 
proliferation whilst stimulating IL-2 production. However although the effect on 
proliferation was maximal at 0.03ng/ml, this did not induce IL-2 production which 
peaked at 3ng/ml PMA. This indicates different PMA sensitivities of the two activation 
events and implies at least two different targets for PMA. Interestingly in the presence of
61
high doses of PMA the inhibitory effect on proliferation was partially reversed which 
may indicate the activation of an additional pathway which antagonises the inhibition of 
proliferation.
Resting T cells, in the presence of ionomycin, required a minimum PMA concentration 
of 0.03ng/ml PMA to observe proliferation whilst a minimun threshold of 0.3ng/ml was 
required for IL-2 output. Therefore as observed with the Jurkat cells IL-2 production 
appears to require a higher level of stimulation than proliferation. However, in the resting 
cells both proliferation and IL-2 production reached a peak at 0.3ng/ml indicating that 
with respect to IL-2 production these cells had an increased sensitivity to PMA compared 
to the Jurkat cells.
The T cell blasts responded almost as a mirror image of the Jurkat cells. The minimum 
dose of 0.003ng/ml induced a high level of proliferation which was maintained over the 
titration. The T cell blasts were also the most responsive to PMA following the 
assessment of IL-2 production implying that the activated cells had a lower PMA 
threshold requirement for IL-2 production than either the transformed or resting T cells.
Having established the responses of different cell types to suboptimal PMA 
concentrations the effects of B7 alone ([PMA]=0) and as a costimulus to the PMA/ 
ionomycin responses, were investigated. Figure 3.6A shows the effect of B7 on 
suboptimal PMA- stimulated Jurkat cells. The addition of B7 transfectants alone had no 
effect on Jurkats however, in the presence of PMA concentrations above 0.03ng/ml the 
B7 stimulation did restore some of the proliferative ability of the cells and considerably 
increased their IL-2 ouput. As these effecs were only observed at high doses of PMA 
(>0.03ng/ml) this indicated a requirement for a certain threshold level of PMA-induced 
activation of the cells.
A similar PMA/ionomycin/ B7 synergy was observed in resting T cells (figure 3.6B) but 
only in the presence of very low concentrations of PMA (< 0.3 ng/ml). As shown, 
0.003ng/ml PMA in the presence of ionomycin did not induce proliferation alone but did 
so in the presence of the B7 transfectants. This indicates that the presence of B7 
increases the sensitivity of these cells to PMA stimulation and implies a synergy between 
the two signals. This stimulation, however, did not result in IL-2 production which 
required a minimum PMA concentration between 0.003ng/ml and 0.03ng/ml in the 
presence of B7. The lower doses of PMA required for activation in resting T cells 
indicated that these were more representative of physiological concentrations and that the 
higher doses used routinely in vitro may invoke unphysiological responses due to 
cytotoxicity.
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In the case of the PMA/ ionomycin blasts, B7 stimulation enhanced the responses seen 
with PMA and ionomycin alone at all concentrations of PMA but most significantly at 
0.3ng/ml (figure 3.6C).
Following this study, for all subsequent experiments involving PMA stimulation, a final 
concentration of 0.3ng/ml was used for the Jurkat cells and T cell blasts and 0.03ng/ml 
for the resting T cells which was deemed to be sufficient to give a submaximal response 
in each of the cell types so allowing the effects of additional stimulations to be observed.
3.4 FACS ANALYSIS OF SURFACE EXPRESSION
Prior to their use in experimental assays the T cells routinely underwent FACS analysis 
to check the viability, purity and surface molecule expression levels. Cells were stained 
for a number of different surface markers chosen to indicate the identity and activation 
state of the cell and then analysed by FACS. Figure 3.7 shows the diagramatic FACS 
profile of Day 8 T cell blasts whilst those for Jurkats and resting T cells are shown in 
figures 3.8 and 3.9 respectively. The percentage of positive cells and MFI for each 
surface molecule are also shown in Tables I to III. Although the expression profiles for 
the cell types were similar some differences were evident. Jurkats and resting T cells 
were IL-2Ra negative (CD25“) explaining their lack of response to exogenous IL-2 
whereas the T cell blasts displayed varying degrees of positive staining. Similar 
observations were made for the MHC class II molecule which was expressed by the 
activated T cell blasts but not by the Jurkat cells or resting T cells. All cells were CD2, 
CD3 and CD28 positive to varying degrees and B7 negative.The majority of resting T 
cells and blasts were CD4+ although a small population were found to be CD8+ T cells.
Figure 3.10 shows the surface expression of the transfectants used. Again these were 
routinely assayed to ensure stable expression levels of the relevant surface markers. CHO 
cells were routinely negative for all relevant surface molecules and were therefore used 
as negative controls in experiments requiring transfectant stimulation.
3.5 SUMMARY
Initial experiments indicated that resting T cells could be induced to proliferate and 
produce IL-2 using a combination of cross-linked anti-CD3 antibody and fixed CHO-B7 
transfectants. High concentrations of PMA in combination with ionomycin provided all 
the necessary activation signals whilst suboptimal PMA doses could be effectively 
costimulated by B7. The T cell blasts also required two signals for full activation but 
were fully activated by extremely low doses of PMA in the presence of ionomycin. 
However, the T cell blasts appeared to be a more physiological model of a resting cell
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than Jurkat cells which were unresponsive to surface stimulation and inhibited by PMA. 
Further studies will be required to decipher the exact effects of PMA in T cells as high 
doses appear to have additional effects to activation of the TCR pathway. A comparison 
of the responses observed in the presence and absence of costimulation using anti-CD3 
or low dose PMA/ ionomycin stimulated cells should enable some of the effects of 

















Figure 3.0 The 
Resting T cells
Resting T cells (A) and PBMCs (B) were left unstimulated or were incubated with aC D 3 
(1 |ig/ml) alone or in the presence o f  fixed CHO cells or fixed B7 cells for 72 hours. 
Proliferation was measured by 3H-Thymidine incorporation. Data are the triplicate mean 




































Figure 3.1 The effect of costim ulation  on the proliferative responses and IL-2 
production of aC D 3 stimulated PM A/ ionomycin T cell blasts and Jurkat cells
PM A/ionomycin T cell blasts (A) and Jurkat cells (B) were left unstim ulated or were 
incubated with otCD3 (l|ig /m l) alone or in the presence of fixed CHO cells or fixed 
B7 cells for 72 hours. Proliferation (i) was measured by ^H-Thymidine incorporation 
whilst IL-2 production (ii) was assessed using a CTLL bioassay. Data are the 
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Figure 3.2 The effect o f costim ulation  on the proliferative responses and IL-2 
production of PM A/ ionomycin stim ulated Resting T cells and T cell blasts
Resting T cells (A) and PM A/ionom ycin T cell blasts (B) were left unstim ulated or 
were incubated with PMA (30ng/m l) and ionomycin ( lp M )  alone or in the presence 
o f fixed CHO cells or fixed B7 cells for 72 hours. Proliferation (i) was m easured by 
3H-Thymidine incorporation whilst IL-2 production (ii) was assessed using a CTLL 
bioassay. Data are the triplicate mean o f a representative experiment.
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Figure 3.3 The effect o f costim ulation on the proliferative responses and IL-2 production 
o f PM A / ionomycin stim ulated Jurkat cells
Ju rka t cells w ere left unstim ulated  or were incubated w ith PM A (30ng/m l) and 
ionom ycin ( l |iM )  alone or in the presence o f fixed CH O  cells or fixed B7 cells for 
72 hours. Proliferation (A) was m easured by 3H -Thym idine incorporation w hilst IL-2 
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JURKAT (OX) PI 24HR
Marker % Total M ean 
All 1 0 0 .0 0  5 7 9 .6 7
M1 8 .2 8 94 .9 1
M2 6 0 .8 0 4 4 6 .6 5








JURKAT (OX) PI 48
Marker % Total M ean
All 1 0 0 .0 0 5 3 9 .0 3
M1 14 .06 9 0 .5 5
M2 4 0 .7 0 4 2 5 .1 7











JURKAT (OX) 72  HR PI
rker % Total M ean Marker % Total Mean
All 1 0 0 .0 0 4 9 9 .7 6 All 1 0 0 .0 0 4 2 1 .5 0
M1 2 5 .8 6 6 7 .9 0 M1 3 8 .8 6 4 9 .7 2
M2 4 4 .8 6 4 2 0 .4 0 M2 3 6 .2 6 4 1 0 .5 7
M3 2 9 .1 0 9 9 4 .1 5 M3 2 5 .7 2 9 9 4 .2 4
Figure 3.4 The effect o f PM A on Jurkat cells
Jurkat cells were left unstim ulated (i) or were incubated with PMA (30ng/m l) for 24 
hours (ii), 48 hours (iii) or 72 hours (iv). The cells were then washed and stained 
with propridium iodide before FACS analysis. Data is plotted on a log scale to show 
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F igure 3.5 The effect o f PM A concentration on the proliferative responses and IL-2 
production o f different cell types
C ells were left unstim ulated or were incubated with increasing concentrations o f PM A in 
the presence o f ionom ycin ( l |iM )  for 72 hours. P roliferation (A) was m easured  by 
3H -Thym idine incorporation w hilst IL -2  production (B) was assessed using a CTLL 
bioassay. Data are the triplicate mean o f  a representative experiment.
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Figure 3.6 The effect o f costim ulation  on the proliferative responses and IL -2  
production o f different cell types stim ulated with suboptimal concentrations o f  PM A
Jurkat cells (A), Resting T cells (B) and T cell blasts (C) were left unstim ulated or 
were incubated with ionomycin (1 jiM ) and increasing concentrations o f PM A  alone
(0) or in the presence o f fixed CH O-B7 transfectants (o) for 72 hours. P roliferation
(1) was measured by 3H -Thym idine incorporation whilst IL-2 production (ii) w as 
assessed using a CTLL bioassay. Data are the triplicate mean o f a representative 
experim ent. 71
Table I- FACS analysis of the surface expression of day 8 T cell blasts
Cells were fluorescent stained for a num ber of surface T  cell m olecules and analysed by 
FACS. Results are shown as percentage o f cells with the mean fluorescent index (M FI).
SURFACE
M OLECULE
M ARKER % OF 
TOTAL
M FI
NEG M l 98.6 3.7
CD2 M2 95.3 218
CD3 M2 89.1 83.6
CD4 M2 54.1 37.7
CD8 M l 78.5 4.6
CD25 M l 69.1 5.5
CD28 M2 73.6 60
CD80 M l 97.5 3.6
HLA-DR M l 64.7 5.6
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Figure 3.7 FACS analysis of Day 8  T cell blasts
Cells were fluorescent stained for a number of surface T cell molecules and analysed by
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Figure 1.8 FACS analysis o f the surface expression o f Jurkat cells
Cells were fluorescent stained for a number of surface T cell molecules and analysed by
FACS. Results are shown as log histograms of surface staining.
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Table III FACS analysis of the surface expression of Resting T cells
Cells were fluorescent stained for a num ber o f surface T cell m olecules and analysed by 
FACS. The results are shown as of percentage o f cells with the MFI.
SURFACE
M OLECULE
M ARKER % OF 
TOTAL
M FI
NEG M l 98.7 2.1
CD2 M2 88.2 47.4
CD3 M2 76.7 74.1
CD4 M2 59.6 31.8
CD8 M l 77.1 2.5
CD25 M l 98.2 2.2
CD28 M2 69.8 19.8
CD80 M l 98.4 2.4
HLA-DR M l 95.4 2.4
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Figure 3.9 FACS analysis of Resting T cells
Cells were fluorescent stained for a number of surface T cell molecules and analysed by
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Figure 3.10 FACS analysis o f the surface expression o f transfected CHO cells
CH O  transfectan ts w ere stained w ith appropriate antibodies or m edia to detect 
surface expression  o f  the transfected m olecules. CHO cells were also stained as 
negative controls. D ata are shown as log histogram s indicating the extent o f surface 
staining.
3.6 DISCUSSION
The data obtained from my studies highlighted the requirement of normal T cells to 
receive two signals to induce full activation whilst PBMCs were activated by aCD3 
alone. This reflected the presence of costimulatory molecules on professional APCs 
present in the PBMC population which were removed during the purification of the T 
cells. Furthermore the failure of aCD3 alone to activate the resting cells validated the 
purification process. Since the PBMC response can be blocked by the CTLA-4Ig 
chimeric molecule (Tan et al., 1993) this would suggest that B7 is involved in the 
activation of these cells. In agreement with previous reports (Linsley et al., 1991a; 
Koulova et al., 1991; Gimmi et al., 1991) the requirement for B7 to enable the activation 
of purified T cells by aCD3 was confirmed by the addition of fixed CHO-B7 
transfectants to a purified T cell population stimulated with anti-CD3 antibodies. As 
antibody alone induced no observable change whilst the combined stimulation resulted in 
proliferation and IL-2 production, this therefore established that B7 was providing the 
critical second signal and that the transfectants could adequately mimic the natural CD28 
ligand. Furthermore these experiments proved that glutaraldehyde fixation of the 
transfectant cells, whilst inhibiting their proliferation, leaves the surface molecules intact 
and functional. Previously many groups have used anti-CD28 monoclonal antibodies to 
activate the costimulatory pathway instead of the B7 ligand, however, this has often 
resulted in misleading observations as different signalling events can be observed 
depending upon whether the antibody is soluble or cross-linked (Ledbetter et al., 1990). 
Furthermore multivalent antibody ligation of CD28 has been shown to induce a calcium 
flux (Linsley and Ledbetter, 1993) and yet this has not been observed using the natural 
ligand, B7.
All further experiments undertaken in the study therefore involved the use of fixed CHO- 
B7 transfectants as a source of costimulation as it was hoped that the results observed 
would also be more physiologically relevant than those obtained using anti-CD28 
antibodies. In fact preliminary experiments in the laboratory indicated the transfectants 
provided a more effective costimulatory signal as observed by the degree of proliferation 
they induced compared to antibody stimulated cells (D.Sansom, A.Wilson, personal 
communication).
Immortal T cell lines such as Jurkat cells and Hut 78 cells, derived from leukaemic 
populations and virally transformed, have long been established as laboratory models of 
T cell function. However, whilst they retain some phenotypic features of normal T cells, 
several of their intracellular pathways have become constitutively activated or altered. 
From the literature it appears that whilst these immortal cells are routinely used, current 
understanding concerning the regulation of their intracellular signalling pathways is
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extremely limited. In the initial studies it was observed that Jurkat cells undergo maximal 
proliferation in culture in the absence of IL-2 and IL-2 receptor. Furthermore the Jurkat 
cells appeared to be fairly unresponsive to surface receptor stimulation in that aCD3 or 
B7 stimulation had very little effect on proliferation and did not induce IL-2 production. 
Thus whilst the Jurkat cells provided a useful control model for mitogenically activated 
signalling pathways an alternative T cell model was required. The second aim of this 
work was therefore to investigate more physiological models of T cell function to enable 
investigation of the role of the costimulatory signal in T cell activation and IL-2 
production.
A study of T cell blast responses at various time points after activation revealed that 
these cells could easily be stimulated to proliferate, so rapidly increasing the total cell 
number. Furthermore, expansion of the PMA/ ionomycin stimulated population helped to 
decrease the differences in the responsiveness of the T cells obtained from different 
donors making inter-experiment comparisons more relevant. Thus large numbers of 
PMA/ ionomycin T cell blasts were prepared and cultured under standardised conditions 
for use in the various assays. Unlike the constitutively activated Jurkat cells, these T cell 
blasts could be quiesced before being used, so enhancing their similarity to a resting T 
cell yet unlike clonal populations of T cells the blast cultures retained the varied 
specificity of a purified T cell population. Stimulation of the quiesced T cell blasts with 
aCD3 and B7 revealed that like purified T cells they required two signals to induce 
proliferation indicating that the T cell blasts were not constitutively activated.
Further comparative experiments using Jurkat cells, T cell blasts and resting T cells were 
then carried out to assess the similarities and differences of the various models. 
Interestingly the addition of stimuli which usually promote proliferation in normal T 
cells, either had no effect or were inhibitory to the Jurkat cells. Preliminary data obtained 
from PMA-stimulated Jurkat cells in the laboratory indicated that the responses observed 
were substantially different from those seen in normal T cells. The results showed that 
whilst stimulation of resting T cells or T cell blasts with PMA, in the presence of 
ionomycin, induced proliferation, stimulation of Jurkat cells with PMA and ionomycin 
was inhibitory, yet IL-2 production occured in all three cell types. Thus it appeared that 
in Jurkat cells, there was an inverse correlation between proliferation and IL-2 
production indicating that these signalling pathways were differentially regulated by 
phorbol esters. These data could be accounted for by the presence of different PKC 
isotypes which induce stimulatory or inhibitory signals following PMA activation.
The observation that stimulation of Jurkat cells with PMA inhibited their basal 
proliferation implied that this constitutively activated pathway was negatively regulated 
by PKC. Further investigation of this effect indicated that the cells were dying when
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incubated with PMA for extended periods (>24 hrs). FACS analysis of these stimulated 
cells showed an inhibition of cell cycle and an increase in cell death compared to 
unstimulated populations of cells. The addition of PMA appeared to prevent the cells 
from entering mitosis with the subsequent accumulation of cells in G 2  phase. The loss of 
S phase cells appeared to confirm the halt in cell cycle progression induced by the PMA 
stimulus whilst the appearance of a population of the cells in the sub G0 /G 1 region 
indicated an increase in cell death compared to unstimulated cells cultured under the 
same conditions. It is possible that this increase in cell death is due to an induction of 
apoptosis although further studies would be required to confirm this. Since Jurkat cells 
proliferate constitutively in the absence of exogenous stimuli this may indicate they have 
a constitutively activated component of the calcium signalling pathway. Thus if PMA 
inhibits the PKC-regulated part of the signalling pathway the resultant calcium signal, in 
the absence of other signals, may be inducing apoptosis. This is just one possible 
interpretation of the data and these events will require further investigation to establish 
the exact effects of PMA in these cells.
The confusion associated with the observed differences in mitogen- induced responses 
between Jurkat and normal T cells was heightened by the limited understanding of the 
effects of phorbol esters such as PMA on intracellular signalling pathways and the 
variability in the dose used. A study of the literature indicated that the concentration of 
PMA used by different groups to induce T cell activation, varied considerably, usually 
between 1 and 50ng/ml. As the aim of this study was to investigate the effects of 
costimulation it was necessary to find a dose of PMA which could be costimulated by 
CD28 engagement.
PMA is commonly used as an activator of T cells in combination with another stimulus 
which triggers a calcium signal, frequently the calcium ionophore, ionomycin (Truneh et 
al., 1985) or the CD2 stimulator, PHA (Weiss and Stobo, 1984). Interestingly whilst 
activation of PKC by PMA, in the presence of calcium, is supposed to represent a 
triggering of the TCR pathway alone, PMA and ionomycin cause full activation of T 
cells whereas TCR engagement alone does not. In fact TCR stimulation in the absence of 
a costimulatory signal is often the cause of anergy (Harding et al., 1992). Thus it appears 
that PMA is not just stimulating the TCR-related PKC pathway but is also activating 
additional pathways which are normally regulated by the costimulatory molecule. In 
support of this hypothesis is the finding that in normal T cells low dose PMA (<1 ng/ml) 
could be effectively costimulated by B7 whereas high dose PMA (30ng/ml) induced a 
maximal response and implies the existence of at least two PMA targets on different 
pathways which display different sensitivities to activation by PMA. In addition this may 
explain the "rebound" effect found in Jurkat cells where high dose PMA partially 
reversed the inhibition of proliferation observed at lower doses. In Jurkat cells it appears
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that low dose PMA may activate the TCR pathway only and induce cell death whereas 
higher doses may also activate the costimulatory pathway which delivers a protective 
signal.
Attempts to identify target sites for PMA-induced effects have lead several groups to 
investigate the different signalling effects observed in PMA-treated cells. Two recent 
reports have indicated the involvement of PMA in both the TCR and CD28 signalling 
pathways. Williams et al (1995) reported an upstream role for PKC in ras signalling 
whilst Hutchcroft et al (1995) reported an inhibition of the association between CD28 
and PI3 Kinase in the presence of PMA. However, if this observation is true then the 
protective effect of the CD28 costimulation in Jurkat cells must involve an alternative 
signalling pathway to PI3 Kinase. Recently Cifone et al (1995) have reported that acidic 
sphingomyelinase, which is also associated with CD28 signalling, can be activated by 
DAG, the physiological intracellular activator of PKC. Thus as PMA activates PKC by 
mimicking DAG it may also be capable of activating acidic sphingomyelinase. This is 
proposed to be upstream of the generation of ceramide which has been reported to 
activate the supposedly PMA-insensitive atypical PKC isoenzyme PKC£ (Muller et al., 
1995b). However, there are numerous PKC isotypes of which very little is known so the 
participation of a second PMA-sensitive isotype in this signalling pathway is possible. 
Interestingly the protective effect of CD28 against apoptosis has been proposed to be 
mediated via an increase in bcl-x expression (Boise et al., 1995) whilst PMA stimulation 
has been shown to protect against some forms of glucocorticoid-induced apoptosis 
(Walker et al., 1993; Gomez et al., 1994) and since glucocorticoids target the 
transcription factors which have been reported to be partially regulated by CD28 
(Auphan et al., 1995; Scheinman et al., 1995), the link between the CD28 costimulatory 
pathway, PMA and protection against apoptosis appears to be strengthening. 
Unfortunately such assays are frequently carried out in different cell types so it is 
difficult to extrapolate the findings across into normal cells. Furthermore if PMA is 
activating more than one signalling pathway, the overall response will be a summation of 
the interaction of these pathways and therefore less easy to define in terms of isolated 
events. Therefore until there is a greater understanding of the expression and PMA 
sensitivity of different PKC isotypes and a development of more specific isotype 
activators and inhibitors, data obtained in PMA stimulated cells should be interpreted 
with caution.
These initial assays have highlighted the requirement for two signals to fully activate 
normal T cells and that the second signal can be efficiently provided by the fixed CHO- 
B7 transfectants. Furthermore it has been shown that high doses of PMA in combination 
with ionomycin can induce full activation by stimulating both the TCR and costimulatory 
pathways but that low dose PMA can be effectively costimulated by B7. These
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experiments also highlighted some of the problems associated with using transformed 
cell lines such as Jurkat cells as models of resting T cells due to their altered signalling 
mechanisms.
Resting T cells are the best in vitro model for the investigation of T cell function but due 
to the extremely low physiological intracellular concentrations of the proteins it is often 
difficult to detect responses without using very large numbers of cells which are difficult 
to obtain. The use of quiescent T cell blasts is thus more amenable and from these initial 
experiments it appears that these cells more closely resemble resting T cells than Jurkat 
cells do. The use of the T cell blasts to study the role of CD28 will hopefully provide 
more relevant information although comparative studies in Jurkats will increase the 
understanding and therefore the usefulness of this T cell model.
Therefore having established that the T cell blasts could be costimulated by B7 in the 
presence of suboptimal doses of PMA, I proposed to investigate the effects of this 
costimulation on transcription factor induction and IL-2 production.
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CHAPTER 4 - INVESTIGATION OF THE EFFECT OF CD28 ON
IL-2-REGULATORY TRANSCRIPTION FACTORS
Having established the requirement for CD28 stimulation in the activation of T cells it 
was decided to next investigate the mechanisms by which signals derived from the 
costimulatory pathway could enhance IL-2 transcription. Since IL-2 production is 
regulated via the binding of transcription factors to the promoter region 5' of the gene 
start site it was proposed that any direct effects of CD28 signalling would involve effects 
on transcription factor regulation.
4.0 USE OF CAT AND LUCIFERASE CONSTRUCTS
The use of reporter constructs enables the attachment of multiple copies of a transcription 
factor binding sequence upstream of the gene coding for a stable enzyme product. This 
provides a system whereby transcription of the enzyme is dependent upon induction of 
functional transcription factor complexes. The role of CD28 in the induction and 
functional activation of individual transcriptional factors could thus be assessed 
independently of and in combination with TCR stimuli. Two reporter construct systems 
are commonly used, those being the assessment of chloramphenicol acetyltransferase 
activity (CAT assays) and the detection of luciferase activity.
To efficiently perform transfection of the reporter constructs into the cells, optimal 
electroporation conditions, with respect to the buffer, voltage and time constant, were 
determined. These were initially calculated for Jurkat cells with the intention of using T 
cell blasts when the assay was established. Cells were electroporated over a range of 
conditions, dual stained with FDA as a viability marker, and PI, as a permeabilisation 
marker and then analysed by FACS. The results obtained from the FACS analysis are 
summarised in Table (IV) overleaf and are shown diagramatically in figure 4.0A .
A titration of electroporation voltage is shown in figure 4.0B and demonstrates that using 
500pF, 200V was inefficient for permeabilisation and 400V resulted in a high level of 
cell death whereas 300V appeared optimal. In addition the effect of varying the 
capacitance was investigated and is shown in figure 4.0C. If the voltage was fixed at 
300V, 500pF then gave optimal results.
Whilst the voltage and the capacitance were the main two factors requiring optimisation, 
variation of the buffer and volume of cells electroporated also affected the duration of the 
pulse. A greater viability was observed in the electroporated cells using Ca2+/Mg2+ PBS 
compared to HeBS and small volumes resulted in a longer time constant whilst larger 
volumes decreased the time constant. Efficient transfection of the cells required the
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identification of optimal conditions which ensured maximal permeabilisation whilst 
retaining cell viability. These optimal values are tabulated below (Table (V)) and shown 
diagramatically in the centre boxes of figures 4.0B and C.
Table IV A summary of the FACS analysis of FDA (viability) and PI (permeabilisation) 
staining for the electroporated cells
QUADRANT FDA STAINING - 
LIVE CELLS
PI STAINING - 
PERMEABILISED
CONCLUSION
LOWER LEFT — — Dead cells - no 
permeabilisation
UPPER LEFT — + Cells died after 
permeabilisation
LOWER RIGHT + — Live cells - no 
permeabilisation
UPPER RIGHT + + Live cells which are 
permeabilised
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2.5xl06 500 300 500 ~ 15 20
Once the conditions had been optimised Jurkat cells were transfected with constitutive 
CAT constructs, the intention being to optimise the detection assay before transfecting 
the transcription factor-regulated CAT constructs into the cells. Figure 4.1 A shows the 
effect of electroporation voltage on CAT activity plotted as a factor of time. Although 
400V resulted in greater enzyme activity, 300V was retained as standard value as this 
resulted in adequate detectable enzyme activity whilst maintaining cell viability. As a 
large number of cells were required to enable investigation of different stimulation 
conditions the number of viable cells obtained from the transfection was more important 
than maximal activity. For the capacitance titration (figure 4.IB), the suboptimal value of 
500|xF was again retained to preserve cell viability. Enzyme activity increased linearly 
over time during the assay, the maximum reached varying depending upon the volume of 
extract analysed. Below lOjn.1 (5xl05 cell equivalents) an approximate linear correlation 
applied, however, above this the substrate was limiting resulting in a plateau by 25jil 
(1.25xl06 cell equivalents) (Figure 4.2).
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Having optimised the electroporation conditions to ensure efficient transfection, attempts 
were made to establish assays using the transcription factor-regulated CAT reporter 
constructs. Unfortunately, stimulation of Jurkat cells transfected with the constructs 
regulated by multiple NFAT or AP-1 transcription factor binding sites did not result in 
any detectable CAT activity. This may have been due to faults or mutations in the 
plasmid constructs or due to very low levels of enzyme induction which could not be 
detected. The CAT assays were therefore exchanged in favour of luciferase assays using 
different plasmids and a more sensitive detection method.
Luciferase reporter constructs comprising quadruple NFAT or AP-1 binding sites 
upstream of the luciferase gene were transfected into Jurkat cells using the optimised 
electroporation conditions. Figure 4.3 shows the activity induced in cells stimulated with 
PMA alone (0.3 ng/ml) or in combination with ionomycin (l|iM). Activity is expressed 
as a relative value compared to control, indicating that PMA and ionomycin stimulation 
produced a 5 fold increase in luciferase activity compared to unstimulated samples. 
Interestingly, in agreement with previous reports, whilst PMA alone induced some AP-1 
regulated activity (Figure 4.3A), both PMA and ionomycin were required for NFAT 
production (figure 4.3B). This is in agreement with previous reports that a calcium signal 
is required for NFAT induction and implies that due to its requirement for two signals 
NFAT generation may be more tightly regulated than AP-1. Unfortunately attempts to 
use more physiological stimuli such as aCD3 and B7 transfectants resulted in only a 
slight increase in AP-1 regulated activity and did not induce any NFAT activity. This 
was in keeping with the absence of IL-2 production in Jurkat cells using these stimuli 
(figure 4.4).
Whilst several attempts were made to optimise the electroporation conditions required 
for the transfection of the blasts the viability of the electroporated cells was insufficient 
to enable equivalent experiments to be carried out, therefore other methods of in vitro 
transcription factor detection were investigated.
4.1 THE ELECTROMOBILITY GEL SHIFT ASSAY (EMSA)
The electromobility gel shift assay (EMSA) is an extremely useful technique which 
enables the visualisation and identification of individual inducible and constitutive 
nuclear transcription factors whilst a DNase 1 footprinting assay identifies the location of 
transcription factor binding within a promoter region and allows for interaction and 
cooperative binding between adjacent factors. Both the techniques involve the 
preparation of nuclear cell extracts from cell cultures and binding reactions enabling the 
association of the transcription factors with their respective DNA binding sites.
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The EMSA was utilised in this study to investigate the role of CD28 in the induction of 
three transcription factors which are involved in the regulation of IL-2 gene expression. 
Oligonucleotides coding the binding sites for NFAT, AP-1 and NFkB were used to detect 
the presence of these transcription factor proteins in extracts from variously stimulated 
cells. Although the methodology for the assay has been fairly well documented the assay 
conditions required optimisation. The stimulation of different cell types results in varying 
levels of transcription factor induction and therefore varying quantities of protein extract 
are required for visualisation. In addition, variation in MgCh concentration can alter the 
binding affinity of the complexes whilst the concentration of the non specific DNA, poly 
dl-dC affects the intensity and clarity of the signal. Therefore prior to analysing 
transcription factor induction using physiological stimuli a series of experiments were 
first carried out to optimise the EMSA .
The protein concentration of the nuclear extracts prepared from the stimulated cells was 
routinely measured using the Biorad assay system, calibrated using a BS A standard curve 
as shown in figure 4.5. Figure 4.6A demonstrates the effect of protein concentration on 
the detection of NFAT in T cell blasts. Compared to the oligonucleotide titration in 
figure 4.6B it can be seen that protein was limiting in the binding reaction. For the 
majority of the assays 10|ig of Jurkat extract and 15pg of extract from T cell blasts 
proved to be sufficient to give a strong detectable signal on an overnight exposure of the 
autoradiograph. Excess or overloading of the extract resulted in smeared bands and 
eclipsing of the signals in adjacent lanes. With respect to the amount of oligonucleotide, 
an optimum of 40000cpm per lane which corresponded to 0.3-0.5ng was deemed to give 
an appropriate signal. The unbound oligonucleotide could be observed at the bottom of 
the gel and acted as an internal control for the activity of the oligonucleotide. Since 
activity was assessed by total counts, loss of label or degradation of the oligo could only 
be observed visually from its appearance on the gel. Activity of the oligos were assessed 
before each assay and adjusted accordingly to give the same strength of signal. Labelled 
oligos typically lasted three weeks before the 32P decay decreased the activity to 
unusable levels.
The effect of MgCl2  concentration on the binding affinity of NFAT in T cell blasts was 
investigated and is shown in figure 4.7A. Although the observable difference was small 
in this experiment an optimum concentration of 0.6mM was found to produce consistent 
binding for all the transcription factors studied.
Poly dl-dC is double stranded DNA with a repetitive inosine/ cytidine sequence. The 
inclusion of this reagent in the binding mix serves to increase the specificity of the 
detected proteins by providing a binding environment for non-specific DNA binding 
proteins. Due to the high concentration of poly dl-dC in the mix non-specific proteins
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preferentially bound this DNA whilst the transcription factors which had a higher 
affinity for their respective oligonucleotide sites bound preferentially to the labelled 
DNA. In the absence of poly dl-dC large non-specific protein complexes bound the 
oligo forming an aggregate which did not enter the gel. However, if excess poly dl-dC 
was added, even the proteins of interest bound to the poly dl-dC and no signal was 
observed. A titration of poly dl-dC concentration was therefore performed (figure 4.7B) 
and an optimal concentration of ljig / reaction was found to result in a strong signal, 
which appeared to be specific to the oligo of interest.
Despite the inclusion of poly dl-dC, some proteins, other than the relevant transcription 
factor, do bind to the oligonucleotides. However, the specificity of the complexes 
observed in the presence of the optimal poly dl-dC concentration can be confirmed by 
cold competition reactions. These involve the addition of 100 fold excess of unlabelled 
oligo of the relevant and an irrelevant binding site to different control tubes. 
Disappearance of the binding complex in the presence of the relevant oligo and not the 
irrelevant oligo was taken to indicate specific binding. As shown in figure 4.8, cold 
competition of the NFAT complex using excess unlabelled NFAT oligo resulted in a 
loss of detectable binding whereas an excess of NFkB oligo had no effect on the 
complex. This would not have been the case if the protein was binding non specifically 
to the DNA. It was also observed, however, that the NFAT complex was partially 
competed by excess AP-1 oligo. This was due to the presence of AP-1 components in 
the NFAT complex, namely fos and jun family members, which resulted in some cross 
reactivity between the two oligos. The AP-1 oligo could therefore not be regarded as an 
entirely irrelevant DNA sequence.
The majority of transcription factor studies reported previously were carried out using 
mitogenic stimulation of Jurkat cells (PMA and ionomycin or PMA and PHA). Whilst 
this gave valuable information on the presence and inducibility of the complexes in T 
cells it did not confirm their induction under physiological conditions. Furthermore the 
signalling pathways active in Jurkat cells have been shown to be somewhat altered from 
normal T cells in that mitogenic stimulation caused a downregulation in their 
proliferative state although IL-2 production was significantly increased. Thus PMA and 
ionomycin were very effective control stimuli for the induction of IL-2 regulatory 
transcription factors in Jurkat cells and were used initially to establish the detection and 
inducibility of the complexes in the cell extracts in order to validate the assay before 
investigating the role of CD28. Figure 4.9A shows the inducibility of the three 
transcription factor complexes in Jurkat cell extracts. Although due to the constitutively 
activated phenotype of these cells a small amount of constitutive NFAT and AP-1 
transcription factor expression was detectable, the levels of all three factors were 
considerably increased following stimulation of the cells. The upper bands
80
in each case represent the specific transcription factor although each factor has a different 
mobility in the gel due to differences in complex size.
Subsequent examination of the PMA/ ionomycin T cell blast extracts revealed that even 
at 8 days after their initial stimulation the basal levels of transcription factors were 
maximal (figure 4.10) and were therefore not visibly upregulated on restimulation. Even 
at a later time point basal levels remained too high to detect further induction. It was 
therefore not possible to use these blasts for the detection of transcription factor 
induction.
The high basal expression of the IL-2 regulatory transcription factors indicated an 
activated cell state which was in agreement with the high basal proliferation observed in 
the initial experiments. However, whilst transcription factor expression appeared to be 
maximal, no IL-2 production had previously been detected in these day 8 unstimulated 
cells indicating an insufficient level of activation to induce IL-2 transcription. However, 
since B7-induced signals had been shown to costimulate suboptimal PMA and 
ionomycin activation, the effects of B7 on these partially activated cells was investigated. 
Figure 4.11 shows a timecourse of the proliferative and IL-2 responses observed 
following B7 stimulation of the PMA/ionomycin T cell blasts in the absence of other 
stimuli. Although not as significant as mitogenic restimulation, B7 transfectants alone 
did appear capable of inducing limited proliferation and IL-2 production in these 
previously activated cells.
4.2 DNase 1 FOOTPRINTING
In parallel with the EMSAs, DNase digestion assays, using the same nuclear extracts, 
were performed on the IL-2 promoter to identify the protected transcription factor 
binding sites. The main aim of this was to investigate the effects of costimulation on the 
promoter region as a whole and it was also hoped that some information concerning the 
occupation of the CD28RE would be gained from such assays. Probes encoding the IL-2 
gene promoter region were subcloned and then labelled at different ends so that the 
footprint could be analysed from either end of the promoter sequence. After extensive 
optimisation of the conditions a footprint was obtained for the 5' end of the promoter 
distal to the start site. As is shown in figure 4.12 whilst incubation of the DNA with 
unstimulated Jurkat cell extracts resulted in full digestion of the DNA, in the presence of 
stimulated nuclear extracts some regions were apparently protected from digestion by the 
binding of transcription factors. The region shown covers the NFAT and OCT binding 
sites which were protected in the presence of extracts from PMA and ionomycin 
stimulated Jurkat cells indicating the presence of bound protein complexes. 
Unfortunately the resolution of the gel was insufficient to detect the downstream
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CD28RE which would have required the synthesis of a new probe nearer to the site of 
interest but there was insufficient time available to continue this study. The assay was not 
carried out using the T cell blasts as an unstimulated control was needed to differentiate 
between transcription factor protected DNA regions and unprotected, incompletely 
digested regions.
4.3 SUMMARY
The reporter construct assays, EMSA and DNAse footprinting were all successfully 
established using mitogenically activated Jurkat cells. However, investigation of 
transcription factor induction in the T cell blasts proved to be more complicated. 
Transfection of the T cell blasts was not possible using electroporation methods due to 
the extremely low viability of the permeabilised cells. Furthermore transcription factor 
analysis in the T cell blasts revealed that despite additional signals being required to 
stimulate proliferation and IL-2 production the original PMA/ionomycin stimulus had a 
prolonged effect on the T cell blasts resulting in constituitve transcription factor 
expression. The effects of CD28 costimulation on transcription factor induction could 
thus not be assessed in these cells.
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Figure 4.0 Optimisation of the electroporation conditions for Jurkat cells
Panel (A) shows the control FDA and PI staining. Jurkat cells were then electroporated 
using varying voltage (B) and capacitance (C) values. The cells were then immediately 































Figure 4.1 Effect of electroporation conditions on constitutive CAT activity in Jurkat 
cells
Jurkat cells were transfected with constitutively activated CAT reporter constructs 
(10|ig) using varying voltage (A) and capacitance (B) electroporation values. CAT 
activity was assessed in vitro  using cytoplasmic cell extracts 48 hours later and is 
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Figure 4.2 Effect of extract volume on the measurement of constitutive CAT activity 
in Jurkat cells
Jurkat cells were transfected with constitutively activated CAT reporter constructs 
and cytoplasmic cell extracts were prepared 48 hours later. CAT activity was then 





Figure 4.3 Assessment of transcription factor regulated luciferase activity in mitogen 
stimulated Jurkat cells
Jurkat cells were transfected with luciferase constructs regulated by quadruple AP-1 
(A) or NFAT (B) transcription factor binding sites. 24 hours later the cells were 
washed and placed in media, media containing PMA (0.3ng/ml) or media with PMA 
and ionomycin ( lpM ). After 4 hours cell extracts were prepared and assayed for 
luciferase activity. Data are the mean of three assays.
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Figure 4.4 A ssessm ent o f  transcription factor regulated luciferase activity in 
stimulated Jurkat cells
Jurkat cells were transfected with luciferase constructs regulated by quadruple AP-1 
(A) or N FAT (B) transcription factor binding sites. 24 hours later the cells were 
washed and left unstimulated or activated with cross- linked anti CD3 ( l | ig /m l)  
alone or in the presence of fixed CHO cells or CHO-B7 cells. After 4 hours cell 
extracts were prepared and assayed for luciferase activity. Data are the mean o f  three 
assays. q<-
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Figure 4.5 Biorad protein assay - standard curve
A standard curve of absorbance at 595 nm for serial dilutions of BSA was produced 
to enable calibration of the assay for the assessment of  nuclear extract protein 
content.
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Figure 4.6 Effect of protein and oligonucleotide on the detection of transcription factor 
complexes
Nuclear extracts were prepared from T  cell blasts and were analysed for NFAT 
induction. V ary ing  concen tra tions  o f  nuc lea r  extract protein (A) or labelled 
oligonucleotide (B) were included in the binding reaction and gel analysis performed as 
stated in the protocol. Complexes were visualised by autoradiography following an 
overnight exposure of the gel.
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Figure 4.7 Effect o f  M gC l2 and poly d l-dC  concentration on the detec tion  of 
transcription factor complexes
Nuclear extracts were prepared from T cell blasts and were analysed for NFAT 
induction. Varying concentrations of M gCl2 (A) or poly dl- dC (B) were included in the 
binding reaction and gel analysis performed as stated in the protocol. Complexes were 
visualised by autoradiography following an overnight exposure of the gel.
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Figure 4.8 Confirmation of transcription factor complex specificity by cold competition
Nuclear extracts were prepared from PMA (0.3ng/ml) / ionomycin ( lf iM ) stimulated t 
cell blasts.These were analysed for NFAT complexes in the absence (--) and presence 
(N FA T (N), AP-1 (A), N F k B ( K)) o f  100 fold excess of cold o ligonucleotide. 
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Figure 4.9 Induction of  transcription factor complexes
Nuclear extracts were prepared from unstimulated (U) ,PMA (0.3ng/ml) / ionomycin 
(1 |nM) and PMA/ionomycin /B7 (PIB7) stimulated Jurkat cells and were analysed for the 
p roduction  o f  NFAT, AP-1 and N F kB com plexes. These were v isua lised  by 






Figure 4.10 Induction of transcription factor complexes
Nuclear extracts were prepared from unstimulated (U) and PMA (0.3ng/ml) / ionomycin 
( IfiM) stimulated T cell blasts and were analysed for the production of NFAT and A P - 1 
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Figure 4.11 Effect of B7 stimulation on proliferation and IL-2 production in PM A / 




PM A/ ionomycin T cell blasts were taken from culture on the day specified after 
restimulation and were incubated in new media alone or in the presence of  fixed CH O 
cells or fixed B7 cells for 24 hours. Proliferation (A) was measured by 3H -Thym idine 
incorporation whilst IL-2 production (B) was assessed using the CTLL bioassay. Data 
are the triplicate mean of a representative experiment.
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Figure 4.12 DNAse 1 Footprinting of the IL-2 promoter
DNAse 1 digestion of the distal end of the IL-2 promoter was assessed in the presence of 
nuclear extracts from unstimulated and PMA/ionomycin stimulated Jurkat cells using a 
range of DNase 1 enzyme concentrations.
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4.4 DISCUSSION
Whilst functional whole cell assays provide valuable information on the response of a 
cell to a certain stimulus they do not give any insight into the intracellular targets of the 
signals derived from stimulation of the surface receptors. Neither is it possible to 
determine the intracellular effects of the costimulatory signals as distinct from those of 
the TCR signals. By studying the regulation of transcription factors it was hoped that it 
may be possible to identify some downstream targets of the CD28 signalling pathway. 
Previous reports have indicated that CD28 signals regulate the IL-2 promoter (Lindsten 
et al., 1989a; Lai et al., 1995; Umlauf et al., 1995) although it is still not known to what 
extent this is due to mRNA stabilisation as opposed to direct effects on transcription 
factor induction. Data obtained from my initial studies indicated that CD28 stimulation in 
the presence of PMA could upregulate IL-2 production and I therefore sought to establish 
whether this response was mediated by a direct effect upon transcription factor induction 
or activation. Several different qualitative and functional assays were established to study 
the effects of CD28 costimulation on IL-2 - associated transcription factor induction.
Despite the observed differences between immortal cell lines such as Jurkat cells and 
resting T cells such as their activated phenotype and IL-2 independence Jurkat cells are 
still frequently used to investigate CD28 signalling mechanisms and IL-2 regulation. 
Furthermore as several groups have already shown that many of the IL-2 regulatory 
transcription factors can be induced in Jurkat cells using PMA in combination with a 
secondary stimulus (Banerji et al., 1991; Durand et al., 1988; Shaw et al., 1988) these 
cells provided a convenient positive control in the establishment of such assays.
Initially a functional assay was developed involving transcription factor-regulated 
reporter constructs as there are several advantages associated with measuring enzyme 
induction rather than cytokine output. Whilst the CTLL bioassay gives a reasonable 
assessment of IL-2 output it relies on effective translation of the IL-2 message and does 
not measure receptor bound or internalised IL-2, hence the Final reading is only an 
estimate of cytokine production. Reporter constructs allow the assessment of induction of 
individual transcription factors and enable measurement of total enzyme induction within 
the cell, unhampered by translation, secretion or reuptake mechanisms.
The electroporation of Jurkat cells proved to be a very effective method for the 
transfection of reporter constructs. However, whilst electroporation is an extremely 
useful technique the optimal conditions vary considerably depending upon the cell type. 
In agreement with other groups, I found transfection of transformed cells considerably 
more successful than transfection of normal T cells (personal communications). The 
latter required harsher electroporation conditions to permeabilise the membranes and
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consequently the cells exhibited poor survival capabilities. Furthermore transformed cells 
are often larger than normal cells thus membrane transfer of plasmid DNA is less of a 
cell stress factor. Preliminary attempts to transfect the T cell blasts using lipid mediated 
transfer techniques (liposomes) (Mannino and Gould-Fogerite, 1988) were unfortunately 
also unsuccessful so alternative methods of transfection such as DEAE-Dextran (Durand 
et al., 1987) or calcium phosphate(Sambrook et al., 1989) may be required.
A comparison of the results obtained from the FDA/PI staining with those of the reporter 
construct enzyme assays showed an extremely good correlation between 
permeabilisation and enzyme activity indicating that the cells which were permeabilised 
took up the reporter plasmid very efficiently. Thus the electroporation/ staining 
procedure enables the optimisation of electroporation conditions prior to the introduction 
of the DNA and could be used for any transfection to ensure the maximum efficiency of 
transfections whilst maintaining cell viability. A further advantage is that the FDA/ PI 
staining provides immediate results on the effectiveness of the electroporation and 
requires very few cells to optimise the conditions .
Whilst significant induction of luciferase activity was observed in the mitogen-stimulated 
transfected Jurkat cells the effects of anti-CD3 stimulation were less convincing. 
Contrary to some reports (Ward and Cantrell, 1990) in my experience despite adequate 
surface expression of CD3 and CD28 on the Jurkat cell surface, activation of these 
receptors appeared to be very ineffective as a means of complete cellular activation 
although B7 stimulation of Jurkat cells could be shown to trigger some receptor proximal 
events as discussed in chapter 5. This therefore implies an alteration in the downstream 
signal transduction pathways as a result of the transformed phenotype of the cells rather 
than an insensitivity of the receptor itself. Overall, however, attempts to activate Jurkat 
cells using physiological stimuli were found to result in less significant responses than 
were observed using PMA and ionomycin: a further reason for developing an alternative 
T cell model which could respond efficiently to physiological stimuli.
Due to the inability to successfully transfect normal T cells it was necessary to establish 
alternative assays to detect transcription factor induction and regulation. Although the 
EMSA does not measure the transcriptional activity of detected complexes it does 
provide detailed information on the induction requirements of specific transcription 
factors. Despite the apparently activated phenotype of Jurkat cells, basal levels of the 
IL-2 regulating transcription factors are either non existent or extremely low and have 
been shown to be strongly induced following stimulation of the cells with PMA and 
ionomycin. Furthermore, the induction of the transcription factors correlates well with 
the induction of IL-2 production indicating that despite the other abnormal responses to 
PMA demonstrated by these cells the IL-2 promoter is still functional. Unfortunately the
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addition of B7 appeared to have little further effect upon the expression of the 
transcription factor complex indicating that the PMA/ ionomycin stimulus was maximal 
for the induction. Although there are no published reports of transcription factor 
induction in B7 stimulated Jurkat cells several groups have shown increased activity 
following the addition of aCD28 antibodies to PMA and iomnomycin stimulated T cells 
(Fraser et al., 1991; Ghosh et al., 1993). However, these studies were investigating the 
induction of the CD28RC which may be more directly dependent upon CD28 mediated 
signals that the other IL-2 regulatory transcription factors. Furthermore the nature of the 
signals delivered by antibody stimulation of the CD28 receptor has been shown to vary 
depending upon the state of cross-linking of the antibody (Ledbetter et al., 1990) 
therefore it is difficult to compare the antibody responses with transfected ligand. Despite 
using suboptimal PMA concentrations to enable detection of the effects of a 
costimulatory signal, the concentration of PMA present still appeared adequate for the 
full induction of the transcription factors. However, the previous experiments showing a 
comparison of the amount of IL-2 produced using this suboptimal concentration of PMA 
in the presence and absence of B7 costimulation revealed a significant increase in output 
with B7. Thus the inclusion of a B7 stimulus may enhance transcription factor 
production but it is not easily observed in this assay. Alternatively the B7 induced effect 
on IL-2 output may be due to its effects on mRNA stabilisation and additional assays to 
measure IL-2 mRNA would be required to determine the exact mechanism of the B7 
induced upregulation of IL-2.
Whilst information on transcription factor inducibility was obtained from these Jurkat 
cell assays the main aim of studying transcription factor induction in the T cell blasts 
activated using PMA and ionomycin proved not to be possible. The initial stimulus used 
to prepare the T cell blasts appeared to have a prolonged effect on their activation state 
and transcription factor analysis revealed high levels of expression in both the 
unstimulated and PMA/ ionomycin stimulated extracts. Comparison of these data with 
the proliferation and IL-2 assays revealed that whilst unstimulated day 8 cells had a 
slightly raised basal proliferation no IL-2 was produced and yet transcription factor 
expression appeared to be maximal. This indicated that the complexes present were 
either insufficient to bridge a threshold required for IL-2 transcription or that the 
complexes were not transcriptionally active. Previous reports have indicated that whilst 
PMA can induce transcription factor expression additional signals are required to 
functionally activate the complexes (Rincon and Flavell, 1994). Since stimulation of 
these cells with B7 alone at early time pointsdid result in some EL-2 output this indicated 
that one role of the CD28 costimulatory signal may be the post translational modification 
of the PMA-induced complexes. Therefore although the cells only received one dose of 
PMA 8 days prior to the transcription factor assay sufficient levels of PMA remained in 
the media to keep the cells in a partially activated state from which they required a
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costimulation to upregulate proliferation and induce IL-2 production. Washing the cells 
24 hours prior to experimental use still revealed an activated phenotype indicating that 
PMA stimulation had a prolonged effect on the activation of the intracellular signalling 
pathways.
Unfortunately although it was possible to establish the technique of DNAse 1 
footprinting the preliminary assays did not yield much significant new information. The 
detection of adjacent NFAT and OCT factor binding indicated that the occupation of 
both of these sites was required for IL-2 transcription. Furthermore since Jurkat cells do 
not express Oct2 (Staudt et al., 1988) the distal Oct site is presumably bound by the Octl 
proteins. The detection of factors at both sites was in agreement with previous studies 
involving the IL-2 promoter (Durand et al., 1988). Of comparative interest is that whilst 
Pfeuffer et al (Pfeuffer et al., 1994) reported the inhibition of OCT factor binding by 
NFAT on the IL-4 promoter, the detection of the binding of both factors on the IL-2 
promoter footprint indicates that the effect is specific to the IL-4 promoter and is not a 
general feature of cytokine regulation.
From the responses observed it appeared evident that the PMA and ionomycin T cell 
blasts, certainly with respect to transcription factor induction, represented a highly 
activated T cell model. Therefore although their overall activation responses at day 8 
mirrored those of resting T cells it was not possible to use these cells to study the effects 
of costimulation on the induction of the transcription factors controlling IL-2 production. 
However, these assays did indicate a role for CD28 signals in the post translational 
modification of the complexes. Exactly what this modification involves is not yet known 
but may involve phosphorylation reactions or conformational changes to alter the 
protein/ DNA interaction.
Due to the prolonged activation effect of the initial PMA stimulus I therefore sought an 
alternative stimulus for the preparation of T cell blasts which hopefully would enable 
complete quiescence of the cells so as to observe the inducibility of the transcription 
factor complexes.
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CHAPTER 5 - CD28 SIGNALLING IN SEA T CELL BLASTS
5.0 ESTABLISHMENT OF SEA-ACTIVATED T CELL BLASTS
Due to the prolonged activated state of the PMA/ ionomycin T cell blasts, it was not 
possible to study CD28-mediated effects on transcription factor regulation in this system 
and in light of this, other stimuli for inducing T cell blasts, including PHA and the 
superantigen SEA, were investigated. PHA may stimulate T cells via binding to CD2, 
whilst superantigens, derived from staphylococcal enterotoxins, activate T cells by cross- 
linking the T cell receptors with MHC class II proteins. As superantigens bind to the 
outside of the receptor and not within the peptide binding groove, they activate a much 
larger percentage of T cells than a conventional peptide antigen. Furthermore the 
requirement for MHC-matched APCs in the presentation of peptide antigen is removed 
allowing the use of DR4 transfectants as APCs. The advantages of this form of activation 
are that the signals produced by superantigens are transduced through the TCRa/p chains 
and so activate the same signalling pathways as a peptide antigen. This, coupled with the 
observation that superantigen-stimulated blasts were more proliferative in culture than 
PHA blasts, led initially to the adoption of SEA as an alternative stimulus for the 
preparation of T cell blasts.
5.1 PROLIFERATION PROFILE OF SEA BLASTS
As for the PMA/ ionomycin blasts, a proliferation profile showing the response to 
various stimuli was produced for the SEA-activated T cell blasts. Figures 5.0 to 5.2 show 
the effects of stimulation on the proliferation and IL-2 production of SEA blasts, taken 8 
days after restimulation with antigen. At this timepoint the cells had a very low basal 
proliferation rate and did not produce any detectable IL-2. Restimulation of the blasts 
with SEA antigen presented on CHO-DR4 transfectant cells resulted in a dramatic 
increase in proliferation and significant IL-2 output as shown in figure 5.0. The 
cotransfection of B7 had only a slight additional effect on proliferation but increased IL- 
2 output by a further 2.5 fold.
Stimulation of the Day 8 SEA blasts with a suboptimal PMA concentration (0.3ng/ml) or 
with ionomycin alone had no appreciable effect on either proliferation or IL-2 output of 
the cells, however, the combination of the two agents produced an effective synergy 
resulting in an approximate 25 fold increase in proliferation (figure 5.1) and a significant 
IL-2 output. The addition of B7 transfectants to the stimulated cells further increased 
proliferation but did not affect IL-2 production indicating the level already induced was 
maximal.
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Control stimulations of the SEA-activated blasts using transfectants alone, however, 
revealed some interesting characteristics of these cells. Whilst the addition of fixed CHO 
cells to the blast cultures had no effect, the presence of B7 transfectants stimulated a 3 
fold increase in proliferation but unlike the PMA/ ionomycin blasts did not induce any 
detectable IL-2 output (figure 5.2). Combined with the previous results this appeared to 
indicate that B7 alone could drive proliferation in these cells but that additional signals 
were required for the production of IL-2. Although not as great as that observed with 
DR4-SEA or PMA and ionomycin, the B7 induced proliferation was significant and 
highly reproducible. Furthermore it provided the opportunity to investigate the CD28- 
driven signalling pathway in relative isolation without interference from TCR derived 
signals. This response to B7 alone appeared to be specific to T cell blasts and was not 
observed with either the Jurkats or resting T cells.
The lack of IL-2 production following B7 stimulation of the SEA blasts was an 
interesting if unexpected observation since IL-2 is known to be the main T cell 
proliferative cytokine and stimulation with PMA and ionomycin did result in IL-2 output. 
Furthermore, unlike the PMA/ ionomycin blasts, investigation of the B7 induced 
responses at day 4 still revealed no detectable IL-2 output from the cells despite their 
expression of IL-2 R a  (CD25). It was proposed that either the cells were producing very 
low levels of IL-2 which was just sufficient for autocrine proliferation and hence rapidly 
internalised or that they may have been producing an alternative cytokine such as IL-4 
which is also known to cause proliferation in T cells. An IL-2 ELISA was carried out on 
cell supernatants to check for low levels of cytokine production whilst an IL-4 ELISA 
was also carried out to investigate the possible production of this cytokine. The standard 
curves for the assays are shown in figures 5.3A and B respectively whilst the sample 
readings are tabulated below (Table VI). However, IL-2 was only detected in the 
supernatant of the PMA and ionomycin stimulated blasts whilst no IL-4 could be 
detected in the supernatant samples of either B7 or PMA / ionomycin stimulated blasts.
Table (VI) Cytokine concentration in sample supernatants measured by ELISA
IL-2 IL-4
PM A+IONOM Y CIN 20.7ng/ml 0
B7 0 0
In an attempt to discover whether the proliferation was indeed mediated by a soluble 
factor a test proliferation involving the addition of supernatant from B7-stimulated and 
SEA-pulsed DR4/B7 SEA blasts to unstimulated blasts was set up. Unfortunately no 
significant proliferation in the set of cells which received the B7-stimulated blasts 
supernatant was observed as shown in figure 5.4 although proliferation was observed
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with the PMA/ionomycin and DR4/B7-SEA supernatants. The interpretation of this 
result was difficult as it could either indicate a cell to cell contact mediated effect or a 
soluble mediated effect which required direct stimulation of the cell to upregulate the 
required receptor. Further investigation of the B7 response will therefore be required.
It became evident that the responses seen when using the SEA blasts changed 
significantly depending upon the period elapsed since their last antigenic rechallenge. Up 
to day 4 after restimulation the blasts were proliferating maximally and further 
stimulation had little effect. During days 4-10 the blasts could be induced to proliferate to 
a single stimulus such as aCD3, PMA and B7 alone but basal proliferation remained 
high until day 7. After day 10 the blasts began to lose their ability to respond to B7 alone 
and by day 12 required full restimulation to maintain long term viability. These data are 
summarised in figure 5.5 which shows the timecourse of B7 stimulation. The fact that the 
blasts could proliferate to PMA and ionomycin on day 12 showed they had not lost 
viability at this time but that the B7 stimulation alone was no longer sufficient to drive 
proliferation.
These data demonstrated that, although not a exact representation of a resting T cell, the 
quiescent SEA blasts appeared to be a good physiological model in which to investigate 
T cell stimulation. Although the blasts could be activated by stimulation through the 
TCR alone this was enhanced in the presence of B7 costimulation. The ability of the 
SEA blasts to respond to B7 alone also provided an opportunity for further investigation 
of the CD28 signalling pathway independently of TCR signals making the model an 
extremely useful laboratory tool in the elucidation of T cell activation mechanisms.
5.2 TRANSCRIPTION FACTOR INDUCTION
Despite a failure to detect IL-2 output from the B7-stimulated blasts the induced 
proliferation implied the activation of downstream CD28 signalling pathways. 
Furthermore an increase in IL-2 output was observed in the DR4/B7-SEA stimulated 
blasts compared to the DR4-SEA stimulated blasts therefore a pertinent question seemed 
to be whether this involved an effect on transcription factor induction. Gel shift assays 
were therefore carried out to assess the differences of these stimulations. Unlike the 
problems encountered when using the PMA/ ionomycin blasts, however, it was found to 
be possible to quiesce the SEA-stimulated T cell blasts after antigenic challenge. 
Therefore whilst transcription factor analysis from unstimulated cells at day 4 revealed 
high levels of all three of the transcription factors studied which were not visibly altered 
by stimulation of the cells, when retested at day 8, basal levels were found to be very low 
and full restimulation of the cells using PMA and ionomycin resulted in a strong 
observable induction (figure 5.6).
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Day 10 blasts were chosen to ensure maximum cell numbers and low basal activity. 
These were stimulated with fixed DR4 and DR4/B7 transfectants pulsed with SEA or B7 
transfectants alone and nuclear extracts prepared. Proliferation and IL-2 assays were 
carried out in parallel to assess the effectiveness of the stimulations. The outcome of this 
assay is shown in figure 5.7. As expected the CHO control stimulation of the cells had no 
effect, resulting in basal expression levels of the three transcription factors, however, 
both DR4-SEA and DR4/B7-SEA stimulations caused maximal induction. This indicated 
that superantigen stimulation was capable of providing sufficient stimulation through the 
TCR in the absence of any costimulation. Interestingly B7 stimulation alone resulted in 
the generation of AP-1 and NFkB but did not induce NFAT. A comparison of these 
results with those obtained from the proliferation and IL-2 studies revealed an interesting 
correlation. Basal proliferation as observed in the CHO stimulated cells was very low 
whilst that induced by DR4-SEA and DR4/B7-SEA stimulation was maximal, the 
presence of B7 in the latter appearing to have only a minimal effect. The proliferation 
observed following B7 stimulation alone, although above basal levels, was fairly 
insignificant compared to TCR stimulation. This was in agreement with initial 
proliferation studies which indicated that by day 10 the ability of B7 to induce a response 
was downregulated, however it could clearly still induce transcription factor generation 
and some proliferation (figure 5.8A). Results from the IL-2 assay revealed that whilst 
EL-2 was produced by both DR4-SEA and DR4/B7-SEA stimulations the output from the 
latter was considerably greater indicating a costimulatory role for B7 in IL-2 generation. 
Furthermore the absence of IL-2 production in CHO and B7 stimulated cells correlated 
with an absence of NFAT production. This implied that NFAT induction may play a 
crucial role in IL-2 gene transcription (figure 5.8B).
The absence of NFAT induction indicated that the B7 stimulation was specifically 
activating the CD28 costimulatory pathway and not delivering a global stimulation as 
was seen with PMA and ionomycin and further supports the finding that normal T cells 
require two signals for full activation. The identification of AP-1 and NFkB as two 
downstream targets of CD28 activation which could be induced in the absence of 
concomitant TCR ligation provided a useful end point to investigate the signalling 
pathways associated with CD28. Further investigation revealed that inducibility of 
factors by B7 no longer occurred after day 12 post antigenic challenge. All experiments 
were therefore carried out on blasts between day 8 and 10 post antigenic challenge.
5.3 INVESTIGATION OF CD28 SIGNALLING PATHWAYS
Since CD28 signalling has been reported to involve the enzymes PI3 Kinase and acidic 
sphingomyelinase, inhibitors of these enzymes were investigated. Wortmannin was used
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to inhibit PI3 Kinase activity whilst the lysosomotropic, alkalating agent chloroquine 
was used to inhibit acidic sphingomyelinase activation.
Wortmannin is a fungal metabolite which acts by irreversibly binding and hence 
blocking the pi 10 catalytic subunit of PI3 Kinase. However, previous studies have 
shown that in the presence of wortmannin PI3 Kinase association with CD28 is still 
observed. At high concentrations (> lpM) wortmannin has been found to inhibit other 
enzymes but below this concentration it is thought to be specific for PI3 Kinase. Its 
action is very rapid and will induce a complete block within 15 minutes however, the 
half life of the compound in aqueous solution is extremely short (< 4 hours). Since the 
enzyme inhibition is irreversible, overcoming wortmannin treatment requires new 
enzyme synthesis, the rate of which appears to parallel the proliferation rate of the cell. 
Figure 5.9 shows the effect of a wortmannin titration on the proliferation of resting T 
cells costimulated with aCD3 and CHO-B7 transfectants. Although the inhibition was 
not absolute at doses of lOOnM it was clear that the extent of the inhibition of 
proliferation was dose dependent. When repeated using the SEA blasts and Jurkat cells, 
however, it was found that wortmannin had very little effect on proliferation (figure 
5.10). Slight inhibition was noted in the basal proliferation of the quiescent blasts which 
increased to an approximate 25% inhibition in the B7 stimulated cells. This may 
indicate some involvement of PI3 Kinase but it does not appear to be essential. 
Wortmannin had even less effect on Jurkat proliferation but appeared to affect the basal 
proliferation rate to a slightly greater extent than the B7 stimulated cells.
Since JNK and hence AP-1 activation are proposed to be associated downstream 
signalling events of PI3 Kinase its activation was implicated in the induction of AP-1 
by B7. The failure of wortmannin to inhibit B7 induced proliferation in the SEA blasts 
therefore made the role of PI3 Kinase in these T cells difficult to assess. A biochemical 
assay was carried out to investigate the regulation of JNK activation in the T cell blasts 
and to test its sensitivity to inhibition by wortmannin. Figure 5.11A shows evidence of 
enzyme activity in Jurkat cells activated by U.V. light whilst figure 5.1 IB shows the 
phosphorylated GST-jun product in B7 stimulated T cell blasts.
Since CD28 signalling has also been proposed to involve the activation of acidic 
sphingomyelinase, the role of this enzyme was also investigated. Low dose chloroquine 
was extremely effective at inhibiting the B7 induced proliferative response (figure 5.12) 
although higher doses were found to be cytotoxic over long periods of time 
(>24 hours). The ability of B7 stimulation to directly activate acidic sphingomyelinase 
in the SEA T cell blasts was also investigated using a biochemical assay to measure 
enzymatic activity. Figure 5.13 shows the percentage increase in enzyme 
activity above basal levels ( around 700cpm) following B7 stimulation over time as 
measured by the generation of 14C radiolabelled phosphorylcholine
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a substrate of the hydrolysis reaction and which was inhibited by preincubation of the 
cells with chloroquine. This did not occur in SEA T cell blasts stimulated with aCD3 
indicating it was a specific response involving activation of the costimulatory pathway. 
However, since DR4-SEA stimulation seemed to be capable of activating the T cell 
blasts the effect of this stimulus on enzymatic activity was also investigated. No 
induction was observed using DR4 cells in the absence of antigen but did occur when 
cells were stimulated with DR4-SEA or DR4/B7-SEA (figure 5.14). These results 
indicate that SEA and aCD3 do not provide comparative signals and that the SEA may 
also activate at least some aspects of the costimulatory signalling pathway.
Having established that B7 stimulation of the T cell blasts did indeed activate 
sphingomyelinase and may have been activating downstream targets of PI3 Kinase and 
and that these pathways could be blocked effectively with chloroquine and wortmannin 
respectively the next step was to assess the effect of these inhibitors directly on the 
induction of the AP-1 and NFkB transcription factors. Gel shift assays were performed 
using nuclear extracts prepared from cells incubated with the relevant inhibitor prior to 
B7 stimulation. Figures 5.15(A) and (B) show the outcome of these assays. Whilst NFkB 
induction was unaffected by wortmannin it was completely inhibited by preincubation of 
the cells with chloroquine. In contrast AP-1 induction was partially inhibited by 
wortmannin but demonstrated variable sensitivity to chloroquine. Whilst no effect was 
seen with chloroquine in some assays (B(i)) others resulted in partial or complete 
inhibition of AP-1 (B(ii)). The present data therefore indicate that whilst PI3 Kinase may 
be involved in the induction of AP-1, sphingomyelinase appeared to regulate both AP-l 
and NF kB.
As wortmannin did not appear to have a significant effect on the B7-induced 
proliferation in T cell blasts and activation of the sphingomyelinase pathway alone is 
reported to induce apoptosis, the involvement of additional " survival" signals in the 
generation of proliferation and IL-2 production was implicated. Other signalling 
molecules which may have been involved in the B7 induced activation and which were 
investigated were S6 kinase, PKC enzymes and calcium (figure 5.16). Although S6 
kinase has been proposed as a possible downstream target of PI3 kinase, unlike 
wortmannin, rapamycin, a known inhibitor of S6 kinase activation, did produce a 
dramatic inhibition of B7-induced proliferation in the T cell blasts. However, since it also 
induced an inhibition of basal proliferation this may be related to an inhibition of cell 
cycle progression. The involvement of PKC enzymes were investigated by preincubation 
of the cells with the PKC inhibitor Ro 31-8220 which slightly reduced the basal 
proliferation levels in the T cell blasts but significantly inhibited the B7 stimulated 
response. This indicated that either a PKC enzyme is a downstream target of CD28 
signalling or that a PKC-derived signal is required to synergise with the CD28 signals to
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produce the observed B7 response. Finally, despite CD28 signal transduction being 
reported as calcium independent, inclusion of CsA, which blocks calcineurin activation 
by the calcium / calmodulin complex, did inhibit the B7-induced proliferation in blasts 
whilst having negligible effects on basal turnover. Furthermore an interesting observation 
was noted when the effects of CsA were examined on B7-costimulated PMA/ionomycin- 
treated SEA blasts. Both the PMA/ionomycin induced proliferation and IL-2 output were 
found to be completely abrogated following CsA treatment as would be expected due to 
the inhibition of the ionomycin-mediated calcium signal. However, whilst the presence 
of CHO cells had no effect on these results, the CsA inhibition was substantially reversed 
in the presence of B7 transfectants (figure 5.17(A)). This indicated that the synergy of the 
PMA and B7 signals could overcome or bypass the CsA block. Similar responses were 
observed for IL-2 output although the B7-induced recovery was less complete.
Unfortunately there was insufficient time to assess the relative contributions of these 
other signalling pathways, as inhibited by rapamycin, Ro 31-8220 and cyclosporin A, on 
the B7 mediated transcription factor induction and which will therefore require further 
study in the future.
5.4 SUMMARY
Using the B7 responsive SEA blasts as a model of resting T cells has provided some 
significant new information on the role of CD28 in T cell activation and the signalling 
pathways it eniploys to undertake this role. The response to B7 alone was shown to be
i
time dependent indicating a requirement of some prior activation of the cell but since no 
NFAT complexes or IL-2 production were observed this appeared to discount a fully 
activated TCR pathway. Furthermore although CD28 signalling is reported to be calcium 
independent the B7 response was inhibited by cyclosporin A and yet B7 stimulation in 
conjunction with PMA and ionomycin could significantly overcome the cyclosporin A 
block of calcium signalling to induce IL-2 production. Finally CD28 activation was 
shown to induce the AP-1 and NFkB transcription factor complexes via activation of the 
PI3 Kinase and acidic sphingomyelinase signalling pathways although further 
investigation will be required to discover the exact mechanisms and control points of 
these pathways.
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Figure 5.0 Effect of costimulation on superantigen induced activation of T cell blasts
Day 8 SEA T cell blasts were left unstimulated or were incubated with CHO-DR4 
transfectants pulsed with SEA (lOng/ml) alone or in the presence of cotransfected 
B7 for 72 hours. Proliferation (A) was measured by -^H-Thymidine incorporation 
whilst IL-2 production (B) was assessed using a CTLL bioassay. Data are the 











Figure 5.1 Effect of costimulation on mitogen induced activation of  T cell blasts
Day 8 SEA T cell blasts were left unstimulated or were incubated with PMA 
(0.3ng/ml) and ionomycin ( lf iM ) alone or in the presence of fixed CHO cells or 
fixed B7 cells for 72 hours. Proliferation (A) was measured by 3H -T h y m id in e  
incorporation whilst IL-2 production (B) was assessed using a CTLL bioassay. Data 





Figure 5.2 Effect o f  CHO-B7 on the proliferation and IL-2 production in T  cell 
blasts
Day 8 SEA T cell blasts were left unstimulated or were incubated with fixed CHO 
cells or fixed B7 cells for 72 hours. Proliferation (A) was m easured by 3H - 
Thymidine incorporation whilst IL-2 production (B) was assessed using a CTLL 
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Figure 5.3 Cytokine standard curves for ELISA
ELISA calibration curves were prepared by serial dilution of  recombinant IL-2 (A) and 






Figure 5.4 Induction of proliferation in SEA blasts by supernatant transfer
Day 8 SEA blasts were incubated in a 96 well plate with media (UNSTIM ), CHO-B7 
transfectants (B7), PMA (0.3ng/ml) and ionomycin ( l j iM ) (P+I) or D R4/B7-SEA for 
24 hours (A). Aliquots of supernatant werethen removed from these wells and added to 
fresh unstimulated blasts (B). Labels represent origin of  supernatant. After a further 
48 hours the proliferation of  both sets o f  blasts were analysed by 3H - T h y m id in e  





Figure 5.5 A timecourse of B7-induced stimulation of T cell blasts
SEA T cell blasts, taken from culture at the specified day after the last restimulation 
and were left unstimulated or were incubated with fixed CHO cells , fixed B7 cells 
or PMA(0.3ng/ml) and ionomycin ( l p M )  for 24 hours. Proliferation (A) was 
measured by 3H-Thymidine incorporation whilst IL-2 production (B) was assessed 








Figure 5.6 Induction of transcription factor complexes.
Nuclear extracts were prepared from unstimulated (U) and PMA (0.3ng/ml) /  ionomycin 
( lp M )  stimulated Day 8 SEA T cell blasts and were analysed for the production of 
NFAT, AP-1 and N F kB complexes.These were visualised by autoradiography following 
an overnight exposure o f  the gel.
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Figure 5.7 Induction of transcription factor complexes.
Nuclear extracts were prepared from CHO, DR4-SEA, DR4/B7-SEA and B7 stimulated 
Day 10 SEA T cell blasts and were analysed for the production of NFAT, AP I and 
N F kB complexes.These were visualised by autoradiography following an overnight 
exposure of the gel.
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Figure 5.8 Proliferation and IL-2 production in stimulated T cell blasts
Aliquots of Day 8 SEA T cell blasts were taken from the incubated cultures o f  cells 
prior to the preparation o f  nuclear extracts and the cells were then incubated for a 
further 24 hours. Proliferation (A) of these aliquots was measured by ^H-Thymidine 
incorporation whilst IL-2 production (B) was assessed using a CTLL bioassay. Data 
are the triplicate mean of a representative experiment.
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Figure 5.9 Effect of Wortmannin on the proliferation of resting T cells
Resting T cells were preincubated for 30 minutes with media or wortm annin  
(lOOnM). The cells were then placed in media or were incubated with a C D 3  
(lf ig /m l) alone or in the presence o f  fixed B7 cells for 24 hours. Proliferation was 














Figure 5.10 Effect o f  Wortmannin on the proliferation of T  cell blasts and Jurkat 
cells
Day 8 SEA T cell blasts (A) and Jurkat cells (B) were preincubated for 30 minutes 
with media or wortmannin (lOOnM) and were then placed in media alone or were 
incubated with fixed B7 cells for 24 hours. Proliferation was m easured by 
3H-Thymidine incorporation and data are the triplicate mean of  a representative 
experiment.
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Figure 5.11 Induction of JNK activity
Jurkat cells were exposed to U.V. light for the time specified (A) whilst Day 8 SEA 
blasts were left unstimulated or were incubated with CHO-B7 transfectants for 1 hour 





Figure 5.12 Effect of Chloroquine on the B7-induced proliferation in T cell blasts
The SEA T cell blasts were preincubated for 1 hour with media or chloroquine at the 
concentrations specified. The cells were then placed in media alone or were 
incubated with fixed B7 cells for 24 hours. Proliferation was m easured by 
































Figure 5.13 Induction of sphingomyelinase activity in B7 and aCD3 stimulated SEA T 
cell blasts
SEA T cell blasts were preincubated for 1 hour in serum free media alone or in the 
presence of chloroquine (200p,M) prior to incubation with CHO-B7 cells (A) or aCD3 
(l|ig/ml)(B) for the time specified. The cells were then washed and cytoplasmic extracts 
were prepared. Enzymatic activity in the extracts was assessed using an in vitro 
biochemical assay as detailed in the methods section and measured by (3 liquid 
scintillation counting. The graph shows percentage enzyme activity as a factor of 
stimulation time in the presence an absence of chloroquine. Basal counts were typically 
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Figure 5.14 Induction of sphingomyelinase activity in DR4 / DR4-SEA stimulated T cell 
blasts
SEA T cell blasts were preincubated for 1 hour in serum free media alone or in the 
presence of chloroquine (200|iM) prior to incubation with fixed DR4 or fixed DR4-SEA 
transfectant cells for the time specified. The cells were then washed and cytoplasmic 
extracts were prepared. Enzymatic activity in the extracts was assessed using an in vitro  
biochem ical assay as detailed in the m ethods section and m easured by (3 liquid 
scintillation counting. The graph shows enzyme activity as a factor of stimulation time in 
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Figure 5.15 Effect of wortmannin and chloroquine on B7 generated transcription factor 
induction.
Day 8 SEA T cell blasts were preincubated for one hour in media (B7), wortmannin 
( lOOnM) (B7+W) or chloroquine (50|iM) (B7+CQ) prior to a four hour stimulation with 
B7 transfectants. Nuclear extracts were prepared and analysed for NFkB (A) or AP-1 (B) 
induction. AP-1 demonstrated a variable inhibition to chloroquine (B(i) and B(ii)). The 
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Figure 5.16 Effect of various inhibitors on the B7-induced proliferation in T cell 
blasts
The SEA T cell blasts were preincubated for 1 hour with media, rapamycin (lOnM), 
Ro 31-8220 ( l | iM )  or cyclosporin A (5|ig/ml). The cells were then placed in media 
alone or were incubated with fixed B7 cells for 24 hours. Proliferation was measured 
by 3H-Thymidine incorporation and data are the triplicate mean of a representative 
experiment. . ^ .
Figure 5.17 Effect o f  costimulation on cyclosporin A-inhibited, mitogen-stimulated 
T  cell blasts
SEA T cell blasts were preincubated for 1 hour with media or cyclosporin A 
(5pg/ml). The cells were then placed in media or were incubated PMA (0.3ng/ml) 
and ionomycin ( lp M )  alone or with Fixed B7 cells for 24 hours. Proliferation (A) 
was measured by 3H-Thymidine incorporation whilst IL-2 production (B) was 
assessed using a CTLL bioassay. Data are the triplicate mean of a representative 
experiment.
5.5 DISCUSSION
Whilst the effects of costimulation on the responses of PMA/ ionomycin activated T cell 
blasts could be observed in proliferation and IL-2 assays it was not possible to detect any 
qualitative or quantitative differences in the transcription factor assays. Therefore other 
methods of generating T cell blasts, which did not result in such a prolonged activated 
phenotype, were investigated. It was found that T cell blasts induced with superantigen 
generated large numbers of cells which could easily be quiesced and then fully 
reactivated with antigenic and costimulatory signals, therefore mimicking a resting 
peripheral blood T cell. Although superantigen stimulation does not exhibit the same 
TCR restriction as observed with natural antigenic peptides, it is still dependent upon the 
a p  chains of the T cell receptor (Kappler et al., 1989) and therefore shows MHC 
dependence and antigen specificity in the activation of T cells.
The requirement for costimulation of superantigen challenged T cells has been a matter 
of some debate. Whilst Damle et al (Damle et al., 1993) proposed the activation was 
costimulation independent as indicated by the failure of a CTLA-4 Ig to inhibit 
superantigen driven proliferation, other groups have found that antibodies directed 
against the CD lla/ CD18 integrin pair did inhibit the stimulation (Fischer et al., 1992). 
However, this could possibly be due to a requirement for integrin binding to bring the 
two cells close enough for the superantigen to cross link the MHC and TCR. Data, 
obtained during restimulation of the T cell blasts, indicated that superantigen presented 
by HLA-DR was sufficient for both proliferation and IL-2 production but that addition of 
B7 as a costimulatory molecule, whilst minimally affecting proliferation, considerably 
enhanced IL-2 production. This may suggest that superantigens are capable of providing 
some costimulatory signals (Damle et al., 1993) and in keeping with the observation that 
MHC-superantigen complexes can also stimulate proliferation in resting T cells (Sansom 
et al., 1993). This raises the question of which in vitro TCR stimulus provides the most 
physiological signals. It has become evident that the signals resulting from a peptide 
encounter do not equate with those induced by superantigen binding nor those arising 
from aCD3 crosslinking or stimulation of the cell with PMA and ionomycin. Data 
obtained from CD28 knockout mice indicate that in the absence of CD28 it is possible to 
initiate but not sustain an immune response. Thus stimuli such as aCD3 which require 
costimulation to initiate a response may not be fully activating the TCR. My data, in 
agreement with other reports, has shown that whilst superantigen stimulation alone 
appears adequate to initiate activation in these cells, further costimulation may be 
required for sufficient IL-2 production and long term survival of the culture. Thus 
superantigen stimulation which ligates the a p  chains of the TCR may be more 
physiologically relevant than crosslinking aCD3 and whilst this SEA T cell blast model 
does not appear to respond to aCD3 stimulation exactly like a resting T cell the latter
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may not actually be a physiologically relevant response. Furthermore there are several 
advantages of this model compared to resting cells and the frequently used T cell model, 
Jurkat cells. The T cell blasts have a normal phenotype, are not transformed and undergo 
normal activation and reactivation cycles which are dependent upon IL-2 and 
costimulatory signals. Thus they are normal cycling, activated T cells and repond as 
such. Furthermore the cells can be quiesced to reduce their basal responses and then 
activated by B7 stimulation alone to enable the observation of the costimulatory signals 
in isolation, independently of TCR derived signals.
In this study it was demonstrated that B7 stimulation of quiescent SEA blasts activated 
both the PI3 Kinase and acidic sphingomyelinase signalling pathways and induced AP-1 
and NFkB transcription factor complexes. Since these effects were not observed in 
resting cells, this indicates that the B7-induced responses may be due to a synergy 
between the CD28-mediated signals and other signals generated during the full activation 
of the cells 8-10 days previous. This observation is in agreement with other reports which 
state that there can be a delay between the first and second signals which will still result 
in full activation of the cells (Vandenburghe et al., 1992; Lu et al., 1992;) and is further 
supported by the observation that the B7 response is time dependent. However, due to 
the lack of NFAT and IL-2 production this implies that a fully activated TCR pathway is 
not a characteristic of these cells and the identity of the signal synergising with the B7 
induced signal still needs further investigation. Data obtained from the enzyme inhibitor 
studies indicated that both PKC and and an active calcium pathway were involved in the 
B7 mediated responses. However, since CD28 signalling is proposed to be cyclosporin A 
insensitive (June et al., 1987) it is possible that a preactivated calcium pathway may be 
involved.
The observation that B7 could partially abrogate the cyclosporin-induced inhibition of 
PMA/ ionomycin stimulated proliferation and IL-2 production in the T cell blasts is 
somewhat surprising and indicates that either in the presence of PMA and B7 calcineurin 
is not required for T cell function or that the signals from the activated PKC enzyme 
enable the synergy of the TCR and costimulatory pathways to occur downstream of 
calcineurin. More information on the pathways involved may be gained from the 
assessment of NFAT induction in such a situation since this has been shown to be 
dependent upon the activation of calcineurin and hence its downstream effects.
The role of PKC is a little more difficult to decipher since the existence of various 
isotypes each having varying sensitivities to PMA and calcium and different positive and 
negative regulatory targets (Hug and Sarre, 1993) makes the delineation of the pathways 
extremely complex. Previous observations made following the activation of Jurkat cells 
with PMA has only served to confuse the issue since I have now shown that the
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responses induced by this agent are completely different in Jurkats compared to T cell 
blasts and resting T cells. Currently without the aid of specific isotype activators and 
inhibitors it is not possible to distinguish TCR-activated PKC from that regulated by 
other signalling pathways. In future studies it may be possible to investigate the role of 
PKC using Jurkat cells with dominant negative or constitutively activated PKC isotypes.
The response to the B7 stimulation of quiesced SEA blasts was an induction of 
proliferation but not of detectable IL-2 production. This appears to indicate discordancy 
of proliferation and IL-2 production and may imply that either they are regulated by two 
different signalling pathways or that whilst for proliferation the CD28 signal is limiting 
in this model, IL-2 production requires concomitant activation of both the TCR and 
CD28 pathways. Whether or not either proves to be correct, one possibility is that the 
observed proliferation may be being driven by another cytokine other than IL-2. 
Although it is currently accepted that IL-2 is the main T cell proliferative cytokine other 
cytokines such as IL-4, IL-6 and IL-7 can induce proliferation but appear to affect only 
specific subsets, however, it is possible that the cytokine output from T cells changes as 
activation occurs. Since such a stimulation did not induce NFAT it is perhaps not 
surprising that no IL-2 was observed and may thus point to the production of a non- 
NFAT regulated cytokine.
Previous reports of downstream targets of CD28 signalling have largely concentrated on 
its ability to increase gene transcription by mechanisms of mRNA stabilisation (Lindsten 
et al., 1989a) and induction of a specific regulatory transcription factor CD28RC. First 
identified by Fraser and Weiss (1991) in PMA/ ionomycin/ aCD28 stimulated Jurkat 
cells, induction of this factor has since been shown to be independent of CD28 receptor 
ligation although this does not preclude activation of the costimulatory pathway by the 
high dose of PMA. The characteristics of the CD28RC indicate it is mainly composed of 
the NFkB like Rel family members (Ghosh et al., 1993) although this is currently 
disputed by another group (Verweij, personal communication). This, in combination with 
reports that CD28 ligation could increase translocation of c-rel (Bryan et al., 1994) 
induced me to study the effects of CD28 ligation on transcription factor induction in my 
SEA blast T cell model. Since these cells could be induced to produce IL-2 when 
stimulated with DR4-SEA and DR4/B7-SEA but not with B7 alone, a comparison of IL- 
2 gene promoter transcription factor induction was made in these stimulated cells. 
Interestingly whilst the DR4-SEA and DR4/ B7-SEA stimulations induced all three 
transcription factor complexes studied, NFAT, NFkB and AP-1, B7 stimulation alone 
was found to upregulate NFkB and AP-1 but not NFAT.
The induction of NFkB following B7 stimulation of the resting SEA blasts indicates that 
this signal is sufficient to release the NFkB complex from its inhibitory protein IkB.
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Although previous reports have shown the ability of CD28 derived signals to increase c- 
rel translocation in the presence of PMA the effects of CD28 stimulation alone were not 
investigated. This may indicate that in these blasts the non-CD28, PMA-regulated 
pathway is still active and that the signals originating from the B7 stimulation synergise 
with this to induce an NFkB DNA binding complex. My data has shown this induction to 
be mediated via activation of acidic sphingomyelinase due to the inhibition of NFkB 
induction by chloroquine. Recently Cifone et al (1995) reported that acidic 
sphingomyelinase could be activated by DAG produced from the the action of PLC on 
the membrane lipid phosphorylcholine and since PMA is a synthetic form of DAG this 
too may activate the acidic sphingomyelinase pathway. Furthermore in chapter 3 I 
proposed that high concentrations of PMA may activate the costimulatory pathway thus 
this proposed interaction of DAG with acidic sphingomyelinase suggests a possible 
target for this activation. Previous reports have indicated that ceramide generated from 
sphingomyelin by the sphingomyelinase enzyme mediates an effect on NFkB via 
activation of PKC £ (Muller et al., 1995b; Lozano et al., 1994). However, as this isotype 
is supposedly insensitive to PMA this cannot be the control point for the PMA regulation 
of the pathway and further investigations will be required to determine the point of 
synergy of the two signals.
Similar conclusions may be drawn from the B7 stimulated induction of AP-1. This shows 
that CD28 signalling is linked to AP-1 production but does not indicate whether this 
occurs alone or in synergy with a second active signal in these cells. It has been shown 
that B7 stimulation of the blasts induced JNK activity. Whilst previous reports 
demonstrated that PMA or aCD28 alone were insufficient to fully activate JNK in 
combination full activation of the kinase was observed (Su et al., 1994). However, since 
JNK activation only regulates c-jun a second signal would also be required to activate c- 
fos in order to generate a complete AP-1 complex. Thus it appears in our model that the 
B7 stimulated signals arising from CD28 engagement are synergising with a previously 
activated pathway to induce AP-1 and NFkB activity. This highlights the importance of 
the costimulatory signal in the activation of T cells since it now appears that under 
physiological conditions in normal, untransformed cells, CD28 derived signals are 
required to synergistically activate the pathways leading to the induction of transcription 
factors which can then regulate gene expression. Since prior to this work the outcome of 
CD28 signals and the specific role they played in the activation of normal T cells was 
unknown, the discovery of AP-1 and NFkB induction is a considerable advancement. 
The failure of TCR-stimulated cells to induce EL-2 production can now be explained by a 
lack of functional transcription factors. Thus whilst TCR derived signals appear able to 
activate OCT and cause the translocation of the cytoplasmic subunit of NFAT, additional 
CD28-derived signals are required for the induction of NFkB and AP-1 which makes 
these crucial factors in the regulation of T cell activation. This has been previously
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shown by the effects of glucocorticoids which suppress AP-1 and NFkB activity 
(Auphan et al., 1995; Scheinman et al., 1995) and which were deemed to be more 
specific than the general immunosuppressants which target the calcium regulated NFAT 
pathway. Thus inhibition of the costimulatory signals seems to be a highly effective way 
of regulating T cell activation.
The activation of both the PI3Kinase and acidic sphingomyelinase pathways was also 
demonstrated following B7 stimulation of these SEA blasts in agreement with previous 
reports (Prasad et al., 1994; Pages et al., 1994; Boucher et al., 1995). However, it is not 
yet known whether in vivo both pathways are activated simultaneously or whether the 
signalling outcome of CD28 ligation is dependent upon other factors such as the 
activation state of the cell. My data suggested that whilst PI3 Kinase activation could be 
demonstrated in these cells, inhibition of kinase activity did not appear to significantly 
affect proliferation. Furthermore previous studies have shown an increase in IL-2 output 
from Jurkat cells and T cell blasts preincubated with wortmannin (Ueda et al., 1995). 
This is consistent with a separation of the proliferative and IL-2 pathways in activated T 
cells and also indicates that PI3 Kinase may play a role as a negative regulator of IL-2 
production. Very little is actually known concerning the downstream targets of the D-3 
phosphoinoside molecules generated following PI3 Kinase activation although recently 
reports of PI3 kinase regulation of PKB (Burgering and Coffer, 1995), PKC£ () and rac/ 
cdc42 (Hawkins et al., 1995) have emerged. Therefore contrary to the above data this 
potentially means that PI3 kinase can also directly regulate transcription factor induction 
as PKC£ induces NFkB and rac is upstream of JNK.
Identification of the two transcription factor targets of CD28 signalling provided a 
convenient end point for the further assessment of the involvement of the PI3 Kinase and 
acidic sphingomyelinase signalling pathways. The results indicate that whilst AP-1 is 
probably regulated by both enzymes, NFkB induction is controlled by acidic 
sphingomyelinase but is independent of PI3 Kinase. The reason for the observed 
variability in chloroquine-mediated inhibition of AP-1 is not known but may be 
dependent upon the exact activation state of the PI3 Kinase pathway at the time of the 
experiment since this provides an alternative induction mechanism. In the absence of PI3 
Kinase activation as implied by the relative insensitivity of the cells to wortmannin, AP-1 
is presumably induced via the sphingomyelinase pathway alone. However, with only one 
pathway inducing AP-1 synthesis instead of two this may result in a decrease in the total 
amount of AP-1 to below the threshold required for IL-2 gene transcription. This may 
result in a shift of the cytokine output away from IL-2 to a second cytokine with a lower 
AP-1 threshold. This is just one possible explanation for the observed lack of IL-2 output 
from these cells and has yet to be substantiated. However, this theory implies that in
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activated cells only the acidic sphingomyelinase pathway is necessary for IL-2 
costimulation.
What then is the role played by PI3 Kinase as in the above discussion it appears that all 
the effects of CD28 can be mediated via acidic sphingomyelinase ? The answer may lie 
in the downstream targets of PI3 Kinase. Since PI3 Kinase has been shown to mediate 
the activation of the cell cycle regulator S6 kinase one role for PI3 Kinase may be to 
coordinate entry into the cell cycle. Resting T cells are known to lie outside the cell cycle 
in Go and require full stimulation to progress to G i whereas the T cell blasts probably 
only quiesce to Gi which may explain their partially activated state and the apparent 
redundancy of PI3 Kinase in the activation of these T cells. However, PI3 Kinase may 
still have a role in the continued survival of activated T cells.
PI3 Kinase has always been considered as a pro-proliferative signal (Yao and Cooper, 
1995) and the sphingomyelinase product, ceramide maybe a mediator of apoptosis 
(reviewed by Pushkareva et al., 1995) so it is rather paradoxical that they should both be 
activated by a surface molecule whose major function is to stimulate proliferation. 
However, since activation of the acidic sphingomyelinase pathway alone is thought to 
induce apoptosis the role of PI3 Kinase in activated cells may be in the provision of 
synergistic signals to prevent apoptosis and promote cell survival via activation of PKB 
and S6 kinase. This suggests that even in activated cells both signalling pathways are 
required. In agreement with this are reports that B7-1 is capable of activating both 
pathways although data concerning the effects of B7-2 are awaited. However, since 
currently no great differences in stimulatory capabilities have been identified using the 
two different ligands and that recently Cai et al. (1995) have demonstrated B7-2 
association with PI3 Kinase it is likely that B7-2 may also activate both signalling 
pathways.
Interestingly, previous work has proposed CTLA-4 as a potent inducer of apoptosis 
(Gribben et al., 1995) supported by the observation that CTLA-4 knockout mice show 
extreme lymphoproliferative disorders (Waterhouse et al., 1995; Tivol et al., 1995) and 
possibly indicating activation of the sphingomyelinase pathway. However CTLA-4 has 
also been shown to interact with PI3 Kinase (Schneider et al., 1995) although this does 
not necessarily mean the pathway is active and the binding may be inhibitory. Thus the 
lack of inhibitory effect of wortmannin on proliferation and IL-2 production in activated 
cells does not exclude a role for PI3 Kinase in cell survival and indicates that different 
emphases may be placed on different signalling pathways dependent upon the activation 
state of the cell and the surface molecules involved in the activation.
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There are still many unanswered questions and further studies to investigate the 
interaction of the two CD28 mediated signalling pathways are obviously required. This 
work has shown that superantigen driven T cell blasts are a useful model for the 
investigation of these signalling pathways and may prove to be of further use yet in 
studies investigating the intracellular events associated with anergy and the CTLA-4 
mediated apoptotic effects.
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CHAPTER 6.0 - CONCLUSIONS
The aim of this work was to investigate the role of CD28 mediated signals in the 
activation of T lymphocytes with specific reference to the regulation of IL-2 gene 
transcription. This has been undertaken using a number of different techniques and cell 
types and has established several important points.
Whilst in resting cells the activation of CD28 is necessary to drive proliferation and IL-2 
production, in activated T cells CD28 signals alone can drive proliferation but do not 
result in the generation of IL-2, implying a separation of the two activation pathways. 
This questions the role of IL-2 as the main T cell proliferative cytokine in these cells and 
indicates there may be a change in the nature of the cytokine output from the cells after 
activation but this will require further investigation. One hypothesis derived from this is 
that whilst in resting T cells CD28 is required to generate IL-2 to launch the cells into the 
cell cycle, once activated, IL-2 is no longer required by the cells to maintain the activated 
state.
Although a number of papers have been published concerning the role of CD28 in T cell 
activation the majority of the previous work has been carried out in mitogenically 
activated transformed cell lines such as PMA stimulated Jurkat cells. However, this 
current work has shown that transformed cell lines such as Jurkat cells show substantially 
different responses to those of normal T cells. In addition to their constitutive, IL-2 
independent proliferation, stimuli such as PMA which can induce proliferation and IL-2 
output in normal T cells have been shown to inhibit the proliferation of Jurkat cells 
whilst stimulating IL-2 output. This provides further evidence for the divergence of 
proliferation and IL-2 production in activated cells and indicates that in Jurkat cells the 
proliferative pathway is inversely regulated by PMA.
Due to the large number of PKC isotypes and possible target sites, PMA can no longer be 
considered a useful and informative T cell activation stimulus. Contrary to just providing 
TCR related PKC signals, PMA now appears to have targets on a number of signalling 
pathways and the high doses of PMA normally used in activation experiments appear to 
result in the activation of several of these signalling pathways simultaneously. Thus the 
observed responses are the summation of the activation of multiple signalling pathways. 
The discovery that the specificity of the compound could be increased by reducing the 
concentration of PMA has improved its usefulness although further studies to identify the 
target sites are required.
This project has involved the development of an alternative model system for the 
investigation of the costimulatory pathway. The use of superantigen driven T cell blasts
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avoids many of the complications associated with the use of constitutively activated 
transformed cells whilst being more readily available than large numbers of resting T 
cells. The T cell blasts are a good physiological model of resting T cells in that they 
require two signals for full activation at the beginning and end of their cycle whilst 
during active cycling (day 4-12) they can be induced to proliferate in response to a single 
stimulus. However, this does not result in IL-2 production indicating that IL-2 
transcription is more tightly regulated and may require simultaneous activation of both 
the TCR and costimulatory signalling pathways. This correlates with the transcription 
factor production whereby in these activated cells CD28 signals can generate AP-1 and 
NFkB whilst additional TCR signals are required for the induction of NFAT.
This work confirmed that CD28 utilises both the PI3 Kinase and acidic 
sphingomyelinase signalling pathways although the present data suggests these two 
pathways may have different roles. Although PI3 Kinase was shown to regulate AP-1 
generation, the inhibition of this enzyme did not have a major effect on the proliferation 
of the T cell blasts whilst it did inhibit resting T cell function. I propose that the main 
role for PI3 Kinase may be in promoting the entry of resting cells into the cell cycle 
probably via activation of S6 kinase but that in activated cycling cells PI3 Kinase 
recruitment is not an absolute requirement. Interestingly whilst wortmannin had very 
little effect on the T cell blasts they were effectively inhibited by rapamycin thus in 
cycling cells a constitutive activation of the pathway between PI3 Kinase and TOR 
appears to occur. Since currently this position is proposed to be occupied by PKB this 
could prove to be a very important mediator of cell cycle and survival in activated cells.
Activation of acidic sphingomyelinase resulted in the generation of both NFkB and AP-1 
implying that this pathway may be important in the regulation of IL-2. This at first 
appears contradictory to the observations that other receptors, such as TNF and Fas, 
which activate this pathway are possible mediators of apoptosis. However, since the 
activation of acidic sphingomyelinase by CD28 occurs in parallel to an active PI3 Kinase 
" survival" pathway and usually occurs in the presence of a TCR signal the reconciliation 
of these data is likely to involve the relative balance between different signalling 
pathways and the synergism of activation signals which override the apoptotic 
mechanism.
This work has provided some new and interesting information concerning the possible 
roles for the different CD28-associated signalling pathways and has identified NFkB and 
AP-1 as two downstream targets of CD28 derived signals. However, even from these 
initial studies the complexity of the interacting pathways which mediate the activation 
process is evident. It is hoped that as improved T cell models are developed and our 
knowledge and understanding of the processes involved in T cell activation increase, the
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complexities will be resolved and rational manipulation of the immune system will be 
possible.
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CHAPTER 7.0 - FUTURE WORK
The work carried out represented a starting point for studies into the signalling 
mechanisms associated with CD28-mediated transcriptional activation and has identified 
a number of important questions which can now be addressed in future work.
1) If the use of mitogenically activated Jurkat cells is to be continued in studies of T cell 
activation it will be necessary to develop a greater understanding of the effects of PMA 
and the activation requirements and regulation of the intracellular signalling pathways of 
the Jurkat cells. Current data indicate that PMA may activate both the TCR -related 
MAPK pathway and the costimulatory regulated acidic sphingomyelinase pathway 
although there appears to be a difference in PMA sensitivity of the two pathways as 
shown by the differences in cell responses using high (both) and low (MAPK only) dose 
PMA. Although the involvement of PKC enzymes in TCR signalling is well known 
further investigations will be required to assess the involvement of PMA in the activation 
of the sphingomyelinase enzyme and direct activation of the downstream targets of 
ceramide such as NFkB and CAPK. Furthermore data acquired in the presence of the 
enzyme inhibitor chloroquine may provide further information on the sites of action of 
PMA.
2) Data acquired from Jurkat cell proliferation assays and the FACS analysis of cell cycle 
indicated that incubation of these cells with PMA resulted in cell death and that this was 
more significant at low dose PMA (ie activation of the TCR pathway in the absence of 
costimulatory pathway activation). Furthermore addition of B7 transfectants to PMA 
treated Jurkat cells did appear to partially restore their ability to proliferate indicating that 
activation of the costimulatory pathway may have a protective effect against apoptosis. 
FACS analysis of Jurkat cell cycle using a dose range of PMA in the presence and 
absence of B7 stimulation should therefore be carried out to further investigate this 
protective effect.
3) Further development of this project should involve a more in depth study of the 
relative roles of PI3 Kinase and acidic sphingomyelinase pathways in both T cell survival 
and in the induction of anergy and apoptosis. Rather than being distinct events it appears 
likely that a complex interplay of the various signalling pathways controls the final 
outcome of the individual T cell in response to a stimulus. A comparison of CD28 and 
CTLA-4 mediated intracellular signals may thus shed some light on the important 
regulatory molecules which control these outcomes and may help in our understanding of 
the regulation of T cell activation. In addition a comparison of the intracellular 
downstream signalling events induced by B7-2 as opposed to those observed with B7-1
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may provide further information on the roles of these molecules during the progression 
of T cell activation.
4) The failure to detect IL-2 production from the stimulated T cell blasts indicated that 
the B7 stimulus was insufficient to induce gene transcription and correlated with a lack 
of NFAT induction. However, at earlier time points (day 6) when the cells demonstrated 
high levels of basal proliferation and when gel shift assays revealed significant levels of 
all three transcription factors investigated it was still not possible to detect any IL-2 
output. However, at this time the cells may be producing minimal levels of IL-2, 
undetectable in the supernatant, which are just sufficient to maintain autocrine 
proliferation and this should be investigated using RT PCR analysis to detect the 
presence of IL-2 mRNA in these cells.
5) Previous studies of T cell activation have involved the use of many different stimuli to 
activate the TCR and current data now indicate that these may not be equivalent. 
Transcription factor analysis revealed that stimulation of the T cell blasts with DR4-SEA 
induced NFAT, AP-1 and NFkB transcription factors as did PMA and ionomycin 
implying an activation of both the TCR and costimulatory pathways. An interesting 
comparison would thus be the effects of aCD3 stimulation on transcription factor 
induction since this is not thought to activate the costimulatory pathway.
6) The observation that B7 could costimulate IL-2 production in PMA and ionomycin 
treated T cell blasts in the presence of cyclosporin A implied an interaction with or a 
bypass of the calcium/ calcineurin pathway although the mechanism of this is unknown. 
However, as the cytoplasmic component of NFAT is a specific downstream target of the 
calcium/ calcineurin pathway, the assessment of NFAT induction in these treated cells 
could provide useful information on the interaction of the TCR and costimulatory 
signalling pathways.
Unfortunately there was insufficient time to investigate these questions but as the assays 
have been established and the SEA T cell blasts shown to be a good physiological model 
it is hoped that this work may be developed further.
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APPENDIX 1 - CELL CULTURE MEDIA
1) RIO for T cell blasts and purified peripheral blood T cells
lx RPM I1640 
10% FCS
lOOU/ml Penicillin 
0.1 mg/ml Streptomycin 
2mM Glutamine
21 RIO for Jurkat cells
500mls(Life Technologies Cat. No.31870-025) 
50mls (Life Technologies Cat. No. 10108-074) 
5mis of lOOOOU/ml / lOmg/ml stock
(Life Technologies Cat. No.15140-114) 
5mls of 200mM stock
(Life Technologies (Cat No.25030-024)
50mls of lOx stock (Life Tech. Cat. No.22511-026) 
50mls
5mis of lOOOOU/ml / lOmg/ml stock




0.2% Sodium bicarbonate 15mls of 7.5% stock (Life Tech.Cat. No.25080-060)
0.015N Sodium hydroxide 0.8mls of 10N stock
2mM Glutamine 5mls of 200mM stock
(Life Technologies (Cat No.25030-024)
Milli Q H20  400mls




0.1 mg/ml Streptomycin 
0.4% Sodium bicarbonate 
ImM Sodium pyruvate 
lx Nucleosides (see below) 5mls of lOOx stock
55mls of lOx stock (Life Tech. Cat. No.12501-029) 
55mls
5mis of lOOOOU/ml / lOmg/ml stock 
28mls of 7.5% stock
5mls of lOOmM stock (Life Tech. Cat. No. 11360-039)
Milli-Q H20 400mls
41 Nucleosides












APPENDIX 2 - BUFFER SOLUTIONS
11 TRIS-EDTA (TE1 pH 8.0
lOx 0.4M Tris Base 48.4g
0.01MEDTA 3.72g
H20  to 1L
21 Tris-Borate-EDTA fTBEl pH 7.8 
lOx 0.445M Tris Base 54g
0.445M Boric Acid 27.5g
0.01MEDTA 3.72g
H20  to 1L
31 Tris Acetate EDTA (TAE1 pH 8.0 
lOx 0.4M Tris Base 48.44g
0.05MNaAc 4.1g
0.01M EDTA 3.72g
H20  to 1L
4) SDS Gel Running Buffer (TSG1 pH 8.3 
lx 25mM Tris Base 3.03g
192mM Glycine 14.42g
0.1%w/v SDS Ig___
H20  to 1L
5) Loading Buffer
6x 40% w/v sucrose 4g
0.25% w/v Bromophenol Blue 25mg
H20  to lOmls
61 Sample Buffer pH 6.8
lOOmM Tris HC1 0.12g
1% W/VSDS O.lg
0.2% w/vBromophenol Blue 0.02g
20% v/vglycerol 2mls
2.5% v/vp-Mercaptoethanol 0.25g
h 2o to lOmls
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APPENDIX 3 - GELS






1.5mls of lOx stock
5mls of 30% 37.5:1 acrylamide:bis stock 
300pl of 10% stock 
30pl (Sigma T8133) 
to 30mls




0.03% Ammonium Persulphate 
0.01% TEMED
h 2o
8.0mls of 1.5M stock pH 8.8
10.6mls of 30% 37.5:1 acrylamide: bis stock
0.32mls of 10% w/v stock
120pl of 10% stock
3Qul 
to 32mls
31 1% Agarose gel:-
1% agarose 1.5g
lxTAE 150mls
0.005% v/v Ethidium Bromide 7.5jil








15mls of lOx stock
30mls of 30% 19:1 bis: acrylamide stock




APPENDIX 4 - BACTERIA CULTURE





H20  to 1L
An alternative broth was prepared using Circle Gro (3.4%w/v) for cultures requiring a 
richer medium.
2) Agar plates
3.4% w/v Circle Gro 3.4g
2% w/y Agar 2g
H20  to 100 mis






H20  to 1L
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APPENDIX 5- PLASMID VECTORS AND CONSTRUCTS
1) pEe6 Expression Vector used for 
transfection o f surface antigens 
CH O cell hosts.
2) pCR3 Expression V ector used the 
for the subcloning o f the IL-2 into 
prom oter to generate the footprint 
probe.
S c u t-  a  a> ro Q  t  </> o
I  CO CD CO X C D U J UiQ. U JC D 2 X  X  <
3) pCA T Control Vector used in the 
transfection o f Jurkat cells to obtain 
constitutive CAT enzym e activity.
4) pGL2 Basic Vector into which 
were inserted multiple transcription 
factor binding sites to regulate 
the luciferase enzyme activity
Syr*r«<ic po M A) s^ v a i * 
rranscnpbonal p au se  see 
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